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Abstract
Inhibin is an ovarian glycoprotein which by definition causes the suppression of
gonadotropin production, preferentially that of FSH. In the sheep inhibin is secreted
by the ovary, but there is confusion as to the actual ovarian source(s). As well as
uncertainty over the source of inhibin, the physiological role of inhibin in the control of
gonadotropin secretion is unclear. It is well established that inhibin can suppress
pituitary FSH production, but the physiological importance of this action requires
further investigation. The main aims of the studies described in this thesis were firstly
to determine the source of inhibin from the ovary of the sheep, and secondly to
investigate the physiological role of inhibin in the control of gonadotropin production,
particularly that of FSH.
The source of ovarian inhibin production was investigated by measuring inhibin
secretion directly from the ovary in vivo, and by individual follicles in vitro. Inhibin
secretion did not differ between animals at different stages of the luteal and follicular
phase of the oestrous cycle. The secretion rate of inhibin was unaffected by the
presence or absence of luteal tissue suggestion that, in the sheep, the corpus luteum
does not produce significant quantities of inhibin. The results of these studies indicated
that, like oestradiol, the majority of inhibin is produced by large (> 3mm) antral
follicles. However, while most oestradiol was secreted by the large oestrogenic
follicle(s), a significant amount of inhibin was also produced by large non - oestrogenic
atretic follicles and by small antral follicles.
A series of experiments involving passive immunisation against inhibin and/or
oestradiol were then undertaken to investigate the relative importance of these two
hormones in the control of gonadotrophin production. Peripheral LH concentrations
were unaffected by immunisation against inhibin, and in further experiments
administration of inhibin in "steroid stripped" ovine follicular fluid was shown to have
no effect on the timing or magnitude of the oestradiol benzoate-induced LH surge in
ovariectomised ewes, or on the concentration of LH following acute ovariectomy. In
the passive immunisation studies, injection of antibodies to inhibin or oestradiol
resulted in a highly significant, though transitory rise in the peripheral plasma
concentration of FSH during both the luteal and follicular phases of the oestrous cycle,
while combined immunisation against both hormones resulted in a significantly larger
rise in FSH concentration of similar size to that seen following acute ovariectomy.
Furthermore, treatment with physiological quantities of inhibin or oestradiol was found
to partly prevent the rise in FSH concentration seen following acute ovariectomy, while
a combined treatment with both hormones completely prevented this rise. Finally,
immunisation against inhibin or oestradiol was shown to cause a large increase in the
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number of follicles per ovary, resulting in an increase in ovarian inhibin secretion
following immunisation against oestradiol, and an increase in ovarian oestradiol
secretion following immunisation against inhibin. These results indicate that inhibin
plays an important physiological role in the control of FSH secretion during both the
luteal and follicular stages of the sheep oestrous cycle, and suggest that inhibin and




1.1. The Ovine Oestrous Cycle
The oestrons cycle of the ewe lasts approximately 17 days, with oestrus
occurring on day 0 and ovulation on day 1. The cycle can be divided into a luteal
phase, lasting from day 2-13, and a follicular phase or periovulatory period lasting
from day 14 (3 days before oestrous) to ovulation on day 1.
1.1.1. The Luteal Phase
Following ovulation a corpus luteum forms which secretes increasing amounts
of progesterone as the luteal phase progresses, culminating in a plateau of progesterone
concentration between days 6 and 12 (Pant et al., 1977) (Fig. 1.1). Immediately
following ovulation no follicles > 2mm are present in the ovaries as a result of the
widespread atresia induced in all non ovulatory follicles > 2mm by the LH surge.
However, by day 2 or 3 one or two large antral follicles develop, as indicated by the
rise in the secretion rate of oestradiol (Hoist et al., 1972), and from this time on
fluctuations in the secretion of oestradiol and androgens can be detected as large antral
follicles develop and undergo atresia (Turnbull et al., 1977). These fluctuations in
oestradiol secretion by developing follicles are accompanied by fluctuations in the
peripheral concentration of FSH, which is suppressed during periods of peak
oestradiol production. While the concentration of FSH shows no consistent trend
during the luteal phase, the concentration of LH gradually declines, reaching low levels
by day 13 (Fig. 1.1). The secretion of LH is pulsatile with pulses occurring at intervals
of approximately 3 - lOh during the luteal phase, each of these pulses of LH
stimulating the secretion of oestradiol and androgens by the ovary (Baird et al., 1976).
Pulses of LH are released from the pituitary in response to pulses of GnRH
from the hypothalamus, each pulse of LH in the peripheral plasma being preceded by a
pulse of GnRH in the blood of the hypothalamo - hypophyseal portal vessels (Clarke &
Cummins, 1982). FSH is also secreted by the pituitary, but unlike the secretion of LH,
FSH secretion does not appear to be pulsatile in the sheep. While the existence of a
separate releasing factor for FSH has been postulated the secretion of FSH is probably
under the control of GnRH. This idea is supported by the fact that neutralisation of
GnRH action on the pituitary by active immunisation (McNeilly et al., 1986), GnRH





Hormonal and follicular changes during the oestrous cycle of the ewe centred
around the onset of oestrus on day 0. Based on Baird & McNeilly (1981)
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(Clarke, 1987) results in a decline in FSH secretion. Furthermore, in hypothalamo -
pituitary disconnected sheep administration ofGnRFl stimulates secretion of FSH, this
secretion declining when treatment is stopped (Clarke et al., 1986). While active
immunisation against GnRH results in a decline in FSH secretion, passive
immunisation, while suppressing LH pulsatility, does not result in a decline in the
secretion of FSH, which remains constant, or may even rise due to the fall in the
secretion of oestradiol (McNeilly et al., 1984). Less than 10% of the pituitary content
of LH is released during each 24h period compared with 60 - 80% of the FSH content
(McNeilly, 1988), and so it appears that FSH secretion may be more closely related to
the rate of synthesis than that of LH, which depends on synthesis and release.
During the luteal phase LH secretion is regulated by the negative feedback of
progesterone and oestradiol, secreted by the ovary (Baird & Scaramuzzi, 1976a; Karsch
et al., 1977). Oestradiol appears to suppress LH pulse amplitude (Goodman & Karscv^
1980), while progesterone acts at the hypothalamic level to suppress LH pulse
frequency (Goodman & KarscV^SO; Goodman et al., 1981a). The idea that oestradiol
acts at the pituitary level to reduce pituitary responsiveness to GnRH is supported by
the fact that oestradiol treatment has been shown to reduce the pituitary response to
exogenous GnRH (Goodman & KarscV\1980), and in hypothalamo - pituitary
disconnected ewes GnRH secretion from the hypothalamus has been shown to
continue after exogenous oestradiol treatment, while LH secretion from the pituitary
ceases (Clarke & Cummins, 1987). This effect of progesterone appears to be exerted
on the hypothalamus as treatment with progesterone does not prevent the stimulation of
LH secetion by exogenous GnRH (Cumming et al., 1973a). During the luteal phase
oestradiol appears to enhance the ability of progesterone to suppress LH release
(Goodman et al., 1980), and so it seems that these two hormones act synergistically to
control LH secretion. While LH release is controlled by the interaction of progesterone
and oestradiol, FSH secretion is thought to be under the dual control of oestradiol and
inhibin (Martin et al., 1988), with progesterone playing little if any role.
Due to the presence of high concentrations of progesterone during the luteal
phase LH pulse frequency is maintained at a low level effectively reducing the
stimulation of follicular oestradiol production. As a result of this, while large antral
follicles are present throughout the luteal phase, ovulation does not occur as there is
insufficient oestradiol secretion to generate an LH surge. Progesterone also appears to
have a direct role in inhibiting the generation of an LH surge during the luteal phase as
the hormone has been shown to inhibit the positive feedback effect of oestradiol in
generating an LH surge in ovariectomised ewes (Scaramuzzi et al., 1971) and in
anoestrous ewes (Howland et al., 1978). This fact would help account for the inability
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of oestradiol to generate a preovulatory gonadotrophin surge until after luteal
regression.
Progesterone is also important in priming the uterus for PGF2a production
(Baird, 1978a), the feedback loop between the ovary and the uterus regulating the
length of the luteal phase. The low levels of LH on days 12-13 results in the corpus
luteum becoming increasingly sensitive to the luteolytic effects of this uterine PGF201
which in turn results in a decrease in progesterone production. This decline in
progesterone production then leads to an increase in uterine PGF2tt release. The
importance of PGF2a in luteal regression is demonstrated by the fact that active
immunisation against PGF2tt results in complete failure of luteal regression
(Scaramuzzi & Baird, 1976), while injections of PGF2a analogues have become
widely used as a method of inducing premature luteal regression. Oxytocin is produced
by the ovine corpus luteum (Wathes & Swann, 1982) and appears also to be involved
in the process of luteal regression. The importance of oxytocin in this process is
supported by the fact that both active (Sheldrick et al., 1980) and passive (Schams et
al., 1983) immunisation against oxytocin results in delayed luteal regression. It is
thought that oxytocin binds to newly developed receptors on the uterine endometrium
stimulating PGF2a production which in turn stimulates further oxytocin release.
Continuous infusion of oxytocin has been shown to prevent the induction of these
uterine receptors and hence delay luteal regression in the sheep (Flint & Sheldrick,
1985). Most ovarian oxytocin production occurs during the first half of the luteal phase
and the hormone is therefore thought to have other roles in the sheep including the
control of reproductive tract motility (Wathes, 1984). Oestradiol is probably also
involved in the process of luteal regression, injections of oestradiol during the mid
luteal phase resulting in premature luteal regression in the sheep (Hawk & Bolt, 1970).
Administration of oestradiol has been shown to stimulate uterine PGF2a production
(Hixon & Flint, 1987), resulting in inhibition of progesterone production and luteal
regression. While the exact mechanism underlying luteal regression remains uncertain,
it seems that luteal oxytocin, as well as perhaps oestradiol, stimulate the production of
uterine PGF2o, which appears to be the luteolytic factor in the sheep.
1.1.2. Luteal Regression to the LH Surge
As a result of the fall in progesterone concentration following luteal regression
there is an increase in LH pulse frequency up to around one pulse every hour (Baird,
1978b) and though pulse amplitude decreases there is also an increase in basal
concentration (Fig. 1.1). This increase in LH pulse frequency and/or basal
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concentration appears to be important in stimulating the large rise that is seen at this
time in the secretion of oestradiol by the the follicles destined to ovulate. Oestradiol
may, itself, also be involved in enhancing LH pulse frequency at this time (KarscMet
al., 1983). The rise in the secretion of oestradiol is accompanied by a smaller rise in the
secretion of androgens and so the oestogen to androgen ratio rises, presumably as a
result of increased aromatisation of androgen to oestradiol by the preovulatory
follicle(s). The importance of the fall in progesterone concentration in causing the rise
in LH and oestradiol secretion is supported by the observation that a sustained rise in
LH release does not occur until after progesterone levels begin to decline, and by the
fact that enucleation of the corpus luteum at various stages of the luteal phase, a process
which dramatically reduces peripheral plasma progesterone levels, induces this rise in
LH secretion. Furthermore, administration of progesterone at the time of luteal
regression, via a progesterone - releasing implant, prevents the rise in both LH
concentration and oestradiol secretion (Karscket al., 1979; Baird & Scaramuzzi, 1976).
Infusion of LH into the ovary via the ovarian artery results in a rapid increase in
oestradiol and androgen release (McCracken et al., 1969) providing evidence for the
role of LH in stimulating the follicular phase rise in oestradiol secretion. This idea is
supported by the finding that infusion of LH into anoestrous ewes at a rate similar to
the preovulatory rise in LH causes a rise in oestradiol secretion, and will elicit an LH
surge (Karsc^et al., 1979). The decrease in LH pulse amplitude seen at this time is
probably the result of direct effects of the increased levels of oestradiol feedback on the
pituitary (Baird & McNeilly, 1981).
The rise in oestradiol production stimulates uterine PGF2a production, adding
to the process of luteal regression, as well as causing a fall in the secretion of FSH
which is thought to be important in the process of follicle selection (see Section 1.2.5).
Inhibin, the peripheral concentration and secretion rate of which have been reported by
some workers to increase at this time (Campbell et al., 1990a; Findlay et al., 1990),
may also be involved in causing the suppression of FSH secretion seen at this time (see
Section 1.4). The rise in oestradiol secretion is also important in inducing oestrous
behaviour and in generating the preovulatory gonadotrophin surge. The importance of
oestradiol in generating this LH surge is demonstrated by the fact that injection of
oestradiol will generate a similar surge of LH secretion in seasonally anoestrous
(Goding et al., 1969; Radford et al., 1971) or ovariectomised (Radford et al., 1971;
Scaramuzzi et al., 1971) ewes, while active (Pant & Rawlings, 1973; Rawlings et al.,
1978) or passive (Rawlings et al., 1979) immunisation against oestradiol during the
follicular phase will prevent both oestrus and the LH surge. The mechanism by which
the gonadotrophin surge is actually initiated is not known. However, as a single
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injection, multiple injections, or a continuous infusion of oestradiol will induce a
gonadotrophin surge (Martin, 1984), it seems unlikely that the pulsatile nature of
oestradiol release is a key issue, and that the total amount of oestradiol present in the
peripheral circulation is the important factor.
In summary, during the period following luteal regression the fall in the
peripheral concentration of progesterone results in an increase in LH pulse frequency
which stimulates the production of oestradiol. The increase in the concentration of
oestradiol in the peripheral circulation then causes a decline in the secretion of FSH,
perhaps in conjunction with inhibin, as well as generating the preovulatory
gonadotrophin surge by positive feedback.
1.1.3 The Preovulatory Gonadotrophin Surge
Between 40 and 60h following the initiation of luteal regression a large rise in
the peripheral concentrations of both LH and FSH occurs (Fig. 1.1). This rise in
gonadotrophin release results from the rise in oestradiol secretion seen at this time, and
it is likely that the positive feedback effects of oestradiol are exerted at the level of both
the pituitary and the hypothalamus (Baird & McNeilly, 1981). In the ewe, as in many
species, the pituitary is more responsive to GnRH stimulation in terms of FSH and LH
release during the period prior to the preovulatory gonadotrophin surge than at any
other stage of the cycle (Reeves et al., 1971, Hooley et al., 1974), this increase in
sensitivity probably occurring in response to the rise in oestradiol. In ovariectomised
ewes treated with oestradiol there is initially a period of LH suppression followed by a
large increase in LH secretion (an LH surge) resulting from the positive feedback
effects of oestradiol. Caraty et al. (1989) have shown that during the period of LH
suppression there is a marked decrease in the frequency and amplitude of GnRH
pulses, while during the period of positive feedback there is a large surge in the
concentration of GnRH due primarily to a large increase in the frequency of GnRH
pulses. An increase in GnRH pulse frequency during oestradiol - stimulated LH surges
in ovariectomised ewes has also been shown by Clarke & Cummins (1985). While the
responses seen were variable, increases in GnRH have also been shown at the time of
the LH surge in oestradiol - treated anoestrous ewes and in normal cyclic ewes (Clarke,
1987). It appears, therefore, that the LH surge is due to both an increase in GnRH
secretion from the hypothalamus and an increase in pituitary responsiveness to GnRH.
During the LH surge there is a rapid increase from basal concentrations to a
peak within 4 - 8h, with concentrations returning to basal levels within lOh, resulting
in a surge of approximately 10 - 18h duration (Land et al., 1973; Martin, 1984). The
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surge usually occurs within 4 - 8h of the onset of oestrus (Acritopoulou et al., 1977;
Land et al., 1973), with ovulation occurring approximately 21 - 26h later (Cumming et
al., 1973b; Wheatley & Radford, 1969). During the initial stages of the LH surge there
is a stimulation of steroid secretion by the dominant follicle (Baird & McNeilly, 1981).
The secretion of androstenedione and testosterone is stimulated more than that of
oestradiol and so the oestrogen to androgen ratio, which has increased over the course
of the follicular phase, shows a marked decline. The LH surge then results in a marked
decline in the secretion of first oestradiol and then androgens (Baird & McNeilly, 1981;
Campbell et al., 1990a). As the secretion of oestradiol is affected before that of
androgens loss of aromatase activity is probably involved in the early stages of this
suppression. This idea is supported by the fact that the treatment of follicles in vitro, or
ovaries in vivo, with quantities of LH equivalent to the LH surge results in a marked
reduction in oestradiol secretion (Moor, 1974). The eventual suppression of all steroid
production is probably the result of the loss of LH receptor activity, and following the
LH surge a fall in LH receptors has been shown in both sheep (Webb & England,
1982) and cattle (Ireland & Roche, 1982).
1.1.4 LH Surge to Ovulation
The LH surge induces morphological changes in the preovulatory follicles
which eventually culminate in ovulation and corpus luteum formation, while inducing
atresia in all other follicles > 2mm. As a result of the loss of steroid production from
the dominant follicle(s) and the atresia induced in other large antral follicles steroid
secretion by the ovary at the time of ovulation is lower than at any other stage of the
oestrous cycle. Despite this fact, LH secretion remains low as a result of pituitary
depletion following the LH surge. There is, however, a second surge of FSH secretion
of similar magnitude and duration to that seen coincidental with the LH surge at around
the time of ovulation, some 18 - 24h after the first peak (Salamonson et al., 1973). The
first FSH peak can be prevented by treatment with antisera to GnRH (Narayana &
Dobson, 1979) suggesting that it results from an increase in the secretion of GnRH.
This second peak cannot, however, be prevented using antisera to GnRH, suggesting
that it occurs independently of an increase in GnRH secretion. Due to the low
concentrations of steroids at this time it would seem likely that this second FSH peak is
caused by a low level of steroid negative feedback at the pituitary level resulting in an
increased sensitivity to GnRH. It has been suggested that inhibin may play a role in the
control of FSH secretion following the LH surge, but at the time of the second FSH
peak there is a marked rise in the secretion rate and peripheral concentration of
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immunoactive inhibin (Campbell et al., 1990a). This finding would suggest that inhibin
is not important in the suppression of FSH during this period. However, it is possible
that the inhibin measured at this time could be a form of the molecule which is
biologically inactive (see Section 1.4).
It has been suggested that this rise in FSH may be involved in controlling the
number of potential ovulatory follicles that are stimulated to develop by the time of the
next oestrus, as appears to be the case in rodents (Sheela Rani & Moudgal, 1977).
However, in the sheep, induction of luteal regression at any time after day 4 of the
cycle results in a similar ovulation rate (Baird & McNeilly, 1981) and so it seems
unlikely that ovulation rate is predetermined as early in the cycle as this second FSH
peak. In cattle, abolition of the second peak of FSH with inhibin from steroid extracted
bovine follicular fluid has been shown to result in a delay in the appearance of large
antral follicles in both the first and second waves of follicle growth, while not affecting
cycle length (Turzillo & Fortune, 1990). It would appear, therefore, that this second
FSH peak is important in reinitiating follicle development at the start of the oestrous
cycle and in controlling the dynamics of follicle growth during the early stages of the
cycle, but not in determining the eventual ovulation rate.
1.2. Follicle Development & Function
1.2.1. Follicle Growth
In the adult ewe the ovary contains between 12 000 and 18 000 small preantral
follicles as well as 100 to 400 growing follicles (Cahill et al., 1979; McNatty et al.,
1982) and it is thought that 3-4 follicles enter this growth phase each day (Turnbull et
al., 1977), at a diameter of 0.03-0.06 mm (Cahill & Mauleon, 1981). Of the large
number of follicles that commence growth only a very small proportion will actually go
on to ovulate, the vast majority facing eventual atresia.
The mechanism of growth initiation is not known though the process appears to
occur independantly of gonadotrophins as hypophysectomy, while causing a reduction
in the number of antral follicles, does not affect the number of preantral follicles in
ewes (Dufour et al., 1979). The rate of growth initiation has been found to differ
between breeds of sheep, with more follicles entering the growth phase in more prolific
breeds of sheep (Cahill et al., 1979), and with season, more follicles entering the
growth phase during anoestrus (Cahill & Mauleon, 1980).
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Follicle growth rate is slow up to a diameter of around 0.4 mm (Turnbull et al.,
1977) and then accelerates. This acceleration in growth rate is due, in part, to the
formation of an antrum, which occurs at a size of around 0.2 mm in the sheep (Mariana
& Machado, 1976; Cahill et al., 1979), as once the antrum has formed further growth
results from follicular fluid accumulation as well as granulosa and theca cell
proliferation. The actual rate of division of granulosa cells (mitotic index) rises to a
maximum at a diameter of 1-2.5 mm (Turnbull et al., 1977), and then decreases slowly
to reach zero in the pre-ovulatory follicle (Cahill, 1981). The entire growth phase, from
growth initiation at a diameter of 0.06 mm to the preovulatory stage (6-8 mm) is though
to take about 6 months, and comprises 130 days of preantral growth (Cahill &
Mauleon, 1980), followed by a period of around 34-45 days of further, more rapid
growth following antrum formation (Turnbull et al., 1977; Cahill & Mauleon, 1980).
During the latter stages of antral growth the follicle takes about 5 days to increase in
diameter from 0.5 to 2.0 mm and a further 4 days to reach 4.5-5.0 mm, the maximum
size seen in the absence of the pre-ovulatory gonadotropic stimulus (Turnbull et al.,
1977). The slower growth rate before antrum formation is reflected in the presence of
twice as many preantral as antral follicles in the sheep ovary (Cahill, 1981; Webb &
Gauld, 1985). In the sheep waves of follicle growth and atresia are thought to occur
throughout the cycle, follicles only avoiding the degenerative process of atresia if the
development of FSH and LH receptors coincides with suitable levels of FSH and LH
in the circulation. While different studies have demonstrated different numbers of
waves and waves at different times during the oestrous cycle the evidence points to the
existence of 3 waves of follicle growth during each cycle (Smeaton & Robinson, 1971;
Cox et al., 1971; Mattner & Braden, 1972).
The actual growth rate of follicles does not seem to be affected by breed, stage
of cycle or season (Cahill & Mauleon, 1980), though more prolific breeds appear to
contain fewer very small follicles (< 2 layers granulosa cells) and a larger number of
growing follicles at each of the various stages above a diameter of 0.06 mm (Cahill et
al., 1979). It has also been reported that the proportion of preantral follicles declines
while the proportion of antral follicles increases during progressive oestrous cycles in
each breeding season (Dufour & Guilbault, 1984).
1.2.2. Gonadotrophic Control
Granulosa cells of both large and small follicle contain FSH receptors and while
binding of FSH by granulosa cells decreases with atresia, this binding is not related to
follicle diameter (Carson et al., 1979). Compared to granulosa cells, ovine thecal cells
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have been shown to achieve only a very low binding of FSH (Carson et al., 1979).
This is probably the result of granulosa cell contamination of the thecal cell preparations
used and, as in the rat (Richards, 1980) it seems probable that ovine thecal cells
possess no FSH receptors. hCG, which binds in a similar manner to LH, showed high
binding to antral follicle of all sizes (1-6 mm) studied by Carson et al. (1979), and like
the binding of FSH to granulosa cells, LH binding to thecal cells declines with the
advancement of atresia (Carson et al., 1979). LH receptors are also found in large
numbers on the granulosa cells of large (> 4 mm), non-atretic antral follicles (Carson et
al., 1979) and unlike FSH the overall extent of LH binding is determined by follicle
diameter, the greatest responsiveness to LH being seen in the large antral follicles. It is
thought that these follicles with LH receptors on the granulosa cells as well as the theca
cells are the follicles that will ovulate, and it has been shown that follicles without such
receptors do not luteinize and produce progesterone in response to the LH surge but
become atretic (Richards & Midgley, 1976). In the sheep, England et al. (1981) found
that most follicles contained either no LH receptors, or LH receptors only in thecal
tissue. However, in 1 or 2 follicles per ewe LH receptors were also present on the
granulosa cells. These "activated" follicles were large antral follicles which invariably
possessed a high antral fluid concentration of oestradiol and were presumably at the
stage during which they were able to respond to the LH surge and ovulate. This idea is
supported by the observation that the number of these follicles, with LH receptors in
both thecal and granulosal tissue, is the same as the ovulation rate in breeds of sheep of
both low and high fecundity (Webb & England, 1982).
FSH appears to be responsible for both the induction of its own receptors and
the induction of LH receptors in granulosa cells (Ireland, 1987), and it is thought that
FSH is necessary for the maintenance of gonadotrophin receptors throughout
folliculogenesis (Richards, 1980). Oestradiol is also thought to be involved in the
generation of LH receptors on granulosa cells, as well as increasing the responsiveness
of granulosa cells to FSH (Richards et al., 1976).
A third gonadotrophin, prolactin has been implicated in the control of
folliculogenesis. Prolactin receptors have been found on the oocytes of small follicles
in the rat (Dunaif et al., 1982), and in the sheep the number of growing preantral
follicles has been shown to decrease following the use of bromocriptine to reduce
prolactin levels (Cahill et al., 1984), though the number of antral follicles remained
unchanged. However, most aspects of follicular growth and development appear to
progress independent of prolactin (Baird & McNeilly, 1981), though the possibility of
a role for this hormone cannot be excluded.
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Evidence suggests that gonadotrophins act by binding to their membrane
receptors and activating the adenyl cyclase enzyme system (Catt & Dufau, 1976;
Marsh, 1976) resulting in cAMP production. cAMP is then thought to activate the
protein kinase system resulting in the phosphorylation of the proteins involved in
folliculogenesis (Catt & Dufau, 1976, Hay & Moor, 1978). cAMP probably then
stimulates an increase in several aspects of steroidogenesis rather than acting at a single
rate-limiting site (Marsh, 1976; Hay & Moor, 1978). In the sheep, the granulosa cells
of small (1-3 mm) and large (4-6 mm) follicles have been shown to produce cAMP in
response to FSH stimulation, while hCG only stimulated cAMP production from large
granulosa cells (Weiss et al., 1978). This finding supports the idea that while granulosa
cells possess FSH receptors at all sizes, LH receptors only appear on the granulosa
cells of larger follicles. In the same study LH was found to stimulate cAMP production
from the thecal cells, but not the granulosa cells, of all sizes of follicles, supporting the
idea that thecal cells never develop FSH receptors.
1.2.3. Follicle Steroidogenesis
Up to a diameter of around 3mm ovine follicles contain low concentrations of
oestradiol and androstenedione compared to that of testosterone (Carson et al., 1981).
Above this size oestradiol production increases rapidly while testosterone
concentrations fall, this change coinciding with the appearance of LH receptors on the
granulosa cells (Carson et al., 1979). Atretic follicles show a similar pattern of
follicular steroid content to healthy follicles below 3 mm, but fail to show an increase in
oestradiol production as their size increases above this diameter (Carson et al., 1981).
The main ovarian androgens in the sheep, androstenedione and testosterone,
appear to be produced entirely by the theca (Moor, 1977; Armstrong et al., 1981).
Androgen release is stimulated by LH (Baird & Scaramuzzi, 1976b; Armstrong et al.,
1981), apparently via cyclic AMP, the production of which is stimulated by the binding
of LH to its receptors on thecal cells in a number of species including the sheep (Weiss
et al., 1978). The main role of LH appears to be the stimulation of the conversion of
cholesterol to pregnenolone (Marsh, 1976), stimulation of this early step in the
steroidogenic pathway resulting in an increase in the production of all steroids.
Granulosa cells lack the necessary enzyme activity to produce androgens, but are
important in converting thecal androgens to oestrogens (Hillier, 1985).
While small antral follicles with thecal cell LH receptors have the ability to
secrete a limited amount of oestradiol (Webb & Gauld, 1985), it is now well
established that the majority of the oestradiol is produced by the large antral follicle(s)
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in the sheep during both the luteal and follicular phase (Moor et al., 1975; Baird &
Scaramuzzi, 1976b). In the sheep, as in many other species, it appears that the theca
and granulosa interact in the production of oestradiol (Falck, 1959; Armstronget et al.,
1981). This "2-cell theory" suggests that thecal cells produce androgen precursors
under LH stimulation, and that these androgens are then converted to oestradiol in the
granulosa cells by an aromatase P-450 enzyme system. This theory is supported by a
large amount of evidence from a number of species. In the sheep, isolated thecal and
granulosa cells are unable to secrete oestrogens, while co-cultures of the two cell types
secrete oestrogens successfully (Moor, 1977; Armstrong et al., 1981), though only for
a short period suggesting that full association between the two cell types was needed
for successful oestrogen production. Ovine granulosa cells are 4 times more effective in
converting testosterone than androstenedione (Hay & Moor, 1978), suggesting that
testosterone is the more important substrate for aromatisation to oestradiol in the sheep.
In vivo evidence for this "two-cell theory" has also been provided in the sheep by
Baird (1977) who found that infusion of antiserum to testosterone resulted in a fall of
over 50 % in oestrogen secretion, presumably as a result of the binding of substrate for
aromatisation. In intact sheep, pulses ofLH are followed by a rapid rise in the secretion
of both androstenedione and oestradiol, suggesting rapid transfer of androgen
precursor from the theca to the granulosa (Baird & Scaramuzzi, 1976b). It has
therefore been suggested that oestradiol production takes place in the granulosa cells
adjacent to basement membrane close to the capillaries supplying the theca (Baird &
McNeilly, 1981), and in the rat these granulosa cells have been shown to contain more
aromatising cytochrome P450 enzyme than the granulosa cells nearer the antrum (Zoller
& Weiss, 1978).
Aromatase activity per follicle increases up to a follicle diameter of 3.5 mm and
is then maintained at a constant level in healthy follicles (Tsonis et al, 1984a), declining
in atretic follicles (Tsonis et al., 1984a; Monniaux, 1987). In the ewe FSH has been
shown to increase aromatase activity in long term cultures (>48h) (Moor, 1977;
McNatty, 1982), though no such effect has been found during shorter culture periods
(Monniaux, 1987). Injection of ewes with FSH has also been shown to increase
aromatase activity (McNatty et al., 1985), while conversely, injection with bFF to
lower FSH concentration has resulted in a reduction of aromatase activity (McNatty et
al., 1985). Henderson et al. (1985) found maximum aromatase activity in cultured
granulosa cells that were highly responsive to FSH in terms of cAMP production,
providing indirect evidence that aromatase activity in ovine granulosa cells may be
regulated by cAMP production in response to FSH. Ovine thecal cell cultures have also
been shown to produce oestradiol, the production of which increased with increasing
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follicle size (Armstrong et al., 1981) but was not increased by the provision of
exogenous testosterone to the cultures, suggesting that the thecal oestradiol production
was not the result of contamination with granulosa cells, which would have responded
to the exogenous testosterone with an increase in oestradiol production.
1.2.4. Follicle Atresia
The majority of follicles do not develop to ovulation, but undergo the
degenerative process of atresia. Follicle atresia is rarely seen in preantral follicles < 1
mm in diameter (Turnbull et al., 1977; Carson et al., 1979; Cahill et al., 1984) but by
1.5-2.5 mm up to two thirds of follicles may show early signs of atresia (Turnbull et
al., 1977) and by the later stages of antral development up to 90% follicles may be
atretic (Brand & de Jong, 1973; Turnbull et al., 1977; Cahill et al., 1979
In the early or primary stages of atresia degenerating granulosa cells with
pyknotic nuclei become visible (Hay et al., 1976; Hay & Moor, 1978). As atresia
progresses to the secondary phase the degree of granulosa cell degeneration increases
and the inner layer of the granulosa may slough off into the antrum (Hay & Cran,
1978). This degeneration of the granulosa then spreads to the theca interna during the
tertiary stage of atresia and it is not until this late stage of atresia that the oocyte is
affected in the sheep, becoming necrotic as the cumulus breaks up (Hay et al., 1976).
During tertiary atresia a reduction of blood flow to the inner capillary network occurs,
presumably depriving the remaining granulosa cells of substrates (Hay et al., 1976),
and as the process of atresia progresses the follicle eventually collapses.
Atretic follicles, however, appear to maintain a degree of viability for some time
as both the thecal and granulosa layers of atretic follicles will, to a large extent,
regenerate if the follicle is cultured in a suitable nutrient environment (Hay et al.,
1979). Reversal of atresia in vivo appears to be possible in mice (Byskov, 1979) but
attempts in sheep have proved largely unsuccessful (Hay et al., 1979). In the sheep and
cow cumulus cells remain healthy, even after the granulosa has undergone marked
degeneration (Hay & Moor, 1978), possibly as a result of preferential blood supply.
As a result of this the oocytes from such atretic follicles appear to maintain full
developmental capacity, as following incubation of atretic follicles under suitable
hormonal conditions oocytes have gone on to produce offspring (Moor & Trounson,
1977). This idea is supported by the fact that unilateral ovariectomy 3 days before
ovulation, results in ovulation by follicles that would normally have become atretic, and
a normal ovulation rate is maintained (Land, 1973), a similar reduction in atresia
following unilateral ovariectomy being shown by Dufour & Guilbault (1984).
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Hypophysectomy results in atresia in large (> 2 mm) antral follicles in the sheep
(Dufour et al., 1979). By using this technique Drwicourt et al. (1987) found that large
follicles took around 8 days to disappear into the ovarian stroma, while ink marking of
follicles has shown that it takes about 7 days from the onset of atresia for a large follicle
to disappear (Smeaton & Robertson, 1971). A rise in the incidence of atresia has been
found as ewes enter anoestrus, the high level of atresia seen during the anoestrous
period being accompanied by a low number of large antral follicles (Cahill et al.,
1984). As the ewes return to cyclicity the level of atresia falls and the number of large
antral follicles rises. These changes are presumably the result of changes in
gonadotrophins, which are known to be affected by photoperiod (Lincoln & Peet,
1977). While seasonal changes in atresia seem to exist, differences in atresia do not
appear to be responsible for different ovulation rates between breeds (Cahill et al.,
1979).
Atretic follicles show a relatively high level of androgen production compared to
that of oestradiol (Hay et al., 1979). As oestradiol production falls in the presence of
high levels of androgen precursor, this is probably due to the loss of aromatase
activity. It has been suggested that oestradiol production from androgens, and the
responses of granulosa cells to these steroids may be important in determining whether
a follicle becomes atretic, and in cattle, injection of androgens has been shown to
induce atresia (Maracek et al., 1977). During atresia there is a fall in the ability of
follicles to bind gonadotrophins (Carson et al., 1979), but it seems unlikely that this is
a cause of atresia as this fall in binding does not become apparent until after the onset of
"morphological" atresia. The removal of gonadotrophins in the sheep by
hypophysectomy results in atresia in all follicles > 2mm (Dufour et al., 1979) as does
the reduction in gonadotrophins resulting from GnRH immunoneutralisation (McNeilly
et al., 1986) or GnRH agonist treatment (McNeilly & Fraser, 1987). This indicates that
gonadotrophins have an important role in preventing atresia. Injection of PMSG has
been shown to reduce the incidence of atresia as has injection of purified FSH
(McNatty et al., 1985), suggesting that it is FSH rather than LH that is more important
in preventing atresia. The preovulatory LH surge is thought to induce atresia in those
follicles not undergoing ovulation, and this idea is supported by the fact that injection
of hCG results in an increase in follicle atresia in the ewe (Turnbull et al., 1977). The
idea that high levels of LH induce follicle atresia is supported by Picton (1989) who
found that high amplitude LH pulses increased the incidence of atresia among follicles
in FSH-stimulated GnRH agonist-treated ewes. It has also been suggested that non¬
steroidal components of follicular fluid may have a role in atresia (Ledwitz-Rigby,
1979), such factors possibly regulating the cellular responses to gonadotrophins.
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1.3. Follicle Selection
The process of follicle selection has been divided into two events; follicle
"recruitment," during which a group of follicles capable of ovulation is established, and
the actual process of "selection," during which the follicle(s) destined to ovulate is
selected from the group of recruited follicles and becomes "dominant", avoiding
atresia.
1.3.1. Follicle Recruitment
The use of ink marking shows that follicles are recruited for ovulation from
those follicles > 2mm in diameter at the time of luteal regression (Dmncourt et al.,
1984; Dr^ncourt & Cahill, 1984). This idea is supported by the observation that
following electrocautery of follicles at the time of luteal regression ovulation is not
delayed providing some follicles > 2mm (either 2 -4 mm or > 4 mm) are left intact
(Tsonis et al., 1984b). If all follicles > 2mm are destroyed a delay to ovulation of some
24h occurs (Tsonis et al., 1984b), suggesting that only follicles > 2mm can be
recruited for preovulatory development. The lack of follicle growth beyond 2mm
following hypophysectomy (Dulfour et al., 1979; Dr ioncourt et al., 1987) indicates that
gonadotrophins are important in follicle recruitment and preovulatory development.
During seasonal anoestrus, ovulation of follicles present at the time of treatment can be
induced by pulsatile injection of LH (McNeilly et al., 1982; McNatty et al., 1984),
suggesting that LH is the key hormone in follicle recruitment. However, a higher
proportion of ewes can be induced to ovulate by pulsatile injection ofGnRH (McLeod
et al., 1982 a,b) or by the administration of FSH with pulsatile LH injections
(McNeilly et al., 1985). In Blackface ewes, which show a deep seasonal anoestrous,
administration of LH and FSH is required if ovulation is to be induced. From these
studies it appears that both LH and FSH are important in follicle recruitment and
preovulatory growth, with FSH perhaps sensitising the follicle to recruitment by LH.
1.3.2. Follicle Selection
As artificially induced luteal regression at any stage of the luteal phase is
followed by ovulation about 72h later (Baird, 1983) it seems unlikely that follicle
selection occurs before the onset of luteal regression. Following luteal regression there
is a decline in the percentage of healthy antral follicles until, by 36h, only the
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preovulatory follicle(s) remain healthy (McNatty et al., 1982). It seems, therefore, that
in the sheep follicle selection occurs early in the follicular phase.
One hypothesis as to how the selected follicle(s) becomes dominant over the
other follicles in the ovary is that the dominant follicle(s) secretes large quantities of
oestradiol and inhibin which feed back on the pituitary gland to suppress FSH
secretion, starving the remaining follicles of gonadotrophs support (Baird, 1983). A
second theory suggests that the dominant follicle(s) releases regulatory substances
which act at an ovarian level to inhibit the development of the other follicles
(Hammond, 1981).
The "FSH theory" of follicle selection assumes that folliculogenesis is a
continual process, and that follicle selection occurs by chance. Following luteal
regression there is an increase in LH pulse frequency which stimulates thecal androgen
production. Those antral follicles with a sufficiently developed level of aromatase
activity are able to convert these androgens to oestrogens which act to increase the
sensitivity of the granulosa cells in these follicles to FSH. In response to this increased
sensitivity to FSH the dominant follicle(s) releases increasing amounts of oestradiol
into the ovarian vein exerting negative feedback on the pituitary gland and resulting in
the fall in FSH concentration seen during the follicular phase (Campbell et al., 1990a).
This fall in FSH, which can be quite modest (30%, Baird, 1983), deprives less
advanced follicles of the gonadotrophic support required for development and they
become atretic. The dominant follicle(s) survives in this FSH-deficient environment as
a result of its increased responsiveness to FSH (Henderson et al., 1985), and possibly
as a result of an increased blood supply (Brown & Dnuncourt, 1979). Healthy follicles
have been shown to contain a higher follicular fluid concentration of FSH than atretic
ones (McNatty et al., 1985). However this concentration of FSH does not seem high
enough to be of importance in maintaining the follicle. Injection of PMSG at this time
prevents the decline in the number of healthy follicles (McNatty et al., 1982) as does
infusion of FSH (Henderson et al., 1988) suggesting that this decline in FSH
concentration is causally involved in the atresia of non-ovulatory follicles at this time.
According to this model multiple follicle selection can occur by one of two
mechanisms (Baird, 1983). Firstly, the number of antral follicles reaching the stage of
development necessary to benefit from the follicular phase rise in LH could be
increased. This idea is supported by the fact that in prolific breeds of sheep, despite a
lower total number of antral and preantral follicles than less prolific breeds, the number
of antral follicles is increased (Cahill et al., 1979) suggesting more antral follicles
would be at the right stage of growth for selection to occur at any one time. Secondly
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resulting in the need for higher levels of oestradiol to be secreted by the follicles before
the fall in FSH could be induced. This increased resistance to oestradiol has been
demonstrated in some highly fecund breeds (Land, 1976), and in such breeds a higher
follicular phase concentration of oestradiol does not result in lower concentrations of
FSH than are seen in less prolific breeds (Cahill, 1981). If identical gonadotropin
regimes are provided to breeds of low and high fertility following hypophysectomy,
highly fertile breeds maintain a higher ovulation rate despite the same peripheral FSH
concentration (Dn'cmcourt et al, 1988; Fry et al., 1988). This finding suggests that
differences in ovulation rate may partly result from differences in sensitivity to
gonadotropins, or be due to factors acting within the ovary.
The second theory of follicle selection suggests that the dominant follicle(s)
secretes a number of hormonal and non-hormonal factors which modulate the
gonadotrophin-induced selection process (Ireland, 1987). Some of these potential
regulatory factors (Table 1.1.) have been shown to have inhibitory effects on granulosa
cell hormone production, supporting the idea that a dominant follicle may inhibit the
development of other follicles. One of these substances, FSH binding inhibitor, has
been found to be more prevalent in atretic than in healthy follicles (Sluss et al., 1984),
suggesting a role for this substance in determining atresia. In primates, gonadotrophs
stimulation has been found to be more effective in inducing multiple follicular
development during time periods when a dominant follicle is not present (diZerega &
Hodgen, 1980), adding weight to the suggestion that the dominant follicle is acting to
inhibit the development of other follicles.
While the precise mechanism controlling follicle selection is not known, it
seems most likely that in the sheep this process is regulated by gonadotrophins,
especially FSH, while non-steroidal substances produced by the dominant follicle(s)
may be important in modulating the actions of gonadotrophins and may have actions
involved in inhibiting the development of other follicles.
1.4. The Structure and Physiology of Inhibin
Inhibin, by definition, is an ovarian glycoprotein hormone which suppresses
pituitary gonadotrophin secretion, preferentially that of FSH. The term inhibin was first
used in 1932 to describe a factor of testicular origin involved in the control of pituitary
FSH secretion (McCullagh, 1932). Evidence for the existence of inhibin was not
produced until the 1970s following the demonstration that FSH secretion could be
suppressed by first testicular extracts (Setchell & Jacks, 1974; Franchimont et al.,
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1975) and then ovarian follicular fluid (de Jong & Sharpe, 1976). It was not, however,
until 1985 that the substance was first isolated (Robertson et al., 1985).
1.4.1. Forms of Inhibin
Inhibin is made up of 2 disulfide - linked dissimilar subunits, the a and the (3
chains, and has been isolated from a number of sources including; bovine follicular
fluid (bFF: Robertson et al., 1985; Fukuda et al., 1986), porcine follicular fluid (pFF:
Ling et al., 1985; Miyamoto et al., 1985) and ovine follicular fluid (oFF: Leversha et
al., 1987). In these and other studies inhibin has been isolated in a number of
molecular weight forms ranging from 30kDa to 120kDa (Fig. 1.2). Some of the
apparently different molecular weight sizes of inhibin differ by only a single or a few
kDa and may result from inherent limitations in the techniques used to determine size,
but it is clear that a number of different molecular weight forms of inhibin can be
isolated. Inhibin a and [3 subunits are coded for by separate genes (Mason et al., 1985;
Forage et al., 1986) and are initially produced in large molecular weight forms as the a
preproprotein and the (3 proprotein (Fig. 1.2). These precursor forms contain a number
of proteolytic cleavage sites and it appears that cleavage at different sites results in the
production of the different molecular weight forms of inhibin that have been detected, a
higher degree of processing resulting in the production of smaller molecular weight
forms (Fig. 1.2). For example 32, 57 and 68 kDa inhibin share a common |3 subunit,
the size differences resulting from the degree of processing of the a subunit. In 68kDa
inhibin the a subunit is made up of 3 regions; the carboxy region (aC), the amino
terminal region (aN) and a further pro region. Cleavage of this pro region results in the
production of 57kDa inhibin with further cleavage of the aN region resulting in the
production of 32kDa inhibin, the smallest active form of inhibin isolated so far (Fig.
1.2).
As well as whole inhibin molecules, "free" a subunit proteins have also been
isolated. Knight et al. (1989) have isolated 25 and 44kDa proteins in bFF which are
thought to be the aC subunit of 32kDa inhibin and the aCaN subunit of 58kDa
inhibin, and have demonstrated the presence of these proteins in bovine but not ovine
utero - ovarian and peripheral plasma by immunoblotting. Both Robertson et al. (1989)
and Sugino et al. (1989) have isolated an a chain protein comprising a 6kDa pro region
disulphide linked to the aC protein of the a chain from bFF, this product being termed
Pro - aC (Fig. 1.2). Robertson et al. (1989) have also isolated the "free" aN portion
of the a chain resulting from the production of the Pro - aC fragment, and
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Fig. 1.2.
Schematic representation of the synthesis of some of the major forms of inhibin isolated
from follicular fluid. (Based on Miyamoto et al., 1986 and Robertson et al., 1989)
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(Findlay et al., 1989). While these a subunit monomers appear to be devoid of inhibin
- like bioactivity (Knight et al., 1989; Robertson et al., 1989) they can be highly
immunoreactive and may present a problem when trying to obtain biologically
meaningful data on circulating inhibin levels.
Two forms of the (5 subunit of inhibin have been isolated (Pa and Pb), and
mRNA for both these forms has been localised in granulosa cells (Mason et al., 1985).
The resultant forms on inhibin, inhibin A and inhibin B, both have similar
physiological properties (Ying, 1988). Activin, a dimer of inhibin P subunits (activin A
- Pa Pa °r activin AB - Pa Pb) has also been isolated from follicular fluid (Ling et al.,
1986; Vale et al., 1986) though not identified in serum (Robertson et al., 1990). In
contrast to inhibin, activin is able to stimulate, rather than suppress, pituitary FSH
secretion (Ling et al., 1986), and may have a role in enhancing FSH stimulation of
aromatase activity (Hutchinson et al., 1987).
The molecular weight forms of inhibin occurring physiologically and their
biological importance in different species is still not clear. Two forms of biologically
active inhibin, 30kDa and 65kDa, have so far been isolated in the sheep (Leversha et
al., 1987), these forms presumably corresponding to the 32kDa form and the 58 or
68kDa form dipicted in Fig. 1.2. While "free" aC and aCaN a chain peptides have
not been found in ovine plasma (Knight et al., 1989), the quantities of aN and Pro -
aC peptides remain to be determined.
1.4.2. Measurement of Inhibin
Initial measurements of inhibin activity were made using a variety of bioassays.
Early bioassays relied on in vivo criteria such as reduction of serum FSH levels by
inhibin (Nandini et al., 1976) or the inhibition of hCG - induced ovarian and uterine
weight gain (Ramasharma et al., 1979). Such assays were able to detect inhibin but
were not sufficiently sensitive to make accurate quantitative measurements. The next
development was the use of bioassays utilising in vitro rat pituitary cell cultures.
Bioassays for inhibin were developed using pituitary cell FSH content (Scott et al.,
1980), inhibition of GnRH stimulated FSH release (Eddie et al., 1979) and inhibition
of basal FSH secretion (de Jong et al., 1979) as end points. These in vitro bioassays
were more sensitive than earlier in vivo assays and were able to measure high
concentrations of inhibin such as those found in follicular fluid. With the advent of
more sensitive bioassays for inhibin, such as that described by Tsonis et al. (1986),
which uses suppression of ovine pituitary cell FSH production as an end point, it has
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now become possible to measure plasma concentrations of bioactive inhibin in certain
physiological situations.
The potential presence of other substances which affect FSH secretion such as
activin or FSH suppressing protein (follistatin), which has been isolated from bFF and
pFF (Ying, 1988) and shown to suppress FSH secretion by pituitary cell cultures,
presents an obvious problem in obtaining true values of inhibin bioactivity. Before
being measured in inhibin bioassays samples are usually treated with charcoal to
remove steroids which would suppress FSH secretion. This treatment may affect the
inhibin present in the samples adding further to the problems in obtaining true estimates
of inhibin bioactivity.
Once inhibin had been isolated and purified it became possible to develop
radioimmunoassays for inhibin. Two types of assay have been developed based on
antisera raised either to native inhibin (Mclachlan et al., 1986; Hasegawa et al., 1987;
Robertson et al., 1988) or to synthetic peptides of the a subunit (Rivier et al., 1986;
McNeilly et al., 1989; Knight et al., 1989). Both types of radioimmunoassay appear to
have been successfully applied to the measurement of inhibin in the serum of a number
of species including the sheep (McNeilly et al., 1989; Campbell et al., 1990a; Findlay
et al., 1990). While both types of inhibin radioimmunoassay appear to show little or no
cross reactivity with inhibin - related proteins such as TGF(3, they do cross react with
some of the forms of biologically inactive "free" a subunit peptide isolated from
follicular fluid (Robertson, 1990). At present detailed information on the levels of these
a subunit fragments in plasma is not available and so, for the moment, the biological
significance of measurements of immunoreactive inhibin concentrations should be
viewed with some caution.
1.4.3. Ovarian Production of Inhibin
Inhibin is produced by the granulosa cells of all species studied so far including
cattle (Henderson & Franchimont, 1981) and sheep (Campbell, 1989), and
accumulates in the follicular fluid. Following cautery of all visible large antral follicles
in the ovary the secretion rate of inhibin into ovarian effluent lymph (Findlay et al.,
1986) and ovarian venous plasma (Findlay et al., 1990) declines, providing evidence
that large antral follicles are a source of ovarian inhibin secretion. The role of the
follicles in inhibin production was supported by the studies of Rodgers et al. (1989)
who demonstrated the presence ofmRNA for both the a and (3a inhibin subunits in the
follicles of sheep and cattle, and by the in situ hybridisation studies of Torney et al.
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(1989) who have localised mRNA for these two inhibin subunits in the granulosa cells
of bovine follicle.
Inhibin production, assessed by the presence of inhibin in the antral fluid, has
been shown in follicles of > 1.4mm diameter (Tsonis et al., 1983), with the follicular
fluid of larger follicle containing more inhibin. Inhibin production by bovine granulosa
cells has been shown to increase with follicle size (Henderson et al., 1984a),
suggesting that larger follicle are a more important source of inhibin. Torney et al.
(1989) found mRNA for the inhibin a subunit in bovine follicles as small as 0.36mm
diameter but only found mRNA for both a and Pa subunits in follicle > 0.8mm. In
agreement with the studies of Tsonis et al. (1983) and Henderson et al. (1984a),
Torney et al. found an increase in mRNA for a and Pa inhibin subunits with follicle
diameter. In their studies Torney et al. (1989) also found mRNA for the Pa inhibin
subunit in thecal cells of follicles > 0.8mm suggesting that the theca may also have
some role in inhibin production. As well as the apparent association with follicle
diameter, inhibin production has been shown to decline with morphologically
(Henderson et al., 1984a) and biochemically (Tsonis et al., 1983) determined atresia.
In humans there is an increase in circulating inhibin concentrations during the
luteal phase (McLachlan et al., 1987), suggesting that the corpus luteum may be an
important source of inhibin. This idea is supported by the fact that human granulosa
cells allowed to luteinize in culture secrete inhibin (Tsonis et al., 1987). Furthermore,
in both the human (Davis et al.j187) and the rat (Davis et alJ186) mRNA for inhibin has
been detected in luteal tisue. In the sheep the secretion rate of bioactive inhibin has been
shown to be higher from ovaries containing luteal tissue, and to decline following luteal
regression (Tsonis et al., 1988a) suggesting that the corpus luteum may also secrete
inhibin in this species. Attempts to localise mRNA for inhibin in the corpus luteum
have failed in sheep and in cattle (Rodgers et al., 1989; Torney et al., 1989), and
cultured bovine luteal cells have failed to secrete inhibin (Henderson et al., 1981). The
potential of the corpus luteum as a source of inhibin therefore remains unresolved in the
sheep.
1.4.4. The Control of Inhibin Production
In the rat, FSH stimulates the production of inhibin both in vivo (Lee et al.,
1981) and in vitro (Bicsak et al., 1986), and LH has also been shown to stimulate
inhibin production in vitro. In sheep, however, the evidence for gonadotrophic
stimulation of inhibin production is less clear. Inhibin secretion from the ovary is
unaffected by endogenous (McNeilly & Baird, 1989) or exogenous (Campbell et al.,
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1989; Scaramuzi et al., 1989) pulses of LH, and inhibin production by cultures of
ovine and bovine granulosa cells also appears to be unresponsive to stimulation by LH
(Henderson et al., 1984a; Campbell, 1989). FSH was shown to cause a small but
significant stimulation of inhibin production by cultures of bovine granulosa cells from
large healthy, but not atretic, follicles (Henderson et al., i984a). In the ewe,
continuous infusion of FSH for 48h after luteal regression results in an increase in
inhibin production (McNeilly et al., 1989), but this increase may have resulted from the
stimulation of the development ofmore follicles as acute stimulation with FSH appears
to have no effect on the ovarian secretion rate of inhibin (Scaramuzzi et al., 1989), and
stimulation of ovine granulosa cell cultures with FSH does not result in an increase in
inhibin production (Campbell, 1989). It appears, therefore, that while FSH may have a
direct role in the control of inhibin production by ovine and bovine granulosa cells, this
role is by no means clear. Luteinizing hormone, on the other hand, does not appear to
have any role in the control of inhibin production in the sheep.
In bovine granulosa cell cultures, testosterone and androstenedione stimulate
Frc.vAiWi/tv -i'c
inhibin production (Henderson efcaL, 1981; Henderson et al., 1984a) while oestradiol
has no effect (Henderson efesl., 1981). This would suggest a role for androgens in the
PfO-A<_W
control of inhibin production. Henderson-tst=al. (1981) found that in the absense of
serum, cultured bovine granulosa cells produced no inhibin, and suggested that the
factor in serum responsible was not FSH or LH as neither gonadotrophs could
stimulate inhibin production in the absence of serum. Campbell (1989) found that
insulin stimulated inhibin production from ovine granulosa cells, and it is possible that
insulin or insulin like growth factormay play a role in controlling granulosa cell inhibin
production.
1.4.5. Inhibin Secretion During the Oestrous Cycle
The secretion of inhibin is pulsatile during both the follicular phase (McNeilly &
Baird, 1989; Murray et al., 1989; Campbell et al., 1990b) and the luteal phase
(Campbell et al., 1990b). These pulses, which occur at intervals of approximately lh at
all stages of the cycle (Campbell et al., 1990), do not appear to be related to pulses of
LH, as is the case for ovarian steroids, and their aetiology remains unknown. Bioactive
inhibin levels have been shown to decline following luteal regression (Tsonis et al.,
1988a) but this finding has not been confirmed by radioimmunoassays. Using an assay
against a peptide fragment of the a chain or inhibin McNeilly et al. (1989) found no
change in the secretion rate of inhibin following luteal regression, while Campbell et al.
(1990) found a significant but inconsistent rise in inhibin secretion at this time. Using
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an assay based on entire 31kDa bovine inhibin Findlay et al. (1990) also found a rise in
inhibin concentration at this time. Following the LH surge Campbell et al. (1990a)
found a rise in the secretion rate of inhibin resulting in a high secretion rate at the time
of the second FSH peak, while Findlay et al. (1990) found a decline in peripheral
inhibin concentration. These differences are hard to reconcile, bearing in mind that the
two assays have been shown to give comparable results (Campbell et al., 1990a), but
may be due to breed differences or to an insufficiently frequent sampling interval.
1.4.6. The Physiological Role of Inhibin
The role of oestradiol in the control of FSH secretion in the sheep is now
beyond doubt, but many aspects of the part inhibin plays in this process remain to be
fully determined. The rise seen in FSH concentration following ovariectomy can only
be partially prevented by treatment with "physiological" amounts of oestradiol
(Goodman et al., 1981b; Martin et al., 1988), while inhibin and oestradiol together are
able to maintain the concentration of FSH (Martin et al., 1988). This suggests that
inhibin and oestradiol act together in the control of FSH secretion.
It is now well established that inhibin in steroid free follicular fluid suppresses
FSH secretion in both intact (McNeilly, 1984; Wallace & McNeilly, 1985) and
chronically ovariectomised (Cummins et al., 1983; Findlay et al., 1985) ewes, and
purified inhibin has now been shown to suppress FSH secretion in ovariectomised
ewes (Findlay et al., 1987). Inhibin from follicular fluid will also prevent the post
castration rise in FSH seen in acutely ovariectomised ewes if supplied in sufficiently
large quantities (Martin et al., 1986, 1987) indicating the potential of inhibin as a
regulator of FSH secretion.
The action of inhibin appears to be exerted, at least in part, on the pituitary as
inhibin in steroid free follicular fluid and purified inhibin both suppress FSH release
from cultured ovine pituitary cells (Tsonis et al., 1986; Findlay & Clarke, 1987).
Clarke et al. (1986) have shown that inhibin in oFF was able to suppress pituitary FSH
production to a large degree in ovariectomised ewes with hypothalamo - pituitary
disconnections which were pulsed with exogenous GnRH, indicating that inhibin does
not exert its negative feedback action at the hypothalamus. This idea is supported by the
fact that inhibin in steroid free bFF has been shown to suppress pituitary FSH secretion
in ewes both before and after desensitization of the pituitary to GnRH by chronic
GnRH agonist treatment (Knight et al., 1990).
Following cessation of treatment with inhibin, a "rebound" in FSH secretion
occurs (Miller et al., 1982; McNeilly, 1984), the release of FSH during this rebound
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period ranging from 100 - 500% of the amount not released during the period of
suppression (McNeilly & Wallace, 1987). This rebound effect is not seen in
ovariectomised ewes (Findlay & Clarke, 1987), suggesting that it is associated with the
ovaries. This effect could be due to a reduction in oestradiol and/or inhibin secretion
from ovarian follicles resulting from the period of FSH suppression, or may be due to
a factor in follicular fluid, other than inhibin, which directly suppresses follicular
development and hormone production (Baird et al., 1990; Law et al., 1990).
Treatment with large amounts of inhibin in follicular fluid has been shown to
partially inhibit the rise in LF1 concentration seen following ovariectomy (Martin et al.,
1986), and to cause a reduction in LH pulse amplitude and/or frequency (Findlay et al.,
1987; Martin et al., 1986, 1987; Clarke et al., 1986). However, other studies using
large doses of inhibin have shown no effect on LH (McNeilly, 1984, 1985) or even an
increase in LH pulse amplitude (Wallace & McNeilly, 1986). Studies in which inhibin
was administered in amounts corresponding to "normal" ovarian output have shown no
effects on LH secretion (Martin et al., 1987, 1988), suggesting that the effects seen in
some of the studies using larger doses of inhibin were pharmacological effects. Inhibin
from oFF has no effect on basal LH production by cultured ovine pituitary cells
(Tsonis et al., 1986) and so it would appear that in the sheep inhibin is acting as a
selective suppressor of FSH secretion, though the possibility of a role for inhibin in the
control of LH secretion cannot be completely excluded.
Active immunisation against oestradiol results in a marked elevation in the
peripheral concentrations of FSH and LH and causes multiple follicular development
(Pant & Rawlings, 1973; Martenz et al., 1979), though ovulation does not occur due to
the lack of a preovulatory gonadotrophin surge resulting from the removal of oestradiol
positive feedback. Active immunisation of ewes against inhibin - enriched fractions of
bFF has been shown to result in an increase in ovulation rate (Henderson et al., 1984b;
Cummins et al., 1986), as has active immunisation of cattle against inhibin purified
from oFF (Price et al., 1987). Ovulation rate has also been shown to increase
following immunisation of ewes against a fragment of the inhibin a subunit produced
by recombinant DNA techniques (Forage et al., 1987) suggesting that the effect seen in
the studies using inhibin purified from follicular fluid were due to antibodies to inhibin
and not to some other factor in the immunogen preparation. In these active inhibin
immunisation studies the expected rise in plasma FSH concentration has not been
detected or has been small and variable. Passive administration of antibodies to inhibin
in ovariectomised ewes prevents the suppression of FSH caused by treatment with bFF
(Al-Obaidi et al., 1986), and inhibin antibodies have been shown to neutralise the
suppressive effects of inhibin preparations on FSH release by pituitary cell cultures
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(van Dijk et al., 1986). It seems probable, therefore, that the effect of active
immunisation against inhibin on ovulation rate is mediated through the control of FSH
secretion, and it is possible that more intensive techniques are required to successfully
detect these changes in FSH. It is, however, also possible that inhibin has direct effects
on the ovary. Active immunisation of ewes against the aN "free" a chain peptide,
which does not appear to possess any inhibin - like biological activity in regard to FSH
secretion, has been shown to reduce fertility (Findlay et al., 1989), supporting the idea
that inhibin may have intra - ovarian roles. Whatever the mechanism governing these
changes in ovulation rate after immunisation against inhibin, these studies do





Two breeds of ewe were used in the experiments described in this thesis,
Scottish Blackface ewes and Finn x Merino ewes. The Blackface ewes were mature
ewes bought each autumn from the Macaulay Land Use & Research Institute Farm,
Sourhope, Berwick, Roxboroughshire, and had been culled on the basis of age or loss
of teeth, all animals being of sound health and reproductive status. The mean weight of
these animals was 58.2±0.6 kg (n = 98). Prior to experiments animals were kept either
in small paddocks outside, or inside in large communal pens and fed on hay and cereal
based ewe nuts (Dalgety Feeds). During experimental procedures animals were housed
inside in small individual pens or metabolism crates with constant access to water, and
were fed hay and ewe nuts twice daily. Experiments on these animals were carried out
during the breeding season between October and February, the breeding season for this
breed lasting from September to March.
The Finn x Merino ewes used in the dose trial in Chapter 6 were mature 2 - 3
year old ewes (mean weight 42.3±2.2 kg; n = 6), while the ewes used in Chapter 9
were mature 7-9 year old ewes (mean weight = 50.3±1.4 kg; n = 12) in which the left
ovary and its vascular pedicle had been transplanted to a site in the neck at least 5 years
previously to allow direct sampling of ovarian venous blood in the conscious animal
(Goding et al., 1967). At surgery the right ovary is removed, and the left ovary along
with its vein and artery dissected out. The left ovary is then located in a surgically
produced fold of skin in the neck and the ovarian vein and artery connected to the
jugular vein and carotid artery, which had both been previously located in a surgically
produced skin loop. The layout of the ovary and its vasculature in this model is shown
in Fig 2.1. These ewes were experimented on during the breeding season in February,
the breeding season in this breed lasting till late March.
2.2. Oestrus Synchronisation
Oestrous cycles were initially synchronised by the removal of
medroxyprogesterone acetate intra vaginal sponges (60mg/sponge; Upjohn Animal
Health Division, Crawley, Sussex, U.K.) which had been left in place for 13 days.
Ewes showed oestr within 72h as indicated by colour marking by a vasectomised
ram with a coloured raddle harness. Closer synchronisation was then achieved by
28
Fig. 2.1.
Diagram of the ovarian transplant preparation showing the location of the
ovary in the neck and the arrangement of the blood vessels in a skin loop.
(Based on Goding et al., 1967).
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giving an injection of 100)ig Cloprostenol, a potent analogue of prostaglandin F2a
(Estrumate; Cooper's Animal Health, Crewe, Cheshire, U.K.) on day 10 of the
resulting cycle, the second oestrum occurring about 48h after the cloprostenol
injection.
2.3. Jugular Venous Blood Sample Collection
Less frequent blood samples (e.g. twice daily) were collected using 7ml
heparinised evacuated tubes (Vacutainers; Becton Dickinson UK Ltd., Oxford) and two
way needles. Where more frequent sampling was required the jugular vein was
chronically cannulated using a plastic cannula (Braunula, 14 G; Dunlop Veterinary
Supplies, Dumfries, U.K.), which was stitched into the neck for security. The cannula
was then connected to a length of polythene manometer tubing (Portex Ltd, Kent,
U.K.) with a three way tap attached (Viggo Products, Helstingborg, Sweden; sterilised
by BOC Health Care). To minimise the effects of stress animals were cannulated
several hours before the start of blood sampling was started. After each sample was
collected the cannula and tube were flushed with sterile 0.9% (w/v) saline containing 20
i.u. heparin/ml (Leo Laboratories, Aylesbury, Bucks., U.K) to prevent clotting. After
withdrawal by syringe (Plastipax; Becton Dickinson UK Ltd., Oxford) blood samples
were placed in 5ml or 7ml plastic tubes (Sarstedt, Leicester, U.K.) containing
heparinised beads (Sarstedt, Leicester, U.K.) and centrifuged at lOOOg for 20 mins.
The plasma was then decanted into 3ml or 5ml storage tubes and frozen at - 20°C prior
to assay.
2.4. Ovarian Transplant Blood Sampling
In these ewes the left ovary and its vascular pedicle had been transplanted to a
site in the neck (Fig. 2.1), as described in section 2.1. A length of Silastic tubing (Dow
Coming Silastic Medical Grade Elastomer; Hospital Management Supplies, Carnegie
Rd, Glasgow, U.K.) was inserted into the jugular vein close to the head through the
bore of a suitably sized needle, and passed down the vein until its tip lay opposite the
site of anastomosis of the ovarian vein. To allow sample collection a pneumatic cuff
was placed around the upper limb of the skin loop and inflated to 100 - 120 mm Hg to
temporarily stem jugular blood flow. Ovarian blood was then collected by free fall
following manual occlusion of the jugular vein in the lower limb of the loop. This
technique ensured that the blood flowing down the ovarian vein passed into the cannula
with minimal dilution by jugular venous blood. To allow the ovarian blood flow rate to
30
be calculated timed samples of 7.5 ml of ovarian blood were collected. Ovarian blood
flow measured by this technique is an over-estimate due to a contribution from the skin
of the loop, but such skin contributions do not alter the calculated ovarian hormone
secretion rate. A small quantity of each blood sample was used to determine the
haematoctrit. This was done by filling heparinised capillary tubes (Hawksley & Son,
Lancing, Sussex, U.K.) with blood, sealing one end of the tube, and then centrifuging
for 10 min in a Minor™ centrifuge (MSE Crawley, Sussex, U.K.). The percentage of
red blood cells was then read using a Micro-Haematocrit reader (MSE Crawley,
Sussex, U.K.). The actual secretion rate of a particular hormone was then calculated
from the ovarian venous plasma hormone concentration, the flow rate and the
haematocrit, and was corrected for peripheral hormone concentration (Collet et al.,
1973).
2.5. Oestradiol Antibody Generation
2.5.1. Conjugate Preparation
To produce the hormone antigen for immunisation 10 mg 6-ketoestradiol 6-0-
carboxy methyl oxime (Sigma, Fancy Road, Poole, Dorset, England) was conjugated
to a rabbit serum albumin (Sigma) carrier protein using a mixed anhydride reaction
(Erlanger, Borek, Beiser & Lieberman, 1957), and the conjugate made up to 10 ml in
sterile saline.
2.5.2. Immunisation Procedure
An emulsion of the conjugate was prepared with Freund's complete adjuvant
(Sigma), using 1ml of the antigen, 1ml saline and 6 ml adjuvant, and 4 doses of 0.5 ml
of this preparation were immediately administered to each of 3 ovariectomized Finn x
Merino. These injections of antigen emulsion were given subcutaneously at sites at the
front and rear of the flank on either side of each ewe. Booster immunisations were
given at 1 month and 2 months after the initial immunisation by an identical procedure.
Blood samples were collected by jugular venepuncture immediately prior to
immunisation and at various times before and after subsequent booster immunisations
to allow plasma antibody titres to be monitored. The titres achieved with time in the ewe
from which antiserum was subsequently used for passive immunisation (Ewe 2G14)
are shown in Fig 2.2. In this ewe exsanguination was performed 12 days after the final
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Fig. 2.2.
The change in plasma titre (assessed at 50% binding of 1251 - labelled oestradiol)
in ewe 2G14 at various time following primary immunisation at time 0 and























Percentage binding of1251 - labelled oestradiol by dilutions of the plasma from
the final bleed of a ewe (2G14) immunised against an oestradiol - rabbit serum
albumin conjugate.
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immunisation studies. During exsanguination blood was collected into heparinised
50ml tubes via a 14 gauge needle inserted into the jugular vein and centrifuged at 2000g
for 30 min. Plasma was then poured off, pooled and then aliquotted and frozen at
- 20 °C until required.
2.5.3. Measurement of Antibody Titre and Specificity
Oestradiol titre in the plasma of immunized ewes was determined by measuring
the binding of 125I - labeled oestradiol by several dilutions of plasma. Incubations were
carried out in 0.075mol phosphate-buffered 0.9% (w/v) saline/1 (pH 7.2) containing
1% (w/v) gelatin and 0.01% (w/v) thiomersalate (PGBS). The 125I - labelled oestradiol
was made up to 15 000 cpm in the buffer and 0.1ml tracer, 0.1ml plasma dilution and
0.1ml buffer (final volume 0.3ml) incubated in 10 x 75mm glass tubes overnight at
4°C. Bound tracer was then separated by adding 0.5ml Dextran Charcoal (0.125%
dextran, 1.25% charcoal in PGBS) and centrifuging at 2000g for 15 min. The
supernatant (bound fraction) was then counted and binding expressed as a percentage
of the total counts added. A plot of plasma dilution against percentage binding was then
plotted, and the titre defined as the dilution of plasma giving 50% binding. A titre curve
of the final bleed from ewe 2G14 is shown inFig 2.3. The titre of the plasma from this
bleed was expressed as 50% binding of total tracer added was 1:500 000.
Specificity of the antibody was determined by incubating several dilutions of the
hormone whose cross - reactivity was being tested with a fixed dilution of the antibody
(1:200 000) which gave 65% binding. The inhibition curve was then compared to the
inhibition curve for oestradiol and specificity estimated on a mass basis (Scaramuzzi et
al., 1975). The cross-reactivities, determined at a final antibody dilution of 1:200000,
were 100% for oestradiol-17b, 14% for oestrone, and < 0.05% for progesterone,
testosterone and androstenedione.
2.6. Inhibin Antibody Production
The anti-inhibin antiserum used in this study was raised in an ovariectomized
Scottish Blackface ewe (McNeilly, Swanston, Crow et al. 1989) to a synthetic peptide
of the 1-26 amino acid sequence of the N-terminus of the a chain of 32 kDa porcine (p)
inhibin (Rivier et al, 1986) conjugated to ovalbumin. The final titre of this antibody,
assessed at 50% binding of 125I-labeled pl-26a peptide was 1: 40000. Prior to its use
in passive immunisation studies this antibody was shown to effectively neutralise the
inhibin activity in oFF in vitro (See Chapter 6).
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The inhibin titre was determined by measuring the binding of 125I-labeled pi-26a
inhibin peptide by a series of dilutions of the antibody. Incubations were carried out in
0.075M phosphate buffered 0.9% saline (pH 7.4) containing 1% bovine serum
albumin and 0.01% thiomersalate. The 125I - labeled pi-26a inhibin peptide was made
up to 15 000 cpm in the buffer and 0.1ml tracer, 0.1ml plasma dilution, and 0.1ml
buffer (final volume 0.3ml) incubated in 10mm x 65mm plastic tubes overnight at 4°C.
Bound tracer was then separated by adding 1ml of 15% PEG + 0.1% Triton-X in 0.9%
saline and centrifuging at 3000rpm for 30 minutes. The precipitate (bound fraction) was
then counted and binding expressed as a percentage of the total counts added.
2.7. Ovine Follicular Fluid Collection
The ovine follicular fluid (oFF) used in the experiments in chapters 5 and 9 was
from a single pool of follicular fluid collected from ovaries obtained from a local
abattoir. All visible follicles were aspirated and the fluid frozen at - 20°C. The follicular
fluid was treated with charcoal to remove steroids. This was done by incubating the
follicular fluid with 5mg charcoal/ml at room temperature and then centrifuging at
lOOOg for 30 min at 4°C to remove the charcoal.To remove any residual steroids the




Samples of plasma and culture medium were assayed by immunoassay for
inhibin using an assay developed by McNeilly et al. (1989). The antibody used in this
assay (R150) was raised in a rabbit to a synthetic peptide fragment of the 1-26 amino
acid sequence of the N - terminus of the a chain of 32 KDa porcine inhibin (Rivier et
al., 1986) conjugated to ovalbumin. This antibody was used at a final dilution of 1:
75000, and the 1 - 26 a peptide fragment was labelled with 125I iodine using
chloramine - T, for use as tracer. The inhibin peptide fragment was also used as
standard in the range 39 - 10000 pg/ml. When assaying plasma samples (up to
300|i.l/tube) an equal volume of plasma from an ovariectomised ewe was added to the
NSB, B0 and standard tubes to offset a small (5 - 10%) degree of suppression of
binding caused by the presence of plasma. Prior to use batches of this ovariectomised
plasma were checked to ensure that they did not displace inhibin tracer in the assay. The
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sensitivity of the plasma assay ranged from 20 - 40 pg/ml, and intra and inter assay
coefficients of variation were 7% and 9.5%. The sensitivity of the culture medium
assay was 50 pg/ml and the intra and inter assay coefficients of variation 9% and 13%.
The protocol for the inhibin immunoassay can be found in the appendix (Section
10.1.6).
2.8.2 Inhibin Bioassay
Inhibin bioactivity was measured using a previously described bioassay (Tsonis
et al., 1986). Briefly cells from ovine pituitaries were dispersed using trypsin digestion
and diluted to a final concentration of 200000 cells per 50|il supplemented Dulbecco's
Modified Eagle's Medium (DMEM; Flow Laboratories, Rickmansworth, Herts)
containing 10% lamb serum, 2.5% fetal bovine serum, lOmmol NaHC03/l, 2mmol
glutamine/1 (Sigma), and penicillin (50i.u./ml) and streptomycin (50|ig/ml; Flow
Laboratories). Viability, measured by Trypan Blue exclusion, was 90-95%. Aliquots of
50|il of cells (200000) were plated out with 550}il modified DMEM into individual
wells of plastic culture plates (Costar; Flow Laboratories) and preincubated for 48h.
After 48h the medium was removed and replaced with inhibin standard (oRTF; 50 (il)
or sample (50 - 250 |il), and supplemented medium to a final volume of 600[il, and
incubated for a further 48 h. Medium was then collected and frozen at - 20 "C until
assayed for FSH.
The standard used was a stable lyophilised preparation of oRTF with an arbitary
potency of lU/mg (Eddie et al., 1979). A quality control of steroid stripped oFF (1083
oFF; Tsonis et al., 1986) was included in each assay. The standard and quality control
were assayed in quadruplicate at 5 doses, while the samples were assayed in triplicate
using 3 doses ranging between 25 - 250 [il/well. An FSH dose inhibition curve,
expressed as a percentage inhibition of control wells with no exposure to inhibin, was
produced for each sample and regression analysis was performed using a computer
p rogram (Scott, Burger & Quigg, 1980). The slope, index of precision (1), and
significance of regression (Finney's G; F statistic for significance/F statistic for
regression) calculated (Finney, 1964), and samples were then compared with a
reference standard and the relative potency calculated, providing there was no
significant deviation from parallelism or linearity (p > 0.05; Borth, 1976). The
minimum sensitivity of the bioassay was 0.05 -O.lU/ml, the index of precission (1)




2.9.1. M91/1 FSH Assay
This specific double antibody radioaimmunoassay, described by McNeilly et al.
(1976), was used to measure FSH concentrations in culture medium from the inhibin
bioassay and plasma samples from the experiment described in chapter 5. The assay
uses a rabbit and - human FSH antiserum M91/1 at a final dilution of 1:30000 and 125I
- labelled ovine FSH (Jutisz, FSH 181 - 2) as tracer. NIH - oFSH - S9 was used as
standard in the range 4 -1000 ng/ml. The sensitivity of the culture medium assay (90%
B/B0) was 16ng NIH - oFSH - S9/ml and the intra and inter assay coefficients of
variation 8.2% and 11.4%. The sensitivity of the plasma assay was 40ng NIH-oFSH-
S9/ml and the intra assay coefficient of variation for 3 quality control pools 4.2%: all
samples were included in a single assay. The protocol for both the plasma and the
bioassay medium assay can be found in the appendix (Section 10.1.3).
2.9.2. NIAMMD - I - 1 FSH Assay
In all other experiments FSH was measured in plasma samples using the assay
described by McNeilly et al. (1976) with rabbit anti- ovine FSH NLAMDD - 1 as first
antibody at a final dilution of 1:96000. This assay was run with a more highly purified
standard, oFSH RP1, used in the range 0.2 - 30 ng/ml, with 125I - labelled NIAMDD
oFSH - I - 1- as tracer. A comparison of the standard curves for the two assays is
shown in Fig. 2.4. The sensitivity of this assay was in the range 0.2 - 0.3ng NIH-
oFSH-RPl/ml and the intra and inter assay coefficients of variation for 3 quality control
pools 7.2% and 10.1%. The protocol for this assay can be found in the appendix
(Section 10.1.4).
2.9.3. LH Assay
LH was measured in plasma samples using the assay described by McNeilly et
al. (1976) with rabbit anti - oLH R29 as first antibody at a final dilution of 1:600000.
The assay was initially run with NIH - oLH - S18 as standard used in the range 0.2 -
50 ng/ml, and with 125I - labelled oLH LER - 1056 - C2 as tracer. The sensitivity of
this assay was 0.2ng NEH - oLH - S18/ml and the intra and inter assay coefficients of




Comparison of the standard curves for the SH FSH standard in the M/91 assay (•)
and the RP1 standard in the NIAMMD -1 - 1 assay (o). %B/Bo represents the label
bound as a percentage of the binding in the presence of no unlabelled hormone:




Comparison of the standard curves for the S18 (•) and the S25 (o)LH standards.
%B/Bo represents the label bound as a percentage of the binding in the presence
of no unlabelled hormone: each point is the mean of triplicate determinations.
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In the later experiments the NIH - oLH - S18 standard was replaced by a new
standard, NIH - oLH - S25. This standard was used in the same range as the S18 and
gave a similar standard curve (Fig 2.5.). The sensitivity of this assay was in the range
0.2 - 0.3ng NIH - oLH - S25/ml and the intra and inter assay coefficients of variation
7.2% and 11.6%. The protocol for this assay can be found in the appendix (Section
10.1.5).
2.10. Steroid Hormones Assays
2.10.1. Progesterone Assay
Progesterone was measured in plasma by a direct non - extraction
radioimmunoassay using a sheep anti progesterone antibody (361) at a final dilution of
1:35000,125I - labelled progesterone 11a glucuronide tyramine conjugate as tracer and
pregn - 4 - ene - 3,20 dione (Sigma, Poole, Dorset, U.K.) as standard in the range
0.08 - 10 ng/ml. The assay was similar to that described by (Djahanbakhch et al.,
1981), validated for the measurement of progesterone in extracted sheep plasma
(McNeilly, 1984). The assay was modified to allow direct measurement in plasma by
lowering the buffer pH to 6 and adding 8 - anilino - 1- naphthalene sulphonic acid
(100|ig/tube; Sigma) to displace binding of progesterone to carrier proteins (McNeilly
& Fraser, 1987). A volume of plasma from an ovariectomised ewe equal to the volume
of standard used was added to the NSB, Bo and standard tubes. Separation of bound
and free tracer was performed by addition of 15% polyethlyene glycol and
centrifugation at 2500 rpm for 30 min. The sensitivity of this assay was 0.1 ng/ml and
the intra and inter assay coefficients of variation 8.4% and 13.2%. The protocol for this
assay can be found in the appendix (Section 10.1.2).
2.10.2. Oestradiol Assay
Oestradiol was measured in plasma following extraction with diethly ether
(Baird et al., 1981) using sheep anti - oestradiol antibody (BW 26/9/82) at a final
dilution of 1:4000000, 125I oestradiol - 17(3 as tracer, and Oestradiol - 17(3 as standard
in the range 20 - 500 pg/ml. The sensitivity of this plasma assay was 25pg/ml and the
intra and inter assay coefficients of variation 10% and 12%. The same assay was used
to measure oestradiol in culture medium but samples were assayed directly without
prior extraction.The sensitivity of this assay was 60 pg/ml and the intra and inter assay
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coefficients of variation 10% and 14%. The protocol for both the extraction and non-
extraction assays can be found in the appendix (Section 10.1.7).
2.10.3. Androstenedione Assay
Androstenedione was measured in plasma by a previously described
radioimmunoassay (Thomson et al., 1989) modified for use in sheep plasma (Campbell
et al., 1990). The assay used an antiserum raised in a rabbit against androstenedione - 3
- carboxymethyloxime - BSA at a final dilution of 1:112000 with androstenedione - 3 -
carboxymethyloxime linked to 125I - histamine as tracer and 4 - androstene - 3,17
dione as standard in the range 4 - 250 pg/ml. Prior to assay plasma samples were
extracted using 10 volumes of a 4:1 hexane:ether mixture. The sensitivity of the assay
was 40 pg/ml and the intra and inter assay coefficients of variation 7.1 and 13.2%.
Androstenedione was measured in culture medium using the same assay but without
prior extraction. The sensitivity of the assay for culture medium was 45 pg/ml and the
intra and inter assay coefficients of variation 8.6 and 12.8%. The protocol for both the
extraction and non-extraction assays can be found in the appendix (Section 10.1.8).
2.11. Plasma Hormone Binding Capacities
2.11.1. Inhibin Binding Capacity
Inhibin binding capacity was determined in the plasma of immunized ewes by
measuring the binding of 125I-labeled pi-26a inhibin peptide in plasma collected at
various time intervals following immunization. Incubations were carried out in 0.075M
phosphate buffered 0.9% saline (pH 7.4) containing 1% bovine serum albumin and
0.01% thiomersalate. The 125I - labeled pi-26a inhibin peptide was made up to 15 000
cpm in the buffer and 0.1ml tracer, 0.1ml plasma dilution, and 0.1ml buffer (final
volume 0.3ml) incubated in 10mm x 65mm plastic tubes overnight at 4°C. Bound tracer
was then separated by adding 1ml of 15% PEG + 0.1% Triton-X in 0.9% saline and
centrifuging at 2000g for 30 minutes. The precipitate (bound fraction) was then counted
and binding expressed as a percentage of the total counts added.
2.11.2. Oestradiol Binding Capacity
Oestradiol binding in the plasma of immunized ewes was determined by
measuring the binding of 1251 - labeled oestradiol by plasma samples at a final diluition
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of 1:1200. Incubations were carried out in 0.075mol phosphate-buffered 0.9% (w/v)
saline/1 (pH 7.2) containing 1% (w/v) gelatin and 0.01% (w/v) thiomersalate (PGBS).
The 1251 - labelled oestradiol was made up to 15 000 cpm in the buffer and 0.1ml
tracer, 0.1ml plasma dilution and 0.1ml buffer (final volume 0.3ml) incubated in 10 x
75mm glass tubes overnight at 4°C. Bound tracer was then separated by adding 0.5ml
tyo A)) I
Dextran Charcoal (0.125% dextran, 1.25% charcoal in PGBS) and centrifuging at 2000
g for 15 min. The supernatant (bound fraction) was then counted and binding
expressed as a percentage of the total counts added.
2.12. Assay Counting and Data Reduction
In Chapters 3, 4, and 5 assay tubes were counted using a 5400 Series
CRYSTAL™ Multidetector Manual Gamma Counter (Packard Instrument Company,
Downers Grove, II) with well type sodium iodide crystal detectors and a detection
efficiency for 125I of 75%. The machine calculates the % B0 and the % NSB and then
calculates the net counts per min (Counts per min - NSB counts per min) for standards,
quality controls and samples. The machine then calculates a standard curve using a 4 -
parameter logistic fit which straightens out hyperbolic curves to provide straight line
curves out to the end point parameters (B0 and NSB). The machine then calculates the
ED20, ED50 and EDgo as well as quality control and samples hormone concentration,
giving the coefficient of variation for each quality control or sample. Sample values are
rejected if they show poor replication (> 3 S.D.) or are out of the standard range.
In chapters 6, 7, 8 and 9 assay tubes were counted using a 1261 Multigamma
Counter (Wallac oy, Turka, Finland) with well type aluminium - covered sodium iodide
crystals and a minimum efficiency for 125I detection of 75%. The counts were collected
in a digital data logger (Mutek Data Grabber) and transfered to an Apple Macintosh
computer on which calculations were made using the Assayzap assay calculation
programme (Elsevier, Biosoft, U.K.). Assayzap plots a standard curve using a 4 -
parameter fit which uses the B0 and NSB values to estimate the upper and lower limits
of the curve and then finds the best estimated fit through the standard points. The
programme then adjusts this fit by weighting individual points according to how closely
they agree with the estimated fit, effectively ignoring outlying points. The programme
keeps a record of quality controls and provides a constantly updated measure of the
inter - assay coefficient of variation, as well as calculating the intra - assay coefficient of
variation for each of the quality controls.
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2.13. Statistical Analysis
Statistical analysis of data was carried out using an Apple Macintosh computer.
Student's t - tests were carried out using the Statworks programme (Data Metrics Inc.),
correlation analysis was performed using the Statview 512+ programme (Brainpower
Inc., Calabasas, CA) an& analysis of variance was performed using the CLR Anova
(Clear Lake Research) programme. Pulse analysis was performed using the Munro
pulse analysis programme (Elsevier, Biosoft, U.K.).
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Chapter 3
Source of Ovarian Inhibin Secretion
During the Oestrous Cycle
3.1. Introduction
Inhibin is produced by the granulosa cells of ovarian follicles (Henderson &
Franchimont, 1981; Tsonis et al., 1983; Bicsak et al., 1988), high concentrations being
found in the follicular fluid of all species studied, including sheep (Tsonis et al., 1983).
There is also evidence to indicate that the corpus luteum secretes inhibin in women
(Davis et al., 1987; McLachlan et al., 1987; Tsonis et al., 1987) and in mature rats,
where mRNA for inhibin has been demonstrated in luteal tissue (Davis et al., 1986).
Although it has also been suggested that the sheep corpus luteum secretes inhibin, as
measured by bioassay (Tsonis et al., 1988a; Tsonis et al., 1988b) efforts to
demonstrate inhibin gene expression in luteal tissue have failed in sheep and cattle
(Rodgers et al., 1989), as have attempts to show inhibin production from cultured
bovine luteal tissue (Henderson & Franchimont, 1983). There is, therefore, some
uncertainty as to whether the sheep corpus luteum secretes inhibin.
As well as uncertainty over the source of inhibin production in the sheep,
reports are contradictory over the changes in inhibin concentration during the oestrous
cycle. Peripheral inhibin levels have been reported as remaining unchanged following
luteal regression (McNeilly et al., 1989), at a time when FSH levels are falling, while
Tsonis et al., (1988a & b) have reported a fall in concentration of bioactive inhibin at
this time. Inhibin levels have, however, also been reported to rise during the follicular
phase (Findlay et al., 1990; Campbell et al., 1990a), though the rise reported by
Campbell et al. was not consistent between animals.
In this study we have investigated the source of inhibin secretion in the ovary of
the sheep by comparing ovarian secretion rates before and after enucleation of the
corpus luteum, and by comparing secretion rates from ovaries with corpora lutea to
contralateral ovaries without luteal tissue. We have also investigated inhibin secretion
rates and peripheral concentrations at different stages of the oestrous cycle, in order to
see whether changes occur as the ewe progresses from the luteal phase through the
follicular phase of the cycle.
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3.2. Materials and Methods
3.2.1. Synchronisation and Grouping
The following experimental procedures were carried out during the breeding
season, in November and December 1987, on 24 mature Scottish Blackface ewes.
Oestrous cycles were synchronised as described in Section 2.2. The animals were then
allocated to four groups of six animals with similar mean group weights (64.3±0.1 kg).
Animals in group A were operated on during the mid luteal phase of the oestrous cycle
(Day 10). Groups B, C, and D were operated on during the follicular phase 26.8±1.4,
36.610.8, and 59.8±0.3h following an i.m. injection of cloprostenol (125|ig) on day
10 of the oestrous cycle.
3.2.2. Experimental Procedure
Anaesthesia was induced by minimal quantities (200-300mg) of a mixture of
two parts thiopentone (Intraval; RMB Animal Health Ltd, Dagenham. Essex, U.K.)
and one part pentobarbitone sodium (Sagatal; May and Barker Ltd, Dagenham, Essex,
U.K.) and maintained using halothane (1.5 - 2.5%). The jugular vein was cannulated
using a plastic cannula and three - way tap. Mid ventral laparotomy was then performed
and the reproductive tract exteriorized. Both ovarian veins were cannulated 1 - 2 cm
from the ovary using a 21 - gauge needle, and 5000 units of heparin administered i.v.
through the jugular cannula. The proximal end of the ovarian vein was then occluded
and two or three serial timed 10 ml samples of ovarian venous blood collected by
syringe on both sides of the tract. The corpora lutea were then enucleated by blunt
dissection, and further timed samples of ovarian venous blood collected. Jugular
venous samples (20ml) were taken before and after enucleation of the corpora lutea.
Finally, the ovaries were removed and all follicles >3mm dissected out. In jugular
venous plasma LH, FSH, immunoactive inhibin and progesterone were measured by
radioimmunoassay and in ovarian venous plasma immunoactive inhibin, progesterone,
and oestradiol were measured. Where sufficient plasma was available bioactive inhibin
was also measured in ovarian venous plasma.
3.2.3. Analysis of Data
Hormone levels at different stages of the oestrous cycle were analysed by
analysis of variance and a Duncan's Multiple Range test. Hormone secretion rates were
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calculated from the concentration of hormone in the ovarian vein, the flow rate, and the
haematocrit (Baird et al., 1981). Secretion rates before and after enucleation of the
corpus luteum were analysed by means of a Student's paired t -test, with pre- and post-
enucleation hormone ratios being analysed by a Student's paired t -test on square root
transformed data. When comparing inhibin secretion rates from ovaries with and
without luteal tissue, and ovaries with and without follicles > 3mm, a Student's paired t
-test was also used. The bioactive/immunoactive inhibin ratios were analysed using a
rankit normality test (Wardlaw, 1987) and found to deviate from normal distribution,
and so a non-parametric Mann Witney U test was applied. The metabolic clearance rate
(MCR) of inhibin was calculated using the formula:
MCR = Ovarian Secretion Rate / Peripheral Concentration
Calculations were made for all animals using the mean secretion rate before enucleation
of the corpus luteum, and the mean peripheral concentration of inhibin at that time.
3.3. Results
Following cloprostenol-induced luteal regression there was a rise in the
concentration of LH and a fall in the concentration of FSH (Fig. 3.1.). This fall in FSH
approached significance (p<0.06) in the group 36h following cloprostenol - induced
luteal regression (3.10±0.34 compared with 4.25±0.41 ng/ml), and in the group 60h
after cloprostenol concentrations of FSH were significantly (p<0.05) elevated
(8.88±1.84 ng/ml). Two of the ewes in the group 60h after cloprostenol - induced
luteal regression were sampled during the LH surge (concentration > lOng/ml)
suggesting that the elevated concentration of FSH in this group was due to the
coincidental periovulatory FSH peak.
Peripheral concentrations of progesterone were significantly (p < 0.001) lower
at 24-30, 36, and 60h following cloprostenol-induced luteal regression compared to the
0 h luteal phase group (Fig. 3.2.), this fall being indicative of luteolysis. During the
experiment there were no significant differences in the concentration of inhibin in
peripheral blood between groups (Fig.3.2.), although a slight decline was evident
which approached statistical significance (p < 0.06) by 60h.
When hormone secretion rates from both ovaries were examined, progesterone
was once again significantly (p < 0.01) lower in the three groups in which luteolysis
was induced by cloprostenol than in the luteal phase group (Fig. 3.3.). Inhibin
secretion rate was not significantly different between the four groups, ranging from





















Time From Cloprostenol (h)
Fig. 3.1.
Mean (+ S.E.M.) peripheral plasma concentrations of (a) LH and (b) FSH
in sheep 0, 24-30, 36 and 60 h after i.m. injection with cloprostenol. (n = 6)
t p < 0.07, * p < 0.05 compared to the 0 h group (analysis of variance
0 *v\vA\}cv.pV<L. revise tot).
was significantly (p < 0.05) higher than during the luteal phase (2.37±0.61 compared
with 0.7810.20 ng/min), but by 60h after injection with cloprostenol the secretion rate
of oestradiol had returned to a value similar to that found during the luteal phase
(0.7110.38 ng/min).
As expected, enucleation of the corpus luteum resulted in a significant
(p < 0.001) fall in the secretion rate of progesterone (Fig. 3.4.). There was also a less
marked fall in the secretion rate of both inhibin (p < 0.001) and oestradiol (p < 0.01).
The changes in hormone secretion rate following corpus luteum enucleation are shown
in a single representative animal in Fig. 3.5., which shows clearly the smaller fall in the
secretion rates of inhibin and oestradiol. As the corpus luteum in the sheep does not

















Time from Cloprostenol (h)
Fig 3.2.
Mean (± S.E.M.) peripheral plasma concentrations of (a) progesterone and
(b) inhibin in sheep 0, 24-30, 36 and 60 h after i.m. injection of cloprostenol.
(n = 6) *** p < 0.001 compared with 0 h group (analysis of variance
QA.AU.WV5
have been the result of the removal of secretion of inhibin by the corpus luteum. To
clarify this problem progesterone to inhibin and oestradiol to inhibin ratios were
compared before and after enucleation. While the progesterone to inhibin ratio fell
significantly (p < 0.001) following enucleation (252.8±69.7 compared with
45.7±12.7), the oestradiol to inhibin ratio remained unchanged (0.61±0.15 compared
with 0.57±0.14).
In 11 animals which contained luteal tissue in only one of the two ovaries, the
secretion rate of progesterone, as expected, was significantly (p < 0.05) lower from the
ovary without luteal tissue when compared with the contralateral one with a corpus

























o 24-30 36 60
Time From Cloprostenol (h)
Fig. 3.3.
Mean (±S.E.M.) combined rate of ovarian secretion of (a) progesterone
(b) inhibin and (c) oestradiol in sheep 0, 24-30. 36 and 60 h following
i.m. injection with cloprostenol. (n = 6) * p < 0.05, ** p < 0.01, *** p < 0.001

























Mean (± S.E.M.) rates of ovarian secretion of progesterone, inhibin and oestradiol
before (HI) and after (S) enucleation of the corpus luteum.** p < 0.01 *** p < 0.001








































The effect of corpus luteum enucleation on the ovarian secretion









































Mean (± S.E.M) ovarian secretion rates of progesterone, oestradiol and
inhibin from ovaries with (JU) and without (□) a corpus luteum (CL) (n =
11). * p < 0.05 (Student's paired t - Test).
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secretion rates of inhibin and oestradiol, however, did not differ between ovaries with
and without luteal tissue (inhibin, 1.41 ± 0.30 compared with 1.32 ± 0.30 ng/min;
oestradiol, 1.00 ± 0.35 compared with 0.86 ± 0.27 ng/min). In four animals, one of
the two ovaries contained no follicles > 3mm while the contralateral ovary possessed a
number of follicles above this size. As expected, in these animals the ovaries with
larger follicles secreted significantly (p < 0.05) more oestradiol than the ovaries without
follicles > 3mm (1.75 ± 0.59 compared with 0.05 ± 0.01 ng/min) (Fig. 3.7.). Inhibin
secretion was also significantly (p < 0.01) higher from ovaries with follicles > 3 mm
than from the contralateral ovaries containing only small follicles < 3 mm (2.28 ± 0.36
























Mean (± S.E.M) ovarian secretion rates of oestradiol and inhibin from ovaries
with (||j) and without (^) follicles > 3 mm (n = 4). * p <0.05, ** p < 0.01
(Student's paired t - Test).
In animals in which the concentrations of inhibin in the ovarian vein were
sufficiently high and enough plasma was available, the concentration of bioactive
inhibin was measured. The bioactive and immunoactive concentrations of inhibin in
these samples showing good correlation (y = 0.49+0.54x, r = 0.71; p < 0.001) (Fig.
3.8.). As a result of this high correlation the pa(ern of bioactive inhibin secretion
between the four groups was similar to that of immunoactive inhibin (Fig. 3.9.),






Correlation between immunoactive & bioactive inhibin concentrations in
ovarian venous plasma samples on which a bioassay was performed, (n = 57)
*** p < 0.001 (Regression analysis).
2 3 4 5
Bioactive Inhibin (U/ml)
0 24 "30 36 60
Time From Cloprostenol (h)
Fig. 3.9.
Mean (± S.E.M.) rates of secretion of immunoactive (El) and bioactive (□)
inhibin per ovary in sheep 0 (n = 12), 24 - 30 ( n = 10), 36 ( n = 6) and 60
(n = 11) h after i.m. injection with cloprostenol, based on samples on which
inhibin bioassays were performed.
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immunoactive inhibin was 0.68 (range 0.30 - 1.40) in the luteal phase (n=17), and
1.04 (range 0.18 - 3.37) in the follicular phase (n=40). While the ratio was higher
during the follicular phase, this difference was not statistically significant.
The MCR of inhibin was 43.0±4.9 ml plasma/min (n=24).
3.4. Discussion
The hormone secretion rates in this study were based on samples collected by in
situ cannulation of the ovarian veins in anaesthetized ewes. Despite the fact that the
ewes were under anaesthetic, the secretion rates were similar to those found in a
previous study on ewes in which the left ovary and its vascular pedicle had been
autotransplanted to the neck, to allow the secretion rate of ovarian hormones to be
measured in the conscious animal (McNeilly et al., 1989). The similarity in the pattern
of progesterone secretion by the ovaries and the concentration in jugular venous plasma
following luteal regression, also suggests that the in situ cannulation accurately reflects
the true ovarian secretion in vivo.
In this study we found no significant changes in the concentration or secretion
rate of immunoactive or bioactive inhibin following luteal regression, a finding similar
to that of McNeilly et al. (1989). Other studies have shown a fall in bioactive inhibin
(Tsonis et al., 1988a & b), or a rise in immunoactive inhibin (Findlay et al., 1990;
Campbell et al., 1990a) at this time, though the rise reported by Campbell et al. was not
consistent between animals. One explanation for the different findings in immunoactive
inhibin levels could lie in the assays used as our assay involves an antiserum raised to a
fragment of the a-chain (McNeilly et al., 1989), while the assay used by Findlay et al.
utilizes an antiserum raised to the whole inhibin molecule. However, both assays been
shown to give similar results when used to measure ovarian vein plasma inhibin
concentrations in the same samples (Campbell et al., 1990a). Breed differences in
inhibin concentrations appear to exist and these could represent one possible
explanation for the differing results. Inhibin secretion also shows marked episodic
fluctuations (Campbell et al., 1989; McNeilly & Baird, 1989) and in cross-sectional
studies the timing of collection of samples in relation to these fluctuations could
influence the findings.
The correlation between immuno and bioactive inhibin in those samples assayed
for both types of activity was highly significant. The immunoassay involves the use of
an antiserum raised to the first 1 to 26 amino acids of the N-terminus of the a-chain of
the inhibin molecule which raises the possibility that as well as measuring whole
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inhibin molecules, this assay could be detecting free a-chains, which would cross-react
completely with the antiserum. There is evidence for the existence of large quantities of
free inhibin a-chain in cultured rat granulosa cells (Bicsak et al., 1988), and in bovine,
but not ovine, follicular fluid (Knight et al., 1989). The fact that our a-chain assay and
the whole molecule assay of Findlay et al. (1990) showed similar results when
measuring different molecular weight forms of inhibin also indicates that free a-chains
do not pose a problem in our ovine assay system. In the sheep, using immunoblotting,
McNeilly et al. (1989) found no evidence for the existence of free a-chains, and found
a good correlation between immunoactive and bioactive concentrations of inhibin in
culture media from ovine follicles. These reports, together with the fact that in this
study the immunoassay showed good correlation with the inhibin bioassay, which
would not measure the non-bioactive free a-chains, indicates that the immunoassay is
giving a true measure of whole inhibin molecule levels.
Inhibin has been reported to be secreted in forms with reduced bioactivity
during the follicular phase of the human menstrual cycle (Robertson et al., 1988). In
this study the ratio of bioactive to immunoactive inhibin was found to be higher during
the follicular phase, though this difference was not statistically significant. It would
appear in the sheep, therefore, that there is no such fall in the bioactivity of inhibin
following luteal regression.
Inhibin and oestradiol are thought to act in combination to cause suppression of
pituitary production of FSH (Martin et al., 1988). In this study the rate of secretion of
inhibin and jugular concentration, as well as peripheral FSH levels, were slightly lower
in the two groups 24-30 and 36h after cloprostenol-induced luteal regression than in the
mid luteal group. These results suggest that changes in inhibin levels are not
responsible for the decline in FSH levels seen after luteal regression, and that
oestradiol, the rate of secretion ofwhich was significantly higher in the two groups 24-
30 and 36h after injection with cloprostenol than in the luteal phase group, is the major
modulator of this change. The low MCR for inhibin (43 ml/min) found in this study is
of a similar order of magnitude to that found in a previous study (21.3±1.2ml/niin;
McNeilly et al., 1989) when compared to a much higher value reported for oestradiol of
1600 ml/min (Challis et al., 1970). This indicates that inhibin may be involved in the
more long term regulation of FSH levels, while oestradiol with its much faster
clearance rate may act as the regulator ofmore acute changes, as well as interacting with
inhibin in longer term regulation. The hypothesis that oestradiol is more important than
inhibin in regulating the fall in FSH seen at this time is supported by the fact that in the
60h group, where FSH levels were increased, the rate of secretion of oestradiol
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showed a significant fall below that seen earlier in the follicular phase, while the rate of
secretion of inhibin showed no such fall.
During the experiment, hormone secretion rates showed a slight tendency to
decline, probably as a result of the anaesthesia. This was accentuated by the disruption
to blood flow caused by the process of enucleation of the corpus luteum. As a result of
this, following enucleation a significant decline was observed in the secretion rate of
oestradiol, which is produced entirely by the follicles in the sheep (Baird &
Scaramuzzi, 1976). A fall was also observed in inhibin secretion rate following
enucleation, this fall appearing to be more closely related to the decline in oestradiol
than to the large fall seen in progesterone secretion. To investigate whether the fall in
secretion of inhibin was the result of the removal of a secretory source (the corpus
luteum) like the fall in progesterone, or an artifact like the fall in oestradiol, the ratios of
progesterone to inhibin and oestradiol to inhibin were compared before and after
enucleation. The results showed that inhibin was following the same pattern as
oestradiol, suggesting that inhibin is being produced largely, if not entirely, by the
follicles, and not by the corpus luteum. This hypothesis was strengthened when
hormone secretion rates were compared from ovaries with and without luteal tissue in
the same animal. While significantly more progesterone was produced by ovaries with
luteal tissue, no differences were found in the secretion rate of inhibin or oestradiol
between the two ovaries. It would seem unlikely, therefore, from this data that the
ovine corpus luteum secretes any significant amount of inhibin, despite previous
reports to the contrary (Tsonis et al., 1988a & b). When rates of secretion of inhibin
were compared from ovaries with and without large antral follicles (>3mm) in the same
animal, secretion of inhibin was significantly higher from ovaries with large antral
follicles, ovaries without large antral follicles secreting low levels of inhibin in all
cases. This finding was similar for oestradiol, suggesting that it is the large antral
follicles which are the most important source of inhibin production. This idea is
supported by the findings of Rodgers et al. (1989) who demonstrated the presence of a
and pA-inhibin mRNA in the antral follicles of sheep and cattle, but were unable to
show mRNA for inhibin in either cyclic or pregnancy corpora lutea in sheep, and could
only show low, declining, levels in early bovine corpora lutea.
In a previous study, Tsonis et al. (1988a) reported that the concentration of
bioactive inhibin was higher in blood draining ovaries with luteal tissue than ovaries
without, and that ovaries with multiple corpora lutea secreted more inhibin than those
with a single corpus luteum. It should, however, be noted that in the earlier study
Merino ewes, with a lower ovulation rate than Blackface ewes, were used, and that
utero-ovarian rather than ovarian venous blood was collected, the concentrations of
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ovarian hormones obviously differing between the two blood types. The earlier study
also involved the pooling of results from normal ewes with ewes immunized against
androstenedione which have been shown to secrete higher levels of inhibin due to the
presence of larger numbers of follicles (Campbell et al., 1988), this larger number of
follicles being reflected in a higher ovulation rate and hence a higher number of corpora
lutea. It would therefore seem likely that in the earlier study more of the ovaries with a
corpus luteum came from immunized animals, and as the Merino ewe usually has a
single ovulation, most of the ovaries with two corpora lutea probably originated from
immunized ewes. This would mean that a disproportionate number of the ovaries with
luteal tissue were coming from immunized animals, with larger numbers of inhibin-
secreting antral follicles, and would explain why ovaries with luteal tissue appeared to
be secreting more inhibin.
From the results of this study we conclude that, in the sheep, the corpus luteum
secretes very little, if any bioactive or immunoactive inhibin, and that large antral
follicles are by far the main source of production of ovarian inhibin. We also conclude
that inhibin does not appear to be responsible for the fall in FSH seen during the
follicular phase of the oestrous cycle in the ewe, oestradiol being more important in this
aspect of FSH regulation.
55
Chapter 4
Hormone Production from Follicles
at Different Stages of the Oestrous Cycle
4.1. Introduction
The results of Chapter 3 indicated that in the sheep, the corpus luteum does not
secrete a significant amount of inhibin into the ovarian vein, and that antral follicles
greater than 3 mm in diameter are by far the main source of ovarian inhibin. Attempts to
show inhibin gene expression in ovine luteal tissue have failed (Rodgers et al., 1989),
supporting the suggestion that the ovine corpus luteum does not produce inhibin, while
in the same study Rodgers et al. were able to show inhibin gene expression in ovine
follicles. A number of studies have demonstrated inhibin production from the granulosa
cells of ovarian follicles (Henderson & Franchimont, 1981; Tsonis, 1984; Bicsak et al.,
1988) and it seems reasonable to assume that follicles are the main source of ovarian
inhibin in the sheep. However, little is known about the inhibin production from
different individual follicles, for example oestrogenic and atretic follicles, at different
stages of the cycle.
Large antral follicles are also known to be the main source of ovarian oestradiol
production (Baird & Scaramuzzi, 1976) and oestradiol secretion is known to increase
as ewes progress from the luteal phase through the follicular phase (Baird & McNeilly,
1981) due to the emergence of highly oestrogenic follicles. Changes in inhibin
concentration at this time are, however, less clear. In Chapter 3 a small decline in both
inhibin secretion rate and peripheral concentration was observed at this time while other
studies have reported no change in inhibin secretion (McNeilly et al., 1989) or a rise in
inhibin secretion (Findlay et al., 1990; Campbell et al., 1990a). As the rise in oestradiol
secretion at this time can be explained in terms of the development of highly oestrogenic
follicles destined for ovulation, it may be that a detailed study of inhibin production
from individual follicles may be able to add further to an understanding of the changes
in inhibin secretion at this time.
In the ewe follicle selection is thought to occur during the early follicular
phase, from the pool of small antral follicles present at that time (McNatty, 1982;
Tsonis et al., 1984a; Webb et al., 1989), the selected oestrogenic follicle(s) emerging
by lOh following luteolysis (McNatty et al., 1982). The decline in FSH concentration
at this time is thought to be important in controlling the number of follicles that develop
to ovulation (Baird, 1983) and the increase in oestradiol secretion from "selected"
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follicle(s) is thought to be the main factor regulating this decline in FSH, though inhibin
may also be important. By investigating the hormonal characteristics of individual
follicles it may be possible to further clarify the role of inhibin during this important
period.
In this study we investigated the hormonal characteristics of individual follicles
in ewes during the luteal phase and at 3 stages of the follicular phase, as well as
patterns of follicle development and hormonal characteristics.
4.2. Materials and Methods
This experiment was performed using the ovaries collected from the animals in
the in situ cannulation experiment described in Chapter 3 and so methods will only be
described in detail where differences from the previous experiment exist.
4.2.1. Synchronisation and Grouping
The following experimental procedures were carried out during the breeding
season, in November and December 1987, on 24 mature Scottish Blackface ewes.
Oestrous cycles were synchronised and animals were then allocated to four groups of
six animals with similar mean group weights (64.3±0.1 kg) and operated on during the
mid luteal phase of the oestrous cycle (Day 10) or during the follicular phase 26.8±1.4,
36.6±0.8, or 59.8±0.3h following a further injection of cloprostenol (125pg) on day
10 of the luteal phase.
4.2.2. Experimental Procedure
Anaesthesia was induced and mid ventral laparotomy was then performed and
the reproductive tract exteriorized. Both ovarian veins were cannulated and serial timed
samples of ovarian venous blood collected by syringe on both sides of the tract. The
ovaries were removed to allow follicle dissection. Follicles judged to be greater than
3mm in diameter were first removed from the ovary by rough dissection, and then the
surrounding stroma was removed under a stereoscopic microscope. Each follicle was
then placed in an individual well of a culture plate and incubated for 2h in 1ml of
Medium 199 (Flow Laboratories) at 37°C. Follicles were then removed from the culture
medium and frozen. Later the antral fluid of each follicle was made up to 1ml in
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phosphate buffered 0.9% saline for hormone measurement. To do this the volume of
each follicle was estimated from its diameter according to the formula:
Volume = 2 x (Diameter 2-7) (Carson et al., 1981)
4.2.3. Analysis of Data
Hormone secretion rates were calculated from the concentration of hormone in
the ovarian vein, the flow rate, and the haematocrit (Baird et al., 1981) and hormone
levels at different stages of the oestrous cycle analysed using analysis of variance and
Duncan's Multiple Range test. The production of hormone during incubation was
correlated to follicular diameter and to the secretion rate into the ovarian vein in vivo by
regression analysis. The number of each type of follicle present at different stages of
the oestrous cycle was analysed by analysis of variance on data that had been
transformed (V(x +V2) due to the presence of no follicles of a particular class in some
animals in certain groups, while hormone concentrations in follicular fluid and incubate
medium were compared between different follicle types by analysis of variance on
untransformed data. A follicle was classified as being oestrogenic if the follicular fluid
oestradiol concentration was > 200 ng/ml and the production of oestradiol during the 2h
incubation period was > 25 pg/min. Follicles were then classified as small or large
based on a size of < 4mm or > 4mm. The small follicles (< 4mm) were all non -
oestrogenic while the large follicles were sub divided into oestrogenic and non -
oestrogenic groups.
4.3. Results
4.3.1. In Vivo Results
The peripheral hormone concentrations and hormone secretion rates into the
ovarian veins have been discussed in detail in Chapter 3 and will only be briefly
described here in order to allow the hormonal conditions at the time of ovary removal to
be established. Following cloprostenol - induced luteal regression at time Oh there was
a rise in the concentration of LH, and a fall in the concentration of FSH (p < 0.06)
(Fig. 4.1 (a) and (b)). In the group operated on 60h following luteal regression LH
concentration was > lOng/ml in 2 of the animals indicating the occurrence of an LH
surge, and suggesting that the elevated concentration of FSH seen in this group
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60
Fig. 4.1.
Mean (± S.E.M.) peripheral plasma concentrations of a) LH and b) FSH and mean
(±S.E.M.) combined secretion rates into both ovarian veins of c) progesterone, d)
inhibin and e) oestradiol in groups of 6 ewes operated on at day 10 of the luteal phase
(time = 0) or during the follicular phase 24 - 30, 36, or 60h following an injection of
125|ig cloprostenol on day 10 of the luteal phase to induce luteal regression. (* p < 0.05,
**
p < 0.01, *** p < 0.001 compared with the luteal phase group, analysis of variance
b3 testy.
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progesterone was significantly (p <0.01) lower in the 3 groups following cloprostenol
injection indicating that luteal regression had occurred (Fig 4.1 (c)) while the secretion
rate of oestradiol was significantly (p < 0.05) elevated in the group 24 - 30h following
luteal regression but returned to luteal phase levels by 60h (Fig. 4.1 (e)), while inhibin
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Correlation between the hormone secretion rates into the vein draining each ovary
and the combined in vitro hormone secretion from all the follicles dissected from that
ovary for (a) oestradiol (n = 48; R = 0.60; p < 0.001) and (b) inhibin (n = 48; R =
0.57; p < 0.001, regression analysis).
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4.3.2. In Vitro Results
Good correlation was found between the concentration in follicular fluid and
hormone production during incubation for oestradiol (correlation coefficient, R = 0.92)
inhibin (R = 0.72) and androstenedione (R = 0.51) (all p < 0.001). There were,
however, large differences in the ratio of follicular fluid concentration and hormone
production during incubation between hormones. During the incubation period the total
amount of androstenedione secreted represented 6.7 ± 0.4% of that remaining in the
follicular fluid. This proportion of androstenedione was significantly (p < 0.001)
greater than that of oestradiol (2.5 ± 0.2) or inhibin (0.5 ± 0.0.4). The production of
oestradiol was, in turn, significantly (p < 0.001) greater than that of inhibin. There was
also good correlation when the ovarian secretion rates of both inhibin and oestradiol
into each ovarian vein in vivo were compared to the total combined rates of hormone
production during culture from all the follicles dissected from that ovary (oestradiol - R
= 0.60; inhibin, R = 0.57; both p < 0.001) (Fig 4.2.). The in vivo secretion rate was,
however, 20 - 30 times larger than the rate of in vitro hormone production.
When inhibin production from follicles during incubation was compared to their
diameter good correlation was found (R = 0.72; p < 0.001), while a similar comparison
for oestradiol resulted in a somewhat lower correlation coefficient (R = 0.56;
p < 0.001) (Fig 4.3.). While 90% of follicles greater than 4 mm in diameter secreted at
least 10 pg/min of inhibin into the culture medium over 60% of follicles above this size
secreted less than 25 pg/min, and a number of follicles as large as 6 - 9 mm secreted
only minimal quantities of oestradiol. Androstenedione production during incubation
was also correlated with follicle diameter, though less strongly than oestradiol or
inhibin (R = 0.39; p < 0.01). Oestradiol and inhibin concentrations in the follicular
fluid were also correlated with follicles diameter (oestradiol, R = 0.55; inhibin,
R = 0.49; both p < 0.001) while androstenedione concentration in the follicular fluid
did not correlated significantly with follicle diameter (R = 0.09).
When the in vitro production of oestradiol in relation to follicle size was
compared in the four groups of ewes individually all the groups were found to contain a
number of follicles of various sizes up to 7 - 9mm which secreted minimal quantities of
oestradiol (Fig 4.4.). However, there were large differences in the number of follicles
secreting significant quantities of oestradiol. In the luteal phase group there were 4
follicles that secreted > 25pg oestradiol/min compared to 7 follicles in the group
operated on 24 - 30h following luteal regression and 12 such follicles in the 36h group,
while in the 60h group there were only 3 such follicles. The number of these follicles in
the 36h group was significantly greater than the number in the luteal phase and 60h
Follicle Diameter (mm)
Fig. 4.3.
Correlation between follicle diameter and the rate of hormone secretion in vitro for a)
oestradiol (n = 113; R = 0.56; p < 0.001) b) inhibin (n = 113; R = 0.72; p < 0.001) and
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groups (p < 0.001) as well as the 24h group (p < 0.05), which in turn contained
significantly more of these follicles than the luteal phase and 60h groups. This pattern
of follicle oestrogen production was not mimicked by the production of inhibin, as
when in vitro inhibin production was compared to follicle diameter a similar
distribution of production in relation to follicle diameter was seen in all groups (Fig
4.5.).
The numbers of each class of follicle per ewe, in each of the 4 groups, are
shown in Fig 4.6. The total number of follicles was lower in the two groups 36 and 60
h into the follicular phase though this difference was not significant. There were,
however, significantly (p < 0.05) fewer small follicles in these two groups than in the
luteal phase group or the 24h group. While the total number of large follicles did not
differ between the four groups, there were significantly more large oestrogenic follicles
in the 24h (p < 0.05) and 36h (p <0.01) groups than in the luteal phase or 60h groups.
The 36h group also contained significantly (p < 0.05) more large oestrogenic follicles
than the 24h group, but possessed significantly (p < 0.05) fewer large non -
oestrogenic follicles than any of the other groups.
Large oestrogenic follicles contained a 20 fold higher follicular fluid
concentration of oestradiol than either large non - oestrogenic or small follicles
(Fig 4.7.). Despite having similar low follicular fluid oestradiol concentrations the large
non - oestrogenic follicles secreted significantly (p < 0.01) more oestradiol during
incubation than the small follicles (8.0 ±1.4 compared with 2.6 ± 0.4 pg/min)
(Fig 4.8.). Like follicular fluid concentration, oestradiol production during incubation
was also significantly (p < 0.001) higher from large oestrogenic follicles than from the
other two groups. The concentration of inhibin in the follicular fluid of large
oestrogenic follicles (1380 ±105 ng/ml) was significantly higher than that of large non
- oestrogenic or small follicles (Fig. 4.7.). However, in contrast to their very low
oestradiol concentrations, these large non - oestrogenic and small follicles still
contained appreciable concentrations of inhibin (676 ± 87 and 488 ± 62 ng/ml
respectively). The production of inhibin during incubation was also greater (p < 0.01)
in large oestrogenic follicles than in the other two groups (Fig 4.7.). While follicular
fluid inhibin concentration did not differ significantly between large non - oestrogenic
and small follicles, inhibin production during incubation was significantly (p < 0.001)
greater from the larger follicles. Androstenedione concentration was significantly (p <
0.05) higher in the antral fluid of large oestrogenic follicles than non - oestrogenic
ones, while the follicular fluid concentration in small follicles did not differ from that in
either class of large follicle (Fig 4.7.). Androstenedione production during incubation
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follicles (Fig 4.8.), while in contrast to antral fluid concentration, androstenedione
production from small follicles was significantly lower than from both large non -
oestrogenic (p < 0.05) and large oestrogenic (p < 0.001) follicles.
At the time of operation, the ovaries of the ewes contained a mean of 1.8 ± 0.1
corpora lutea per ewe indicating the ovulation rate in the previous cycle.
4.4. Discussion
In this study we have used hormone production over a 2h incubation period as
an indication of the secretory capacity of individual follicles. When the secretion rate
into the ovarian vein draining an ovary was compared to the combined in vitro
hormone production from all the follicles dissected from that ovary, a good correlation
was found for both inhibin and oestradiol. While the rate of secretion measured in vivo
was some 20 to 30 fold higher than that seen during incubation, these high correlations
do indicate that the incubation procedure was giving a reasonable indication of the
pattern of secretory capacity of individual follicles. A lower production rate during the
incubation procedure used in this study would, however, be expected due to the lack of
gonadotropic stimulation and the absence of capillary blood flow. These results are in
agreement with those of Webb & Gauld (1985) who showed that a similar 2h
incubation reflected in vivo steroid production, as well as follicular fluid steroid
content (Webb & Gauld, 1987).
There was a good correlation between the inhibin production in vitro and the
diameter of the follicle. However, when a similar comparison was made for oestradiol
the correlation was somewhat lower. This was due to the presence of a number of large
follicles with low oestradiol production, i.e. the population of large atretic follicles
which were still producing considerable quantities of inhibin. While large non -
oestrogenic follicles were found to have lower follicular fluid inhibin concentrations
and secrete less inhibin during culture than large oestrogenic follicles, the magnitude of
these differences was much lower than was the case for oestradiol (2 fold for inhibin
compared with 10 to 20 fold for oestradiol). The results of this study also revealed that
small follicles provided a larger proportion of the total inhibin production than that of
oestradiol (12% of inhibin production compared with 3% of oestradiol production), as
did large non - oestrogenic follicles (33% compared with 7%). This resulted in large
oestrogenic follicles contributing only 55% of the total inhibin production while
contributing 90% of the total oestradiol production. The more even distribution


















Mean (±S.E.M.) (a) concentration in the follicular fluid, and (b) secretion rate during
incubation of oestradiol, inhbin and androstenedione from small (< 4 mm; n = 36, □)
follicles and large (£ 4 mm) non - oestrogenic (n = 49, Ei) and oestrogenic (n = 26. E2)
follicles. Columns with different letters differ significantly; ab p < 0.05, ac, be, (
p < 0.01 (analysis of variance).
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inhibin secretion seen in vivo between groups of ewes with widely differing follicle
populations in terms of follicle oestradiol production.
When oestradiol production from follicles was examined separately in the 4
groups of ewes at different stages of the oestrous cycle (Fig. 4.4.) more oestrogenic
follicles were found in the ewes in the early and mid follicular phase groups than in the
luteal phase or late follicular phase groups. This pattern results from the selection of
ovulatory follicles early in the follicular phase, which then produce large quantities of
oestradiol in response to increasing LH pulse frequency (Baird, 1978). By 60h an LH
surge has occurred in most animals, which results in a fall in oestradiol production
(Baird et al., 1981), hence there were a low number of oestrogenic follicles in this
group. This pattern of follicle development is able to explain the elevation in the ovarian
secretion rate of oestradiol seen in the early and mid follicular phase groups in vivo.
When the same comparison was made for inhibin production (Fig 4.5.), a similar
number of follicles producing large amounts of inhibin were found in the groups of
ewes at all four stages of the oestrous cycle. This lack of change in the pattern of
follicle inhibin production is in keeping with the relatively small differences in the
ovarian secretion rate of inhibin in vivo between the four groups at different stages of
the oestrous cycle. In the group operated on 36h following the induction of luteal
regression there wevs an average of 2.0±0.4 large oestrogenic follicles per ewe, which
corresponds closely to the ovulation rate value of 1.8± 0.1 obtained at surgery by
counting the number of corpora lutea present. As the large oestrogenic follicles present
at this time are the ones that will go on to ovulate, the similarity between these two
values indicates that the definition of an oestrogenic follicle adopted in this study was
an appropriate one.
It has been suggested that large "dominant" preovulatory follicles release
oestradiol which feeds back on the pituitary resulting in a fall in FSH secretion which
prevents development in the other less advanced follicles (Baird & McNeilly, 1981;
Baird, 1983). Inhibin is also produced by the dominant follicle(s) and may be involved
in the control of FSH secretion at this time. However, due to the relatively low
proportion of inhibin production seen from the large preovulatory follicles compared
with that of oestradiol (55% compared with 90%) and the lack of a rise in rate of
ovarian inhibin secretion in vivo at this time it would seem that inhibin does not have a
major role in this aspect of the follicle selection process. It has been suggested that
inhibin may have an intra - gonadal role in the process of follicle selection and
dominance (Ireland, 1987) the lack of a consistent rise in the peripheral concentration of
FSH during the increase in ovulation rate seen following active immunisation against
inhibin supporting this idea (Henderson et al., 1984). Once again the relatively low
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proportion of inhibin production by the large preovulatory follicles and the fairly high
inhibin production by atretic follicles shown in this study would suggest that inhibin
does not play a major intra - gonadal role in the follicle selection/dominance process.
From the results of this study we conclude that unlike oestradiol, where most of
the hormone is secreted by the large oestrogenic preovulatory follicles, a considerable
amount of inhibin is also produced by large non - oestrogenic atretic follicles, and by
small follicles, suggesting inhibin does not play an important role in follicle selection.
The results also show that the lack of variation in the inhibin secretion rate in the intact




Effect of Ovine Follicular Fluid on the Oestradiol
Benzoate Induced LH Surge in Ovariectomized Ewes
5.1. Introduction
It is well documented that both ovine follicular fluid (oFF) and bovine
follicular fluid (bFF) can suppress the concentration of FSH in sheep (oFF: Findlay et
al., 1985; Clarke et al., 1986. bFF: McNeilly, 1984; Martin et al., 1987). The effects of
oFF inhibin on LH are, however, far less clear. Suppression of FSH production has
been shown by doses of follicular fluid containing quantities of inhibin similar to
normal ovarian output (Martin et al., 1987), while suppression of LH has only been
shown by administering large pharmacological doses of follicular fluid inhibin, well in
excess of normal ovarian output. Pharmacological doses of oFF (Findlay et al., 1985;
Clarke et al., 1986) and bFF (Martin et al., 1987) have been demonstrated to cause a
reduction in mean LH levels by lowering pulse amplitude while not affecting pulse
frequency. However, these effects are not consistent, as other studies involving large
doses of follicular fluid inhibin have failed to exhibit any effects on LH (McNeilly,
1984; McNeilly, 1985; Al-Obaidi et al., 1986) or have shown an increase in mean LH
concentration (Martin et al., 1986; Wallace & McNeilly, 1986). Scott & Burger (1981)
showed that inhibin from ovine testicular lymph did not affect LH production from
dispersed rat pituitary cells while Tsonis et al., (1986) showed that inhibin from oFF
suppressed the production of FSH by dispersed ovine pituitary cells while not affecting
LH production, even at high doses. This suggests that inhibin does not affect
production of LH by the pituitary, even at pharmacological doses. While follicular fluid
inhibin does not appear to affect basal LH production in vitro, there is evidence for the
existence of a gonadotrophin surge-inhibiting factor in porcine follicular fluid (pFF),
distinct from inhibin, which has been shown to inhibit the GnRH-stimulated release of
FSH and LH from rat pituitary cell cultures, while not affecting basal LH
concentrations (Danforth et al., 1987). pFF has also been shown to exhibit
gonadotrophin surge-inhibiting activity in vivo, blocking the positive feedback effects
of oestradiol benzoate in generating LH surge release in both entire (Hodgen et al.,
1980) and castrate (Sopelak & Hodgen, 1984) female monkeys.
In this study we investigated the effects of oFF on oestradiol benzoate-induced
gonadotrophin responses in ovariectomised ewes in order to study further the role of
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inhibin in the control of gonadotropin release, and also to investigate the possibility of
the presence of a gonadotropin surge-inhibiting factor in oFF.
5.2. Materials and Methods
5.2.1. Purification Procedure
Immunopurification of inhibin was performed using an affinity gel composed
of an ovine anti porcine 1 - 26a inhibin antiserum (S55) bound to cyano-bromide
activated sepharose - 6B (Pharmacia) (McNeilly et al., 1989). One hundred ml from a
pool of ovine follicular fluid (oFF) which had been charcoal - stripped and passed
through CI8 Sep-pak columns (Waters Associates, Milford, MA, USA) to remove
steroids was centrifuged to remove particulate matter, passed down a 70ml inhibin
affinity gel column 5 times and then frozen for use as an oFF treatment with lowered
inhibin content. The column was then washed with 140 ml (2 x column volume) of
0.05M Tris FICL buffer (pH 7.5) containing 0.05% CHAPS (Tris buffer), followed by
140ml Tris buffer containing 2 mol NaCl/1. The immunopurified inhibin was then
eluted from the column using Tris buffer containing 8 mol urea/1. The inhibin was then
dialysed for 24 hrs against 4 changes of 51 deionized water at room temperature. The
oFF inhibin was then lyophilysed and reconstituted in 5ml Tris buffer. The pooled oFF
had a protein content of 46.8 mg/ml and an inhibin concentration of 2.8 |ig/ml. The
partially purified inhibin was made up to 100ml before injection giving protein and
inhibin contents of 1.9 mg/ml and 0.8 Jig/ml. The oFF which had been passed down
the column had a protein content of 18.6 mg/ml and an inhibin content of 0.06 fig/ml.
5.2.2. Experimental Procedure
The experiment was performed in 23 mature Scottish Blackface ewes which
had been ovariectomised 8 weeks previously. Animals were allocated to one of four
groups with similar mean group weights (58±2kg).
1 - Saline (Control; n=6)
2 - Steroid-stripped ovine follicular fluid (oFF; n=6)
3 - Partially purified inhibin (Inhibin; n=6)
4 - Inhibin with lowered inhibin content (Low Inhibin oFF; n=5)
72
One ml of saline or test substance was injected subcutaneously at 8h intervals
throughout the 40h experimental period, and 50|ig oestradiol benzoate injected i.m. 8h
into the experiment to induce an LH surge. Prior to treatment jugular veins were
cannulated using plastic cannulae with three-way taps and 5 ml samples of jugular
venous blood collected at hourly intervals throughout the experiment.
5.2.3. Analysis of Data
The suppression of LH following the injection of oestradiol benzoate was
analysed by analysis of variance, while the timing and magnitude of the LH surge were
compared between groups by means of a Students unpaired t-test on untransformed
data. The FSH decline following oestradiol benzoate administration was analysed
between groups using analysis of variance and Duncan's multiple range test on data that
had been transformed to a percentage of the mean concentration during the 8h period
prior to oestradiol benzoate administration in order to overcome differences in FSH
concentrations between groups. The maximum degree of FSH suppression was
determined by comparing the FSH concentration from 36 - 40h, during which time no
further suppression of FSH occurred, with the concentration prior to oestradiol
benzoate injection.
5.3. Results
Following ovariectomy the mean concentration of inhibin in the jugular venous
plasma of the experimental animals fell from a mean of 76 ± 7 pg/ml to below the
sensitivity of the assay (< 20 pg/ml). In all three treatment groups the concentration of
inhibin was increased following the injection of test substance (Fig. 5.1). Treatment
with oFF generated a mean inhibin concentration, during the period from 8h to 40h, of
112.5 ± 9.6 ng/1 which was significantly (p < 0.001) higher than that seen in the group
injected with the inhibin preparation (63.4 ± 5.3). In the group injected with the low
inhibin oFF the mean concentration of inhibin was 36.9 ± 1.8, however in the animals
in this group concentrations of inhibin were not consistently maintained above the
sensitivity of the assay.
Following the administration of oestradiol benzoate all 4 groups exhibited a
marked suppression in the plasma concentration of LH (p < 0.001), this suppression
not differing significantly between the 4 groups (Fig. 5.2). This suppression of LH
was then followed by an LH surge in all animals. In the control group this surge was
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generated by 15.2±0.6h, reaching a peak of 57.0±11.0jig/l by 17.7±0.6h and lasting
8.3±1.2h. In the three treatment groups the characteristics of the LH surge showed no
significant difference from the control group (Table 5.1).
In all 4 groups FSH showed a significant (p < 0.001) decline following the
injection of oestradiol benzoate, with a small rise, concurrent with the LH surge, being
seen in all groups by about 16h following oestradiol benzoate administration (Fig 5.3).
Table 5.1. The effect of treatments on the characteristics of the LH surge.




























While during the 8h period prior to oestradiol administration, there was no change in
the concentration of FSH in any group (p > 0.5), the mean concentration of FSH was
significantly (p < 0.05) lower in the control group (210±12) than in any of the treatment
groups (oFF 257±24; inhibin 278+30; low inhibin oFF 261+27). To allow the
comparison of the degree of FSH suppression between groups with differing initial
FSH concentrations, the level of FSH suppression was therefore converted to a
percentage of the concentration during this period prior to oestradiol benzoate
administration Fig 5.4. The mean and maximum levels of FSH suppression in the four
groups are shown in Table 5.2.
Table 5.2. The effects of treatments on the degree of FSH suppression.
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The mean degree of suppression of plasma FSH concentration in control
ewes (•) compared to treated ewes (o) injected at 8 h intervals with a) oFF
(n = 6), b) a partially purified inhibin preparation (n = 6) or c) oFF with
lowered inhibin content, and injected at 8 h with a single i.m. injection of
50 |ig oestradiol benzoate (E2).
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The mean suppression over the response period was significantly greater in the oFF-
treated group than the control group (66.8+3.9 v 76.3±3.2% of pre-treatment levels; p
< 0.01), as was the maximum degree of suppression (28.4±4.0 v 45.2±2.6 % of pre-
treatment levels; p < 0.001). The groups treated with inhibin and low inhibin oFF
showed no significant differences from the control group in the mean or maximum
degree of FSH suppression.
5.4. Discussion
In this study we have shown that a dose of follicular fluid sufficient to generate
peripheral plasma inhibin concentrations in ovariectomised ewes only slightly higher
than concentrations found prior to ovariectomy, while causing a significant suppression
of FSH concentration, resulted in no significant changes in the characteristics of an
oestradiol benzoate - induced LH surge. This result adds weight to the definition of
inhibin as a selective suppressor of FSH, while providing further evidence that inhibin
does not play a role in the regulation of LH production.
In a study performed on the same breed of sheep Martin et al., (1987) concluded
that a dose of 0.6ml bFF every 8h delivered quantities of inhibin approximately
equivalent to normal ovarian output. The bFF used in that study had an inhibin content,
measured in a sheep pituitary cell bioassay (Tsonis et al., 1986), of 13.4kU/ml which
works out at a dose rate of 8kU inhibin bioactivity per 8h. In this study we used a dose
of 1ml of oFF every 8h with a bioactivity, measured in the same assay, of 8.7kU/ml.
Our slightly higher dose of inhibin generated peripheral inhibin concentrations higher
than those seen prior to ovariectomy and so it would seem that a dose a little less than
8kU/8h would be appropriate to restore normal inhibin concentrations in this breed of
sheep following ovariectomy.
In the group treated with oFF no decline in the concentration of FSH was seen
following the first injection, the decline in FSH not being evident until after the
injection of oestradiol benzoate 8h into the experiment. Delays in the response of FSH
following i.v. injection of follicular fluid of 2 - 3h (McNeilly, 1984; Wallace &
McNeilly, 1986) and 4h (Tsonis et al., 1986) have been reported, as has a loss of
pituitary responsiveness to inhibin with time following ovariectomy (Martin et al.
1987). These factors, together with the fact that in this study a subcutaneous route of
oFF administration was used are therefore probably sufficient to account for the delay
in response seen in this study.
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The fact that the low inhibin oFF did not cause any suppression of FSH
concentration over that produced by the oestradiol benzoate suggests that it was the
inhibin in the oFF that was producing the suppression of FSH in the oFF group. This
conclusion is confounded by the fact that in the animals injected with the partially
purified inhibin preparation there was no suppression of FSH over that produced by
the administration of oestradiol benzoate. This was probably due to the use of too low a
dose of inhibin to exert a detectable effect on FSH concentration in the presence of the
high dose of oestradiol. In this group the peripheral concentration of inhibin was only
half that seen in the group treated with the neat follicular fluid, and inhibin
concentrations remained significantly lower than those seen prior to ovariectomy until
20h into the experiment.
In monkeys porcine follicular fluid has been demonstrated to block oestradiol
benzoate - induced LH surges in both intact (Hodgen et al., 1980) and ovariectomised
(Sopelak & Hodgen, 1984) animals and the substance responsible for this activity has
now been isolated (Danforth et al., 1987). The fact that in this study the oFF and the
low - inhibin oFF did not affect the timing, magnitude or duration of the LH surge
would indicate that in the sheep, follicular fluid does not contain a gonadotrophin -
surge - inhibiting factor as appears to be the case in pFF.
From the results of this study we conclude that inhibin in oFF acts to suppress
FSH production alone, and does not affect the production of LH. Furthermore we
found no evidence for the existence of a "non-steroidal" factor in the follicular fluid of
this species responsible for the modulation of the LH surge.
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Chapter 6
Passive Immunisation against Inhibin
during the Luteal Phase of the Oestrous Cycle
6.1. Introduction
While it is now well established that inhibin has the ability to suppress follicle
stimulating hormone (FSH) production by the anterior pituitary gland both in vitro and
in vivo, the physiological role of inhibin remains uncertain. Inhibin in charcoal-stripped
follicular fluid causes suppression of the production of FSH (McNeilly, 1985; Wallace
& McNeilly, 1985) and large doses of follicular fluid can suppress the concentration of
FSH in normal ewes to undetectable levels (Martin et al., 1987), indicating the potential
power of inhibin as a regulator of FSH. However, doses of inhibin estimated as
approximately equivalent to normal ovarian output produce only transient falls in the
concentration of FSH (Martin et al., 1987). Oestradiol will also suppress the production
of FSH, but is unable to restore fully the normal concentration of FSH when
administered to acutely ovariectomized ewes (Goodman et al., 1981). There is now
evidence that inhibin and oestradiol act synergistically in the regulation of FSH
production by negative feedback on the anterior pituitary (Martin et al., 1988), but the
relative importance of inhibin in this negative feedback system still remains unclear.
Antisera raised to inhibin partially purified from bovine follicular fluid (bFF)
have been shown to neutralise the in vitro FSH-suppressive activity of inhibin in
follicular fluid from a number of species (van Dijk et al., 1986). Active immunization of
ewes against a subunit of bovine inhibin produced by recombinant DNA techniques
(Forage et al., 1987; Findlay et al., 1989), a synthetic peptide fragment (Wrathall et al.,
1989) or against partially purified preparations of inhibin from bovine follicular fluid
(bFF) (Cummins et al., 1986; Henderson et al., 1984) all resulted in an increase in
ovulation rate. However, in these studies no consistent increases in the concentration of
FSH have been demonstrated. Antisera raised to inhibin from bovine follicular fluid
have also been shown to neutralise inhibin activity in vivo in castrate ewes where
passive immunization against inhibin was shown to reduce the FSH-suppressing effects
of bFF (Al-Obaidi et al., 1986) and in rats where neutralisation of endogenous inhibin
by an inhibin antiserum caused an increase in plasma concentration of FSH (Rivier et
al., 1986; Culler & Negro-Vilar, 1988). By acutely perturbing the feedback
mechanisms, passive immunization may permit a change in the concentration of FSH to
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be detected before a compensatory increase in the secretion of inhibitory factors by the
ovary has taken place.
In this study we have investigated the ability of an ovine antiserum, raised to a
synthetic inhibin peptide fragment, to neutralise, in vitro, the suppressive effect of
ovine inhibin on the production of FSH by dispersed cells from the anterior pituitary.
We have then determined the optimum dose of this antiserum for passive immunization,
and used this dose to neutralise circulating inhibin in intact ewes as a means by which to
investigate the importance of inhibin in the control of the production of FSH in the
luteal phase of the sheep oestrous cycle.
6.2. Materials and Methods
6.2.1. Inhibin Antiserum
The anti-inhibin antiserum used in this study was raised in an ovariectomized
Scottish Blackface ewe (McNeilly et al., 1989) to a synthetic peptide of the 1-26 amino
acid sequence of the N-terminus of the a chain of 32 kDa porcine (p) inhibin (Rivier et
al., 1986) conjugated to ovalbumin. The final titre of this antibody, assessed at 50%
binding of 125I-labeled pi-26a peptide was 1: 40000.
6.2.2. In Vitro Inhibin Neutralisation
6.2.2.1. Pituitary Cell Cultures
Cultures of dispersed ovine pituitary cells from mature female sheep were
produced by the method previously described for the inhibin bioassay. Aliquots of 50|il
of cells (200000) were plated out with 550|il modified DMEM into individual wells of
plastic culture plates (Costar; Flow Laboratories) and preincubated for 48h. The
medium was then removed and replaced with varying dilutions of ovine follicular fluid
(oFF) with or without inhibin antibody, and allowed to incubate for a further 48h. The
incubate media were then collected and frozen at -20°C.
6.2.2.2. Neutralisation of Inhibin Activity
Inhibin activity was obtained by using a pool of ovine follicular fluid (oFF) which
had been charcoal stripped (Tsonis et al., 1986) to remove steroids. The potency of this
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oFF pool was 9000 U/ml, expressed against a stable lyophilized ovine rete testis fluid
preparation with an arbitrary potency of lU/mg (Eddie et al., 1979). Five dilutions of
this oFF (containing 0.8 - 66.7nl oFF) were used to generate an FSH inhibition curve,
expressed as a percentage of control FSH production with no oFF. This inhibition was
then neutralised using the inhibin antibody (S40). Aliquots of 50nl of oFF diluted to a
final volume of 50p.l were preincubated with 50pl aliquots of 8 dilutions of inhibin
antibody (0.078- 10(J.l antibody/dilution) at room temperature for lh. Antibody/oFF
incubates were then added to the pituitary cell cultures in quadruplicate, made up to a
final volume of 600p.l with supplemented DMEM, and incubated for 48h. FSH
concentration was then measured in all samples of culture medium by
radioimmunoassay.
6.2.3. Pilot Dose Study
The dose trial was carried out during the breeding season in November on six
mature (2-3 year old) Finn x Merino ewes. Oestrous cycles were synchronized and
animals were then allocated to three groups of two animals with similar mean group
weights of approximately 42kg. On Day 10 of the luteal phase animals were given an
intravenous bolus injection of either 1ml, 5ml, or 10ml of inhibin antibody, and hourly
peripheral 5ml plasma samples collected for 4h before and 16h after antibody
administration. Sampling rate was then reduced to 4 hourly for 16h, and finally to 8
hourly until 48h after antibody administration when sampling ceased. Samples were
then assayed by radioimmunoassay for FSH, and the inhibin binding capacity of the
plasma determined.
6.2.4. Immunization Experiment
The experiment was carried out during the breeding season, in November and
December, on 10 mature Scottish Blackface ewes. Oestrous cycles were synchronized
and the animals were then allocated to two groups of five animals with similar mean
group weights (Control: 54.6±3.0kg; immunised: 54.0±1.5kg; mean ± S.E.) and their
jugular veins cannulated using plastic cannulae and three-way taps. Animals were then
given an intravenous bolus injection on Day 8 of the luteal phase of the oestrous cycle
of either 10ml of normal sheep plasma (Control) or 10ml of the inhibin antibody (
immunised). Hourly 5 ml peripheral venous blood samples were collected for 4h before
and 16h after administration of either antibody or control plasma. Samples were then
collected 4 hourly for a further 16h, and then 8 hourly until 144h after treatment. On
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day 10 of the luteal phase, 48h after antibody/plasma administration, all animals were
injected i.m. with Cloprostenol (100p.g) to induce luteal regression and hence
ovulation. Animals were checked for oestrus by teaser ram, and six days after
Cloprostenol injection laparoscopy was performed on all animals to determine ovulation
rate. Blood samples were then assayed by radioimmunoassay for FSH, LH, and
progesterone and the inhibin binding capacity in the plasma of immunised ewes
determined.
6.2.5. Analysis of Data
The rise in FSH in response to immunization was defined to have commenced at
the first point on a sequential FSH rise with an increase in concentration over the
previous sample in excess of the sum of the assay error, and to have ended at the point
where the concentration was no longer greater than pretreatment level by more than the
assay error. The assay error was estimated from the the coefficient of variation
determined in a plasma pool containing approximately the same concentration of FSH,
and was defined as two times the standard deviation at that concentration. The
maximum FSH response was defined to have started at the point when a sample was
not followed by a rise in concentration greater than the sum of the assay error, and to
have ended at the point on a sequential fall which was followed by a fall in
concentration greater than the assay error.
Due to the small group size (n = 2) statistical analysis was not performed on the
FSH responses in the pilot study. However, due to the variation in concentration of
FSH between animals the results were expressed as a percentage of the baseline
concentrations.
In the main experiment the response of FSH seen in the immunised group was
compared to the control group by analysis of variance on repeated samples, and the
concentrations of FSH in control and immunised animals, during the 48h period
following injection of plasma or antiserum, compared by analysis of variance and
Duncan's multiple range test. A -Student's unpaired t-test was used to compare
progesterone concentrations before and after injection of cloprostenol and to compare
binding capacities at different times.
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6.3. Results
6.3.1. In Vitro Neutralisation
From the FSH inhibition curve (Fig. 6.1.) it can be seen that 50nl oFF per well,
used as the dose of inhibin for neutralisation by the antibody, produced an almost
maximum degree of suppression (46% of control compared to 44% of control by
66.6nl oFF). It can also be seen from Fig. 6-1. that the inhibin antibody neutralised the
suppression of FSH production by the inhibin in the oFF in a dose related manner, and
was able to neutralise this inhibin activity completely.
6.3.2. Pilot Dose Study
The inhibin binding capacity generated in the plasma of immunised ewes, at a
dilution of 1:15, is shown in Fig. 6.2. The 3 doses of antibody each generated a greater
mean inhibin-binding capacity than the previous dose (1ml: 53.7%; 5ml: 64.4%; 10ml:
70.7%). All 3 doses showed a fall in binding capacity by 40h (1ml: 33.9 %; 5ml: 58.2
















Responses in the inhibin - binding capacity of plasma at a dilution of 1:15 resulting
from the injection at time 0 of an i.v. bolus of 1 (c), 5 («) or 10 ml (») inhibin
antibody in ewes. (Values are means of duplicate determionations).
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In all 3 groups immunization was followed by a rise in the concentration of FSH
in the peripheral plasma (Fig. 6.3.). In the 1ml group FSH concentration rose from a
mean of 1.61 ng/ml before treatment to a maximum of 2.40 ng/ml (mean 150%; range
133 to 167%), in the 5ml group this rise was from 1.68 to 2.87 ng/ml (mean 183%;
range 131 to 235%) and in the 10ml group 2.27 to 4.48 ng/ml (mean 200%; range 167
to 232%). Due to the small group size, and the variable nature of the responses it is not
possible to draw firm conclusions, but it would appear that, depending on animals, a
maximum response to immunization can be achieved with between 5ml and 10ml of the
antiserum. To ensure a maximum response of FSH to immunization a dose of 10ml
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Fig. 6.3.
The plasma concentration of FSH as a percentage of the pretreatment baseline
concentration resulting from the injection at time 0 of an i.v. bolus of 1 (o) 5 («) or
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Fig. 6.4.
Mean (± S.E.M) inhibin binding capacity generated in the plasma, at a dilution of
1:15, of ewes injected at time 0 with a single i.v. bolus of inhibin antibody (n = 5).
6.3.3. Luteal Phase Immunization
Following immunization there was an increase in the ability of plasma to bind
inhibin in all the immunised animals (Fig. 6.4.). At a dilution of 1:15 pre-immunization
plasma exhibited a non specific binding of 3.5±0.3% while lh after injection of
antibody the same dilution of plasma bound 75.0±1.2%. By 48h binding had fallen to
65.1±1.2% (p < 0.001) and by the end of the experiment at 144h a further fall had
taken place to 48.3±1.1% (p < 0.001).
Concentrations of progesterone in the plasma of both groups were similar during
the 32h period following injection of plasma or antiserum (Fig. 6.5.; 2.54±0.32 ngl/ml
in the control group compared with 2.52±0.26 ng/ml in the immunised group), neither
group showing any response to treatment. Following cloprostenol-induced luteal
regression the concentration of progesterone fell significantly (p < 0.001) in both
groups by 16h, and by 32h following cloprostenol the concentration of progesterone in
the peripheral plasma of all animals had fallen to below 0.1 ng/ml in both groups.
Administration of the normal sheep plasma or the antiserum to inhibin had no
effect on the mean concentration of LH in peripheral plasma (Fig. 6.6.). In the control
group the mean concentration LH was 0.73±0.02 ng/ml before treatment and
0.80±0.04 ng/ml during the 32h period following treatment. In the immunised group
the corresponding concentrations of LH were 0.69±0.03 and 0.77±0.06 ng/ml.






















Mean (± S.E.M.) concentration of progesterone in the plasma of ewes injected at time 0
with a single i.v. bolus of either (a) 10 ml nornal sheep plasma (NSP) or (b) 10 ml
inhibin antibody (AB) before and after injection of cloprostenol (PG) at 48 h. (n = 5)
in both the control and the immunised group (54.4±3.9h and 54.4±1.6h
respectively), as was the magnitude of the surge (86.2±18.7 ng/ml in the control group
and 85.5±24.4 ng/ml in the immunised group).
In the control group the mean concentration of FSH in peripheral plasma was
unaffected by injection of normal sheep plasma (Fig. 6.7.), concentration ranging from
1.65±0.02 ng/ml before treatment to 1.61±0.02 ng/ml during the 32h period following
treatment. In the immunised group, in contrast to the control group, there was a
significant (p < 0.001) response in the concentration of FSH in plasma following
injection of antiserum (Fig. 6.7.). The concentration of FSH rose from a mean
1.42±0.06 ng/ml before treatment to a maximum of 2.58+0.23 ng/ml by 5.6±0.9h, this
rise starting 3.8±0.7h following immunization. This maximum response lasted for
9.0±l.lh, but it was 32.8±6.9h before the concentration of FSH had returned to pre-
treatment levels. As a result of this response, despite the initially lower baseline
concentration of FSH in the immunised group compared to the control group
(1.42±0.06 compared with 1.65±0.02 ng/ml), the concentration of FSH was
significantly (p < 0.05) higher in the immunised group during the 32h period following
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cloprostenol-induced luteal regression both groups showed normal FSH responses,
exhibiting a primary surge coincident with that of LH and a second surge 16-24h later.
At laparoscopy there were three single and two double ovulations in the control
group, and one single and four double ovulations in the immunised group. However,
in the immunised animal with a single corpus luteum half the left ovary was hidden by
an adhesion.
6.4. Discussion
In this study we have demonstrated that injection of antiserum to inhibin, during
the luteal phase of the sheep oestrous cycle, results in a marked rise in the plasma
concentration of FSH thus providing strong evidence that inhibin is involved in the
negative feedback loop, from the ovary to the pituitary, regulating the production of
FSH at this time.
As the injection of inhibin antiserum did not result in any effect on peripheral
plasma concentrations of LH, this study supports the definition of inhibin as a selective
suppressor of FSH. Following immunization a marked rise in the plasma concentration
of FSH was observed in all animals injected with the inhibin antiserum. While the
inhibin binding capacity in the plasma of immunised animals had reached a peak by lh,
the concentration of FSH did not start to rise until 3.8±0.7h after immunization. This
delay in the response of FSH is similar in length to the delay in the response of FSH of
4-5h seen following unilateral ovariectomy (Findlay & Cumming, 1977; Campbell,
1988). A similar delay (3 - 4h) is also seen between injecting bovine follicular fluid and
the onset of the resultant decline in FSH (McNeilly, 1985) indicating that a lag exists
between the pituitary registering changes in plasma concentration of inhibin and its
being able to respond with a change in output of FSH. The magnitude and duration of
the rise in concentration of FSH following immunization is also similar to the response
following unilateral ovariectomy (Findlay & Cumming, 1977; Campbell, 1988), a
process involving the abrupt removal of half the ovarian factors regulating the pituitary
release of FSH. As passive immunization against inhibin gave a similar response to
unilateral ovariectomy, it would appear that inhibin is making a considerable
contribution to the control of pituitary production of FSH during the luteal phase of the
oestrous cycle.
During the period following the rise in FSH, when concentrations were starting to
decline, there was little change in the inhibin binding capacity in the plasma of
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some form of physiological compensation and not due to clearance of the antibody. The
most likely mechanism by which the animals were compensating for the rise in FSH
would be a rise in the ovarian secretion rates of inhibin and oestradiol.
In other studies in which inhibin antibodies have been successfully used to
neutralise the effects of inhibin in suppressing the production of FSH by pituitary cells
in vitro (Channing et al., 1982; McLachlan et al., 1986; van Dijk et al., 1986), antisera
were raised to partially purified preparations of follicular fluid. This raises the
possibility that in these studies, as well as antibodies against inhibin, antibodies against
other follicular fluid products with inhibin-like activity might also have been present. In
this study the antiserum was raised to a synthetic peptide fragment of inhibin, thus
removing the possibility of the presence of antibodies against other follicular fluid
products with inhibin-like effects. As such an antiserum was shown to completely
neutralise the FSH suppressing effects of steroid-stripped oFF it appears that other than
oestradiol, inhibin is the sole FSH suppressing substance present in the follicular fluid
of sheep.
Studies involving active immunization against inhibin have all resulted in an
increase in ovulation rate (Henderson et al., 1984; Cummins et al., 1986; Forage et al.,
1987; Findlay et al., 1989; Wrathall et al., 1989). As inhibin suppresses the production
of FSH it would seem likely that this increase in ovulation rate would be the result of
neutralisation of inhibin resulting in an increase in the plasma concentration of FSH,
which would in turn stimulate an increase in ovulation rate. However, these studies
have reported small, inconsistent rises in the plasma concentration of FSH, or even no
rise at all. In this acute, passive immunization study a highly significant rise in FSH
was observed in all immunised animals. Within 48h, however, this rise had been
compensated for in all animals, and no further differences in the levels of FSH were
observed between control and immunised animals. As it appears that compensatory
mechanisms can reverse the rise in FSH seen following passive immunization against
inhibin, it may be that active immunization is not of a sufficiently acute nature to detect
reliably the changes that are occurrring in plasma concentrations of FSH. This leads to
the suggestion that following active immunization there may be a certain critical period
during which such compensation is not possible and FSH levels become elevated, and
that more extensive blood sampling is required to demonstrate the effects of active
immunization on FSH. It may, however, be possible that only small rises in FSH are
necessary to mediate the effects of inhibin immunization on ovulation rate. A further
possibility may be that inhibin has an intra-ovarian role in the regulation of ovulation,
and that neutralisation of inhibin by immunization can result in a rise in ovulation rate
without the need for elevated plasma concentrations of FSH.
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The results of the laparoscopy indicate that the immunization against inhibin may
have resulted in an increase in ovulation rate, though numbers of animals and the degree
of increase are too small to allow any firm conclusions to be drawn. The increase
observed in this study (1.4 to 1.8) was, however, of a similar size to that seen in some
active immunization studies (Henderson et al., 1984; Cummins et al., 1986), and
supports a hypothesis that immunization against inhibin is a means of producing
controlled increases in ovulation rate in sheep.
From the results of this study we conclude that passive immunization against
inhibin during the luteal phase of the ovine oestrous cycle results in a marked rise in
plasma concentration of FSH. While this effect can be compensated for, presumably by
increased ovarian output of oestradiol, this study still provides very strong evidence that




Passive Immunisation against Inhibin and Oestradiol
during the Follicular Phase of the Oestrous Cycle
7.1. Introduction
In the sheep it is well established that both oestradiol and inhibin can suppress
the production of follicle stimulating hormone (FSH) (Findlay & Clarke, 1987).
However, when doses of follicular fluid containing quantities of inhibin estimated as
equivalent to normal ovarian output are administered to ewes only transient falls in the
concentration of FSH are produced (Martin et al., 1987), while in the experiment
described in Chapter 6 passive immunisation against inhibin produced only a short lived
rise in the concentration of FSH. Oestradiol alone is unable to restore fully the normal
concentration of FSH when administered to acutely ovariectomized ewes (Goodman et
al., 1981; Martin et al., 1988) while together, inhibin and oestradiol can maintain
normal FSH concentrations (Martin et al., 1988). It would appear, therefore, that these
two hormones act together in the regulation of FSH production, though their relative
importance still remains unclear.
Antisera raised to inhibin partially purified from bovine follicular fluid have been
shown to neutralise the FSH-suppressive activity of inhibin in follicular fluid in vitro
(van Dijk et al., 1986) but while active immunisation of ewes against inhibin from
various sources all result in an increase in ovulation rate, such immunisations have not
produced consistent increases in the concentration of FSH (Henderson et al., 1984;
Cummins et al., 1986; Forage et al., 1987; Findlay et al., 1989; Wrathall et al., 1989).
Active immunisation against oestradiol-17(3 has been shown to produce more consistent
rises in FSH concentration, as well as increases in the concentration of LH (Pant et al.,
1978; Rawlings et al., 1978; Martensz et al., 1979; Scaramuzzi et al., 1980) but such
immunisations prevent ovulation by blocking the oestradiol-induced LH surge. In
Chapter 6 neutralisation of endogenous inhibin by passive immunisation was shown to
cause an increase in the plasma concentration of FSH, an effect that is also seen in rats
(Rivier et al., 1986; Culler & Negro-Vilar, 1988). Passive immunisation with
antibodies against oestradiol blocks the ability of oestradiol benzoate to induce oestr^
in ovariectomized ewes (Scaramuzzi, 1975) and prevents ovulation in normal ewes
when administered from day 13 to day 17 of the cycle (Fairclough et al., 1976).
However, when a single immunisation was given in the luteal phase Pathiraja et al.
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(1984) showed a transient rise in the concentration of FSH, together with an associated
rise in ovulation rate.
In this study we have passively immunised ewes against inhibin and oestradiol,
both separately and in combination, as a means of investigating the importance of these
two hormones in the control of FSH production during the follicular phase of the sheep
oestrous cycle.
7.2. Materials and Methods
7.2.1. Inhibin and Oestradiol Antibodies
The antibody to inhibin used in this study was raised in an ovariectomised ewe to
a synthetic peptide of the 1-26 amino acid sequence of the N - terminus of the a chain
of 32 kDa porcine inhibin and an appropriate dose of the antiserum was determined in
the study described in Chapter 6. The oestradiol antibody was raised in an
ovariectomised ewe to an oestradiol - rabbit serum albumin conjugate, and an
appropriate dose was then determined in a pilot study similar to that used for the inhibin
antibody.
7.2.2. Pilot Dose Study
A dose trial was performed during the breeding season in January on six mature
Blackface ewes in order to determine a suitable dose of oestradiol antibody to use in the
main experiment. Oestre^cycles were synchronised and animals allocated to three
groups of two animals with similar mean group weights of approximately 50 kg. On
day 10 of the luteal phase animals were given an i.v. bolus injection of either 1 ml, 5
ml, or 10 ml oestradiol antibody . Hourly venous blood samples were collected by
vacutainer for 3 h before and 2 hourly sample for 48 h after injection of antibody.
Samples were then assayed for FSH.
7.2.3. Immunisation Experiment
The immunisation experiment was carried out during the breeding season, in
February, on 20 mature Scottish Blackface ewes. Oestrous cycles were synchronized
and the animals were then allocated to four groups of five animals with similar mean
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group weights (control, 57±2kg (±S.E.M.); inhibin immunisation, 55±4kg; oestradiol
immunisation, 55±2kg; combined immunisation, 56±4kg) and their jugular veins
cannulated using plastic cannulae with three-way taps. On day 10 of the luteal phase
luteal regression was induced by a further i.m. injection of Cloprostenol (100 pg) and
24h later animals were injected with a single i.v. bolus injection of one of four
treatments:
A. Control - 10ml normal sheep plasma (n=5)
B. Inhibin Immunised - 10ml inhibin antibody (n=5)
C. Oestradiol Immunised - 10ml oestradiol antibody (n=5)
D. Combined - 10ml inhibin antibody and 10ml oestradiol antibody (n=5).
Samples of jugular venous blood (5ml) were collected every 2h from 8h before
until 24h after the induction of luteal regression (at time Oh). Following administration
of antibody at 24h samples were collected at decreasing time intervals (24-48h,
1 hourly; 48-72h, 2 hourly; 72-168h, 4 hourly; 168-228h, 12 hourly) until the end of
the experiment. Blood samples were then assayed by radioimmunoassay for FSH,
luteinizing hormone (LH), and progesterone and the inhibin and oestradiol binding
capacities in the plasma of immunised ewes was determined.
7.2.4. Analysis of Data
The rise in FSH in response to immunisation was defined to have commenced at
the first point on a sequential FSH rise with an increase in concentration over the
previous sample in excess of the sum of the assay error, and to have ended at the point
where the concentration was no longer greater than pretreatment level by more than the
assay error. The assay error was estimated from the coefficient of variation determined
in a plasma pool containing approximately the same concentration of FSH, and was
defined as 2x the standard deviation at that concentration.
Hormone concentrations and binding capacities were compared both within and
between groups by analysis of variance on repeated samples and LH surge
















Plasma concentration of FSH as a percentage of the pretreatment baseline
concentration resulting from the injection at time 0 of an i.v. bolus of (a) 1 ml, (b)




7.3.1. Pilot Dose Study
Both the 5 ml and 10 ml groups showed a marked rise in plasma FSH
concentration following antibody injection , while the 1 ml group showed a smaller rise
in FSH concentration (Fig 7.1). In the 1ml group FSH concentration rose from a mean
of 1.80 ng/ml before treatment to a maximum of 2.37 ng/ml (mean 135%; range 120 to
151%), in the 5ml group this rise was from 2.13 to 3.55 ng/ml (mean 160%; range 134
to 187%) and in the 10ml group 1.75 to 3.12 ng/ml (mean 180%; range 147 to 213%).
Due to the small group size, and the variable nature of the responses it is not possible to
draw firm conclusions, but it would appear that while the 5 ml and 10 ml doses gave a
similar magnitude of response the 10 ml antibody injection resulted in a more sustained
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Fig. 7.2.
(a) mean (±S.E.M.) inhibin binding capacity ( at a dilution of 1:15) in
the plasma of ewes injected at time 24 h with a 10 ml i.v. bolus of either
inhibin antibody alone (o; n = 5) or in combination with a 10 ml i.v.
bolus injection of oestradiol antibody (•; n= 5) I
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7.3.2. Plasma - Binding Capacity
Following immunisation there was an increase in the ability of plasma to bind
inhibin and/or oestradiol in all the immunised animals (Fig. 7.2 & 7.3). In the animals
immunised against inhbin (Fig. 7.2), by 2h following immunisation, plasma inhibin-
binding capacity, at a dilution of 1:15, was 76.3±2.3 % (± S.E.M.) in the inhibin
immunised group and 77.0±1.3 % in the combined immunisation group. The binding
capacity then showed a similar steady decline (p < 0.001) over the course of the
experiment in both groups, falling to 59.9±3.3 and 58.1±1.7 % by 120h and to
47.7±2.5 and 41.8±1.0 % by 216h in the inhibin immunised and combined
immunisation groups respectively. In the oestradiol-immunised animals, by 2h
following antibody injection, plasma oestradiol-binding capacity, at a dilution of 1:400,
was 68.7±1.3 % in the oestradiol-immunised group and 67.0±0.5 % in the combined
immunisation group. Like the inhibin-binding capacity, the oestradiol-binding capacity
then showed a steady decline (p < 0.001) which did not differ significantly between the
two groups, falling to 48.4±2.6 and 45.2±1.6 % by 120h and to 37.6±4.4 and
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Fig. 7.3. Time (h)
(a) mean (±S.E.M.) oestradiol binding capacity ( at a dilution of 1:15)
in the plasma of ewes injected at time 24 h with a 10 ml i.v. bolus of
either oestradiol antibody alone (o; n = 5) or in combination with a 10
ml i.v. bolus injection of inhibin antibody (•; n= 5)
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7.3.3. Progesterone
Following Cloprostenol-induced luteal regression the concentration of
progesterone had fallen significantly (p < 0.001) by 16h in all four groups (Figs 7.4
and 7.5), and by 32h the concentration of progesterone was less than 0.1 ng/ml in all
groups. In both the control and inhibin immunised groups the concentration of
progesterone rose significantly (p < 0.001) following the LH surge (Fig.7.2), this rise
starting on day 4 following the surge and reaching 1.82+0.35 ng/ml in the control
group and 2.13±0.63 ng/ml in the inhibin-immunised group by day 7. The timing and
magnitude of this rise was not different between the two groups. In the oestradiol-
immunised and combined immunisation groups the concentration of progesterone
showed no rise at this time.
7.3.4. Luteinizing Hormone
During the 12h period following Cloprostenol - induced luteal regression at time
Oh there was a significant (p <0.01) rise in the concentration of LH in all four groups
(Figs 7.4 and 7.5). Following injection of normal sheep plasma (control) or inhibin
antibody (inhibin immunised) there was no significant change in the plasma
*
concentration of LH during the period before the onset of the LH surges (Fig 7.4). In
these two groups luteal regression was followed by an LH surge in all animals, the
timing (control, 45.0±4.6h; inhibin-immunised, 56.2±8.2h), duration (control,
8.4±0.8h; inhibin-immunised, 7.4±l.lh) and magnitude (control, 149.7±25.2 ng/ml;
inhibin-immunised, 117.2±24.5 ng/ml) of these surges not differing significantly
between the two groups. However, in animals immunised against oestradiol either
alone or in combination with inhibin an LH surge did not occur (Fig. 7.5). In both
these groups there was a significant increase in plasma concentration of LH with time
during the 96h period following antibody administration (oestradiol immunised p <
0.05; combined immunisation p < 0.01), this response not differing significantly
between the two groups. The mean concentrations of LH over this period compared
with the 12h period before administration of antibody were 3.4±0.2 compared with
2.8±0.3 ngm/1 in the oestradiol-immunised group (26.3±9.9% rise) and 3.3±0.4
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7.3.5. Follicle Stimulating Hormone
Following the induction of luteal regression at time Oh with Cloprostenol there
was a significant (p < 0.001) decline in the plasma concentration of FSH in all four
groups (Fig. 7.6). During the 6 h period before antibody administration all four groups
showed no significant changes in the concentration of FSH. During the 14 h period
following normal sheep plasma (NSP) injection there was no significant change in the
mean concentration of FSH compared with the mean of the previous 6 h period
(1.6±0.1 compared with 1.6±0.1 ng/ml; Fig. 8.4). Following the administration of
antibodies there was a significant (p < 0.001) increase in the concentration of FSH
during this period in both the inhibin- and oestradiol-immunised groups. Following the
combined immunisation there was also a significant (p < 0.001) increase in the mean
concentration of FSH, which was significantly greater than the rise seen following the
two individual immunisations (p < 0.01). Due to differences in the duration of FSH
responses between animals, and the lack of LH surge - associated rises in FSH in the
two oestradiol immunised groups, when examining entire responses it is more
appropriate to look at individual representative profiles than at mean graphs. Such
profiles are shown in Fig. 7.7, while the characteristics of the responses in FSH
concentration following immunisation are shown in Table 7.1. In all the control animals
there was no change in the concentration of FSH following NSP injection until the first
FSH surge. In four of the five inhibin immunised animals the response in FSH
concentration started 4.8±0.6h following antibody injection and finished 17.0±0.5h
later while in the fifth animal the FSH response started 5h following antibody injection
but the FSH surge occurred before the end of the FSH response and so this animal was
excluded from further analysis. The time to the onset of the rise in FSH did not differ
significantly between the three immunisation groups, while the duration of the
response was significantly (p < 0.05) greater in the oestradiol immunised and combined
immunisation groups than in the inhibin immunised group. When the mean
concentrations of FSH during the responses to immunisation were compared with the
mean concentrations of FSH during the 6h period before antibody administration in
each group the inhibin and oestradiol immunisations were found to give rises of
42.0±6.1 and 42.6±3.5% respectively, while the combined immunisation resulted in a
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Mean (± S.E.M.) plasma concentration of FSH following injection at time 0 with 100 |ig
cloprostenol and at time 24 h with an i.v. bolus of either, (a) 10 ml normal sheep plasma
(NSP; n = 5), (b) 10 ml inhibin antibody (Inh; n = 5), (c) 10 ml oestradiol antibody (E2;
n = 5) or (d) 10 ml inhibin antibody and 10 ml oestradiol antibody in combination
(E2/Inh; n = 5). In the control and inhibin immunised animals the graphs cease at the
time when the first animal started an LH surge.
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Table 7.1 Characteristics of the FSH responses in the three immunised groups
Group Time to Response % Rise Duration
Inhibin 4.8 ± 0.6 h 42.0 ± 6.1 17.0 ±0.5 h
Oestradiol 3.8 ± 0.5 h 42.6 ± 3.5 43.6 ± 12.8 h
Combined 4.4 ± 0.6 h 95.2 ± 16.6 40.6 ± 11.7 h
7.4. Discussion
In this study we have shown that the injection of antisera to both oestradiol and
inhibin, during the follicular phase of the oestrous cycle, results in a rise in the
peripheral plasma concentration of FSH. This, together with the fact that the injection
of both oestradiol and inhibin antisera simultaneously resulted in a larger increase in the
concentration of FSH demonstrates that both oestradiol and inhibin are involved in the
control of FSH production at this stage of the cycle.
In all control and inhibin immunised animals the LH surge was followed by a rise
in progesterone to normal luteal phase concentrations, indicating ovulation and
formation of the corpus luteum had occurred normally, and had not been affected by the
inhibin antibody. In contrast, no animals showed such a rise in progesterone in the two
groups immunised against oestradiol, indicating that ovulation had been blocked, due to
the failure of the oestradiol-induced preovulatory LH surge. Earlier studies involving
passive immunisation have shown a block of oestr^ and ovulation (Scaramuzzi,
1975, Fairclough et al., 1976), but in the study of Pathiraja et al. (1984) ovulation was
not blocked, as a single antiserum injection was given earlier in the luteal phase. In the
present study, as in the experiment described in Chapter 6, the administration of inhibin
antibodies had no effect on either the concentration of LH in the peripheral plasma or
the characteristics of the LH surge, this finding adding further weight to the hypothesis
that inhibin has no role in the control of LH production.
Following luteal regression in the sheep, there is a marked fall in the
concentration of FSH, while at the same time oestradiol, the classical hormonal
regulator of FSH, shows a marked increase (Baird & McNeilly, 1981). During this
period McNeilly et al., (1989) found little change in immunoactive inhibin
concentration, while Tsonis et al. (1988b) found a fall in inhibin bioactivity. However,
immunoactive inhibin concentration has also been found to exhibit moderate increases at
this time (Findlay et al., 1990; Campbell et al., 1990a). From these reports it would
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seem unlikely that inhibin has a major role in regulating the fall in FSH concentration
following luteal regression, and that oestradiol is the major factor involved in this
process. However, in this study the injection of inhibin antibodies 24h after luteal
regression resulted in a significant (p < 0.001) rise in the concentration of FSH. This
supports a hypothesis that, while changes in oestradiol secretion are responsible for the
change in the pattern of FSH concentration, the absolute concentration of FSH is under
the joint control of oestradiol and inhibin. Thus oestradiol with its fast metabolic
clearance rate (1600ml/min; Challis et al., 1970) may modulate the change in the
concentration of FSH while combining with inhibin, with its much slower clearance
rate (21ml/min, see Chapter 3), to regulate the actual level to which FSH concentration
is suppressed. As a result of the oestradiol immunisation there was a moderate increase
in FSH concentration (43%) to a level not significantly different to that seen before
luteal regression, the magnitude of this rise being similar to that produced by the inhibin
immunisation (42%). The combined immunisation with oestradiol and inhibin resulted
in a rise in FSH concentration approximately double that seen following the individual
immunisations (95%), providing further evidence that oestradiol and inhibin act in
combination to regulate the concentration of FSH.
The increase in FSH concentration following inhibin immunisation lasted
approximately 17h while the response to oestradiol and combined immunisations lasted
significantly longer (44 and 41h respectively). During these periods there was only a
small decline in the respective binding capacities of plasma, and so the compensatory
fall in the concentration of FSH was probably not due to clearance of antibody. It
would seem likely that following the rise in FSH concentration, after inhibin
immunisation, the compensatory fall in concentration of FSH may be due to an increase
in the secretion of oestradiol by the ovary, while following oestradiol immunisation
there may be an increase in inhibin output. A similar increase in the secretion of inhibin
occurs following active immunisation of ewes against androstenedione which results in
multiple follicular development but near normal levels of FSH (Campbell et al., 1988).
The rise in the concentration of FSH following injection of inhibin antibodies during the
follicular phase was smaller/ynore short lived than that obsereved following the luteal
phase inhibin immunisation described in Chapter 6, probably as a result of the increased
availability of oestradiol, secreted by the large preovulatory follicles during the follicular
phase (Baird & McNeilly, 1981).
In this study we have shown that passive immunisation against oestradiol or
inhibin during the follicular phase of the sheep oestrous cycle resulted in a rise in the
plasma concentration of FSH. From this we conclude that as well as oestradiol, inhibin
is also important in the regulation of FSH production at this time.
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Chapter 8
Passive Immunisation against Inhibin and/or Oestradiol
During the Luteal Phase, and Replacement of Inhibin
and/or Oestradiol Following Acute Ovariectomy
8.1. Introduction
From the results of the studies described in Chapters 6 and 7 it seems clear that
inhibin and oestradiol are acting together in the control of FSH secretion. This idea is
supported by a number of studies including one by Martin at al. (1988) in which
"physiological" doses of inhibin and oestradiol were each shown to partly negate the
post - castration rise in FSH in ewes, while a combination of the two treatments
completely prevented this rise. The idea that oestradiol is only partly responsibe for the
control of FSH secretion is further supported by the fact that "physiological" doses of
oestradiol and progesterone will only partly prevent the rise in FSH seen following
ovariectomy, while maintaining LH concentration (Goodman et al., 1981). Compared
to the control of FSH secretion, the control of LH secretion is more clearly understood
and appears to be almost entirely under the joint control of oestradiol and progesterone
during the breeding season (Martin, 1984). There are, however some conflicting
reports on the nature of this control mechanism, and further investigation is required.
For example Karsd-,et al. (1977) found that progesterone alone was able to prevent the
post - castration rise in LH for up to 48h while Martin et al. (1988) found that
progesterone was ineffective in preventing this rise.
In Chapter 7 immunisation against inhibin or oestradiol during the follicular
phase of the cycle was shown to cause a rise in FSH concentration, while a combined
immunisation against both hormones resulted in a much larger rise. In this experiment
the approach of single immunisations against inhibin or oestradiol in conjunction with a
combined immunisation against both hormones was repeated during the luteal phase to
investigate the interaction between these two hormones at this time. The "classical"
approach to investigating the importance of steroids in the control of gonadotrophin
secretion has involved the use of steroid - releasing implants, while much of our
knowledge of the role of inhibin in this process has come from experiments involving
the injection of inhibin in follicular fluid from which steroids have been removed by
charcoal treatment. In this study these two approaches were combined with passive
immunisation in the same experiment in an attempt to achieve further clarification of the
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interaction between steroid hormones and inhibin in the control of gonadotropin
secretion in the ewe.
8.2. Materials and Methods
8.2.1. Experimental Animals
The experiment was carried out during the breeding season, in January, on 43
mature Scottish Blackface ewes. Oestrous cycles were synchronized and the animals
were then allocated to nine groups of four to five animals with similar mean group
weights (58.1±0.3):
A. Ovariectomised Control (Ovx; n = 5)
B. Ovx + Progesterone Implants (P4 Imp) (OVX/P4; n = 5)
C. Ovx + P4 Imp + 0.8ml 0FF/8h (Ovx/P4/Inh; n = 5)
D. Ovx + P4 Imp + 1cm E2 Implant (OVX/P4/E2; n = 4)
E. Ovx + P4 Imp + 1cm E2 Implant + 0.8ml oFF/8h (Ovx/P4/Inh/E2; n = 4)
F. Control (10ml normal sheep plasma; n = 5)
G. Inhibin Immunised (10ml inhibin antibody, Inh Imm; n = 5)
H. E2 Immunised (10ml E2 antibody, E2 Imm; n = 5)
I. Combined Immunisation (10ml inhibin & 10ml E2 antibody, E2/Inh Imm; n = 5)
Animals in Groups A to E were ovariectomised on day 10 of the luteal phase and in
Groups B to E animals were simultaneously treated with P4 implants to maintain luteal
phase progesterone levels. Animals in Group C were also injected at 8h intervals with
0.8 ml "steroid stripped" oFF to replace ovarian inhibin production while in Group D
animals were treated with oestradiol implants to replace ovarian oestradiol secretion. In
Group E animals were treated with both oestradiol implants and "steroid stripped" oFF
injections to replace both ovarian inhibin and oestradiol production. Animals in Group
F were injected with 10ml normal sheep plasma to act as a control group while animals
in Groups G and H were injected with 10ml inhibin and oestradiol antibody
respectively to immunoneutralise these two hormones individually. Finally animals in
Group I were injected with 10ml of inhibin antibody and 10ml oestradiol antibody in
order to neutralise the two hormones simultaneously. Jugular veins were cannulated
using plastic cannulae with three-way taps on day 9 of the luteal phase of the oestrous
cycle and blood samples were collected at 2h intervals from lOh before treatment on
day 10 until 48 after treatment. Between 12 and 24h after treatment blood samples were
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collected at lOmin intervals to allow the pulsatile release of LH the be measured. After
collection samples were frozen at - 20°C until assayed for FSH, LH and progesterone.
8.2.2. Ovariectomy
Anasthesia was induced using a mixture of two parts thiopentone (Intraval;
RMB Animal Health Ltd, Dagenham. Essex, U.K.) and one part pentobarbitone
sodium (Sagatal; May and Barker Ltd, Dagenham, Essex, U.K.), and if necessary
further anaesthetic mixture was injected during ovariectomy via the jugular cannula.
Ovaries were then removed through a mid - ventral meision. Within each group
ovariectomies were performed within a one hour period, with the two hourly blood
samples collected 1.5 - 2.5h before and 1.5 - 2.5h after removal of the ovaries.
8.2.3. Steroid and Inhibin Treatments
Progesterone and/or oestradiol was administered by means of hormone -
releasing silastic implants which were inserted subcutaneously at the time of
ovariectomy. The progesterone implants used in this study contained 375 mg (10%)
progesterone in a silicone elastomer (Silestrus Implants; Cevar, Southampton, U.K.).
Two such implants were inserted into each animal, a number which has been shown to
generate luteal phase progesterone concentrations (Martin et al., 1988). The oestradiol
implants used in this study were similar to those described by Goodman et al. (1981)
and were made by filling lengths of Silastic tubing (i.d. 0.132" o.d. 0.183"; Dow
Corning Silastic Medical Grade Elastomer; Hospital Management Supplies, Carnegie
Rd, Glasgow, U.K.) with oestradiol 17(3 and sealing the ends with Silastic plugs and
Silastic rubber adhesive. When incubated with agitation at 37"C, in phosphate buffered
0.9% saline containing 1% BSA, these implants released 2.1±0.1(ig/24h. Prior to use,
the implants were soaked at room temperature in distilled water over a 24h period to
dissipate surface oestradiol contamination and prevent excessive release during the
period immediately following insertion. Prior to insertion the implants were washed
several times with sterile 0.9% saline. The implants used in this study were 1 cm in
length, a size of implant that has been shown to generate luteal phase levels of
oestradiol in the peripheral circulation (Martin et al., 1988). The inhibin treatment used
in this study involved subcutaneous injections of ovine follicular fluid from a pool
which had been charcoal - stripped and passed through CI8 Sep-pak columns to
remove steroids (see Section 2.7.). In the experiment in Chapter 5 1ml injections of this
pool of oFF at 8h intervals was found to generate peripheral concentrations at the top of
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the physiological range and so in this study injections of 0.8ml oFF at 8h intervals were
used. The oFF had an inhibin bioactivity of 8.7kU/ml measured in the ovine pituitary
cell inhibin bioassay of Tsonis et al. (1986) and so the dose used represented 7kU/8h.
8.2.4. Antibody Treatments
The antibody to inhibin used in this study was raised in an ovariectomised ewe
to a synthetic peptide of the 1-26 amino acid sequence of the N - terminus of the a
chain of 32 kDa porcine inhibin (see Section 2.6) and a dose of 10ml of the antiserum
was found to give a maximum response in the study described in Chapter 6. The
oestradiol antibody was raised in an ovariectomised ewe to an oestradiol - rabbit serum
albumin conjugate (see Section 2.5), and a dose of 10ml shown to give a maximum
response in a pilot study described in Chapter 7.
8.2.5. Statistical Analysis
Progesterone concentrations were analysed using analysis of variance on
repeated samples and Duncan's multiple range test. Mean peripheral concentrations of
FSH and LF1 over the experimental period were analysed using analysis of variance on
data that had been converted to a percentage of the mean pretreatment concentration in
order to compensate for differences in initial mean group concentrations. LH pulse
characteristics were analysed using the Munro Pulse Analysis programme. The G
parameters used (the number of standard deviation units by which a peak must exceed
the baseline concentration at that time to be accepted as a pulse), G1 - G5, were 5, 3.5,
2.0, 1.5 and 1.0 standard deviation for pulses containing 1-5 samples above baseline
concentration. Differences in pulse characteristics were then compared between groups
using a student's unpaired t - test on data which had been log transformed due to large
within group variation. In the immunised animals the rise in FSH in response to
immunisation was defined to have commenced at the first point on a sequential FSH
rise with an increase in concentration over the previous sample in excess of the sum of
the assay error, and to have ended at the point where the concentration was no longer
greater than pretreatment level by more than the assay error. The assay error was
estimated from the coefficient of variation determined in a plasma pool containing
approximately the same concentration of FSH, and was defined as 2x the standard
deviation at that concentration. Characteristics of the FSH responses were compared
using a Student's unpaired t -test.
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8.3. Results
8.3.1. Plasma Hormone Binding Capacity
Following immunisation there was an increase (p < 0.001) in the ability of
plasma to bind inhibin and/or oestradiol in all the immunised animals. In the animals
immunised against inhibin, by 4h following immunisation, plasma inhibin-binding
capacity, at a dilution of 1:15, was 71.4±2.3 % (± S.E.M.) in the inhibin immunised
group (G) and 68.9±3.1% in the combined immunisation group (I) compared to a pre-
immunisation non specific binding of C5% in both groups. The binding capacity then
showed a similar steady decline (p < 0.001) over the course of the experiment in both
groups, falling 64.3±2.9 and 62.7±3.4% by 48h in the inhibin immunised (G) and
combined immunisation (I) groups respectively. In the oestradiol-immunised animals,
by 2h following antibody injection, plasma oestradiol-binding capacity, at a dilution of
1:400, was 65.4±1.3% in the oestradiol-immunised group (H) and 64.9±2.3% in the
combined immunisation group (I) compared to a preimmunisation non specific binding
of < 4% inboth groups. Like the inhibin-binding capacity, the oestradiol-binding
capacity then showed a steady decline (p < 0.001) which did not differ significantly
between the two groups, falling to 61.6±4.2 and 58.2±1.7% by 48h and in the
oestradiol-immunised (H)and combined immunisation (I) groups respectively.
8.3.2. Progesterone
The mean peripheral concentrations of progesterone in the 9 groups over the
experimental period are shown in Fig. 8.1. Prior to treatment all groups showed normal
luteal phase concentrations of progesterone, this concentration ranging from 2.7±0.7 to
3.4±0.4 ng/ml. In the Ovx group (A) there was a significant (p < 0.001) decline in the
peripheral concentration of progesterone following ovariectomy, the concentration
falling from 3.3±0.3 to 0.4±0.1ng/ml by 12h following ovariectomy. In the four
groups treated with progesterone implants (B), (C), (D) and (E) there was a small
though significant (p <0.01) decline in the peripheral concentration of progesterone
following treatment. However, in these four groups the mean concentration of
progesterone over the experimental period did not differ from that in the control group,
and was maintained above 2 ng/ml at all time points except at 48h in Group B where it
fell to 1.9±0.2ng/ml. In the control group (F) and the three immunised groups (G, H
and I) there was no significant change in the peripheral concentration of progesterone
over the experimental period.
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Mean (± S.E.M) peripheral concentration of progesterone in groups of ewes that were
either ovariectomised alone (a), ovariectomised and treated with progesterone (b),
ovariectomised treated with progesterone and treated with inhibin (c) oestradiol (d) or
oestradiol and inhibin (e), injected with control normal sheep plasma (f) or immunised













Mean (±S.E.M.) peripheral concentrations of LH as a percentage of the mean
concentration prior to treatment in groups of ewes either (a) ovariectomised
alone, (b) ovariectomised and treated with progesterone or (c) ovariectomised and
treated with progesterone and inhibin on day 10 of the luteal phase (time = Oh).
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8.3.3. Luteinizing Hormone
Before treatment there were large between group variations in the mean
peripheral LH concentration, values ranging from 1.7±0.2 to 3.5±0.4 ng/ml. As a
result of this it was necessary to convert data to a percentage of the mean pretreatment
concentration within each group to allow valid comparisons to be made between
groups.
The concentrations of LH, as a percentage of pretreament levels, in the 9
groups are shown in Figs. 8.2, 8.3 and 8.4. Following ovariectomy there was a
significant (p < 0.001) rise in the concentration of LH (Fig. 8.2a) which was not
prevented by treatment with progesterone either alone (Fig. 8.2b) or in combination
with inhibin (Fig. 8.2c). In the ovariectomised group treated with progesterone and
oestradiol (Fig. 8.3a) this rise in LH concentration was prevented, and in the group
treated with progesterone, oestradiol and inhibin (Fig. 8.3b) the rise was greatly
attenuated, only a small though significant (p < 0.05) rise being seen. However, in
both these groups the LH concentration over the experimental period did not differ
significantly from that seen in the control group (Fig. 8.3c). In the group immunised
against inhibin (Fig. 8.4a) LH concentration over the experimental period did not differ
significantly from the control group. There was a significant elevation in the
fcKe
concentration of LH iry^group immunised against oestradiol alone (Fig 8.4b; p < 0.01)
and the group immunised against oestradiol in combination with inhibin (Fig. 8.4c;
p < 0.05), and in both these groups the mean concentration of LH following treatment
was significantly (p < 0.01) higher than in the control group.
LH pulse frequency and amplitude are shown in Fig. 8.5. LH pulse frequency
in the control ovariectomised group (A) was significantly (p < 0.001) higher than in the
Control Group (F) as well as significantly (p < 0.05) higher than in the ovariectomised
groups treated with progesterone alone (B) or in combination with inhibin (C). The LH
pulse frequency was in turn significantly higher than in the control group (F) in the
ovariectomised groups treated with progesterone (B; p < 0.01) or progesterone and
inhibin (C; p < 0.05), while in the two ovariectomised groups treated with oestradiol
and progesterone, either with (E) or without (D) inhibin LH pulse frequency did not
differ significantly from the control group. In the groups immunised against inhibin (G)
oestradiol (H) or inhibin and oestradiol (I) the pulse frequency did not differ
significantly from the control group (F).
LH pulse amplitude was highly variable within groups resulting in a lack of
statistical significance between groups. LH pulse amplitude was higher in the control
ovariectomised (A) and progesterone treated - ovariectomised (B) groups than in the
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Fig. 8.3
Mean (±S.E.M.) peripheral concentrations of LH as a percentage of the mean
concentration prior to treatment in groups of ewes that were either ovariectomised,
treated with progesterone and treated with oestradiol (a) or oestradiol and inhibin
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Fig. 8.4
Mean (±S.E.M.) peripheral concentrations of LH as a percentage of the mean
concentration prior to treatment in groups of ewes immunised against (a) inhibin,














































(a) mean (±S.E.M.) LH pulse frequency and (b) mean (±S.E.M.) LH pulse amplitude
(□) and nadir ( D during the period from 12 to 24h following treatment in groups of
animals either ovariectomised alone (A), ovariectomised and treated with progesterone
(B), ovariectomised treated with progesterone and treated inhibin (C), oestradiol (D) or
oestradiol and inhibin (E), injected with control sheep plasma (F), or immunised
against inhibin (G), oestradiol (H) or oestradiol and inhibin (I) on day 10 of the luteal
phase (time = Oh). (Groups D and E n = 4; other groups n = 5).
(Note: in Group C mean LH concentration prior to treatment was significantly (p <
0.05) lower than in the other groups and so a relatively low pulse amplitude would be
expected) (@c*r$ wiAK LsWos/s s ig i
cx V> t pt O-Oj <XC p t C? ■©\ Vc-t^-5^-)
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ovariectomised group treated with progesterone and inhibin (C) pulse amplitude was
significantly (p < 0.05) lower than in groups A or B. However, in this group treated
with inhibin the mean pretreatment LH concentration was also significantly (p < 0.01)
lower than in the other two groups and so a lower pulse amplitude would be expected.
In the ovariectomised groups treated with progesterone and oestradiol with (E) or
without (D) inhibin LH pulse amplitude was similar to the control group (F). LH pulse
amplitude was elevated in the two groups immunised against oestradiol either alone (H)
or with inhibin (I) compared to the control group, though not significantly so, while in
the group immunised against inhibin alone (G) pulse amplitude was similar to the
control group (F).
8.3.4. Follicle Stimulating Hormone
Mean peripheral concentrations of FSH in the 9 groups during the experimental
are shown in Figs. 8.6 and 8.7. Due to differences in the mean pretreatment
concentration of FSH between groups, concentrations of FSH were converted to a
percentage of these pretreatment values to allow an accurate comparison to be made of
differences in response between groups, and these percentage responses are shown in
Figs. 8.8 and 8.9.
Following ovariectomy there was a significant rise in the peripheral
concentration of FSH in the control ovariectomised group (A; p < 0.001), and in the
ovariectomised groups treated with progesterone either alone (B; p < 0.001), or in
combination with inhibin (C; p < 0.001) or oestradiol (D; p < 0.05), while in the group
treated with progesterone, oestradiol and inhibin (E) there was no significant change in
the peripheral concentration of FSH (Fig. 8.6). In the control group (F) there was no
significant change in the peripheral concentration of FSH, while FSH showed a
significant rise following treatment in the inhibin immunised group (G; p < 0.001), the
oestradiol immunised group (H; p < 0.01) and the combined immunised group (I; p <
0.001) (Fig 8.7)
The magnitude of the rise in FSH concentration in the progesterone - treated
ovariectomised group (B) did not differ significantly from that seen in the control
ovariectomised group (A), the responses in both these groups differing significantly (p
< 0.001) from the control group (Fig. 8.8). In the ovariectomised groups treated with
inhibin (C) or oestradiol (D) the rises in FSH, though significantly (p < 0.001) greater
than the control group, were significantly lower than those seen in group A (p < 0.001)
or Group B (p < 0.01). In the ovariectomised group treated with inhibin and oestradiol
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Mean (± S.E.M) peripheral concentration of FSH in groups of ewes that were
either ovariectomised alone (a), ovariectomised and treated with progesterone (b)
or ovariectomised treated with progesterone and treated with inhibin (c) oestradiol
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Fig. 8.7
Mean (± S.E.M) peripheral concentration of FSH in groups of ewes treated
with (a) control sheep plasma, (b) inhibin antibody, (c) oestradiol antibody or




the groups immunised against inhibin (G) or oestradiol (H) individually the rise in FSH
concentration differed significantly (p < 0.05) from the control group (Fig. 8.9), while
the rise in FSH concentration in the combined immunisation group (I) was significantly
(p < 0.01) larger than that seen in either of the individual immunisation groups. The
time to the onset of the rise in FSH, the duration of this rise and the mean elevation of
FSH concentration over this period for the 3 immunised groups are shown in Table
8.1. The delay from immunisation to the onset of the response showed no significant
differences between groups, while the duration of the response was significantly
(p < 0.05) lower in the oestradiol immunised than in the combined immunisation
group. The magnitude of the rise was significantly larger in the combined
immunisation group than in groups immunised against inhibin (p <0.01) or oestradiol
(p < 0.001) alone.
Table 8.1 Characteristics of the FSH responses in the three immunised groups




4.0 ± 0.6 h
4.8 ± 1.0 h




18.4 ± 0.5 h
15.4 ± 0.8 h
22.8 ± 2.3 h
Over the 12h period immediately following treatment the rise in FSH
concentration in the group immunised against inhibin and oestradiol did not differ
significantly from that seen in the control ovariectomised group (Fig. 8.9) or the
ovariectomised group treated with progesterone, but was significantly (p < 0.01)
greater than that seen in the ovariectomised groups treated with inhibin or oestradiol.
Finally, the responses in FSH seen following the individual immunisations did not
differ significantly from the responses seen in the ovariectomised groups treated with
progesterone and inhibin (C) or progesterone and oestradiol (D).
8.5. Discussion
In this study we have shown that passive immunisation against either inhibin or
oestradiol during the luteal phase results in an increase in the peripheral concentration of
FSH, and that passively immunising ewes against the two hormones in combination
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two hormones are acting together in the physiological control of FSH secretion at this
time. We have also demonstrated that oestradiol and inhibin, when administered to
acutely ovariectomised ewes in "physiological" quantities, are able to maintain
peripheral FSH concentrations within a normal range. This result confirms the finding
of a similar study performed by Martin et al. (1988) in which the post - castration rise
in FSH concentration was prevented by the use of a regime of oestradiol implants and
follicular fluid injections similar to that used in this study. LH is under the dual control
of oestradiol and progesterone, and in this study the doses of oestradiol and
progesterone used were able to maintain basal LH concentrations, as well as LH pulse
frequency and amplitude within the normal physiological range following ovariectomy.
This suggests that the oestradiol implants used were supplying oestradiol at a rate
similar/\normal ovarian output. In the experiment described in Chapter 5 it was found
that a dose of lml/8h of the same pool of steroid - stripped follicular fluid as that used
in this experiment was sufficient to generate peripheral plasma concentrations of inhibin
at the top of the physiological range. This would suggest that the dose of inhibin used
in this study (i.e. 0.8ml oFF/8h) was probably appropriate. While we were unable to
measure inhibin concentrations in the plasma of the animals in this study, the fact that
the dose of inhibin used combined with an apparently physiological dose of oestradiol
to maintain normal FSH concentrations after ovariectomy would suggest that the dose
of inhibin used was approximately equivalent to normal ovarian output.
The fact that the provision of physiological quantities of oestradiol and inhibin
was sufficient to maintain peripheral FSH concentrations following ovariectomy
suggests that these two hormones are the major factors involved in the control of FSH
secretion. However, progesterone was also administered to these animals and so a role
for this hormone cannot be excluded. In the group immunised against inhibin and
oestradiol in combination, the initial rise in FSH concentration matched very closely
that seen following ovariectomy. As FSH levels showed a rise similar to the post -
castration rise in this immunised group in the presence of luteal phase progesterone
concentrations this would suggest that the action of inhibin and oestradiol can account
fully for the physiological suppression of FSH secretion, and that no other factors,
including progesterone, play a significant role in this process.
Over the 48h period following treatment the groups immunised against inhibin
or oestradiol alone showed similar responses in the concentration of FSH, while in the
two ovariectomised groups treated with either inhibin or oestradiol the degree to which
the post - castration rise in FSH secretion was suppressed was similar. These facts,
together with the fact that over the 12h period following treatment these four groups all
showed statistically similar rises in the concentration of FSH would suggest that during
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the luteal phase inhibin and oestradiol are of similar importance in the control of FSH
secretion.
The finding in this study that individual inhibin immunisations both resulted in a
rise in FSH concentration while a combined immunisation against both hormones
resulted in a significantly larger rise is similar to the result obtained when the same
approach was used in the follicular phase (Chapter 7). One difference between the two
stages of the cycle was that during the follicular phase the rise in FSH concentration
following immunisation against oestradiol resulted in a larger and more prolonged
elevation in FSH concentration (43% rise over 44h during the follicular phase
compared with 21% over 15h during the luteal phase). This is probably a reflection of
the consistently high levels of oestradiol found during the follicular phase compared
with much lower and more variable levels during the luteal phase, and suggests
oestradiol may be playing a more important role in controlling FSH secretion during the
follicular phase. This idea is supported by the fact that immunisation against inhibin,
the peripheral concentration of which shows less variation through the oestrous cycle
than oestradiol, resulted in a rise in FSH concentration in this experiment of similar
magnitude and duration to that seen following immunisation during the follicular phase.
In the experiment described in Chapter 6 immunisation against inhibin during the luteal
phase resulted in a rise in FSH concentration of greater magnitude and duration than
that seen in this experiment. This difference is difficult to explain, but may have been
the result of immunisation being carried out on day 8 of the cycle in the earlier
experiment compared to day 10 in this experiment. A further difference in the two
experiments was that the immunisation described in Chapter 6 was carried out earlier in
the breeding season than in this experiment (November compared with January). It
should, however, be noted that the differences in the magnitude of the response of FSH
to inhibin immunisation in the two luteal phase experiments was relatively small when
compared to the large differences in the responses to oestradiol immunisation between
the two stages of the cycle, and also that there was considerable overlap in both the
magnitude and duration of the response in individual animals between the two luteal
phase immunisation experiments.
In this experiment, treatment with progesterone implants which maintained
normal luteal phase progesterone concentrations had no effect on the post - castration
rise in the peripheral concentration of LH. This finding is in keeping with that ofMartin
et al. (1988) while Kars<het al. (1977) found that a similar dose of progesterone was
sufficient to prevent this rise in LH concentration. The experiment performed by Martin
et al. involved ovariectomy between days 13 and 15 of the cycle while in the
experiment of Kar&^et al. ovariectomy was performed on day 2 after oestrus.
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Oestradiol priming has been shown to increase the ability of progesterone to suppress
LH secretion (Goodman et al., 1980), and when ovariectomy was performed early in
the luteal phase the hypothalamus was probably still "sensitised" to the action of
progesterone, while later in the luteal phase this effect would have diminished resulting
in progesterone being ineffective in preventing the rise in LH secretion following
ovariectomy. In the experiment of KarscUet al. (1977) progesterone was only able to
maintain LH concentrations for 48h, supporting this suggestion. In this experiment
treatment with progesterone alone resulted in a significant decrease in LH pulse
frequency in ovariectomised ewes. Goodman & Kars^L,(1980) found a much larger
decline in LH pulse frequency, but as suggested previously, this probably was once
again due to the differences in the timing of the ovariectomies.
A feature of this experiment which requires explanation is the fact that in
ovariectomised ewes in which normal progesterone levels had been restored (Group B)
LH pulse frequency was significantly higher than that seen in the control group, while
in intact ewes in which oestradiol had been immunoneutralised no such elevation was
evident. Immunoneutralisation involves an equilibrium between bound and free
hormone, with a certain amount of free hormone invariably present. LH pulse
frequency was measured between 12 and 24h following immunisation, and it is
possible that by this time an increase in ovarian oestradiol production may have ocurred
in response to the oestradiol immunisation, increasing the amount of free oestradiol
present. This free oestradiol would then be able to enhance the ability of progesterone
to maintain LH pulse frequency, while in the ovariectomised animals treated with
progesterone virtually all oestradiol would have cleared from the circulation by this
time.
In conclusion, the results of this study indicate that the actions of oestradiol and
inhibin are sufficient to account fully for the control of FSH secretion in the ewe, and
show that during the luteal phase these two hormones may be of similar importance in
this process. The results also confirm that oestradiol and progesterone are the main
hormones involved in the control of LH secretion, and that inhibin does play any
significant role in the physiological control of LH secretion.
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Chapter 9
Passive Immunisation against Inhibin and Oestradiol
in Ewes with an Ovary Transplanted to the Neck
9.1. Introduction
The experiments on passive immunisation performed in Chapters 6, 7 and 8
have demonstrated that immunisation against inhibin and/or oestradiol results in a
marked elevation in the peripheral concentration of FSH during both the luteal and the
follicular phases of the oestrous cycle. However, in all cases this rise in FSH was
transitory, concentrations of FSH returning to those seen prior to immunisation within
17 to 29h of immunisation with antibodies against inhibin and within 40h of
immunisation with antibodies against oestradiol. In the ewes used in this experiment
one ovary and its vascular pedicle had been transplanted to a site in the neck (Goding,
et al., 1967) allowing repeated sampling of ovarian venous blood in the conscious
animal. By measuring hormone secretion rates directly from the ovary after
immunisation it was hoped that useful information could be obtained on the
compensatory mechanism causing this fall in FSH seen following the post -
immunisation rise.
Rises in the peripheral concentration of FSH following PMSG treatment (Cahill
& Dufour, 1979; McNatty et al, 1982), infusion of FSH (McNeilly, 1985; Henderson
et al., 1988) or during the "rebound" rise in FSH concentration following cessation of
bFF treatment (Henderson et al., 1986; Wallace & McNeilly, 1985) all promote follicle
growth, and result in an increase in ovulation rate if treatment is undertaken at an
appropriate time in the oestrous cycle. Cross - sectional studies have been used to
investigate the changes in follicle populations following such treatments (Dott et al.,
1979), but longitudinal studies have not been possible. In horses (Palmer, 1987) and
cattle (Pierson & Ginther, 1987a,b; Sirois & Fortune, 1988) longitudinal studies of
follicle development during the oestrous cycle have been performed using ultrasound
scanners fitted with intra-rectal probes. In the ewes used in this study an ovary was
situated under the skin in the neck in a site ideally suited to ultrasound scanning, and by
using this technique it was possible to monitor the changes in follicle populations at
different times in the same animal during the rise in FSH concentration resulting from
immunisation against inhibin and oestradiol.
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9.2. Materials and Methods
9.2.1. Experimental Procedure
The following experimental procedures were carried out during the breeding
season, in February and March, on 14 mature Finn x Merino ewes in which the left
ovary and its vascular pedicle had been transplanted to the neck in order to allow
ovarian venous blood sampling in the conscious animal (see Section 2.1). Oestrous
cycles were synchronized (see Section 2.2) and on day 9 of the luteal phase animals
cannulated (see Section 2.4) and then allocated three groups:
1. Control - 10ml normal sheep plasma (n = 5)
2. Inhibin Immunised - 10ml inhibin antibody (n = 5)
3. Oestradiol Immunised - 10 ml oestradiol antibody (n = 4)
All plasma/antibody treatments were given on day 10 of the luteal phase of the oestrous
cycle by means of a single i.v. bolus injection. Samples of jugular and timed ovarian
venous blood were collected at 4h intervals from 12h before until 48h after treatment,
and ovarian secretion rates calculated after correction for the haematocrit (Collet et al.,
1973). From 12 to 20h following treatment jugular and ovarian venous blood samples
were collected at 15 min intervals to permit monitoring of pulsatile hormone release.
Jugular samples were assayed for; FSH, LH, progesterone and inhibin while ovarian
samples were assayed for oestradiol, androstenedione and inhibin. Plasma inhibin and
oestradiol binding capacities were also determined in jugular plasma.
9.2.2. Ultrasound Scanning
The follicle populations of the animals were monitored 24h before treatment,
and at 12h intervals from treatment until the end of the experiment using a combined
sector real time ultrasound scanner (DSL 300) with a sector 7.5 MHz transducer probe
(Diagnostic Sonar, Kirkton Campus, Livingstone, Scotland). Prior to scanning the area
of skin over the ovary was clipped and scanning gel (Siel Sound Gel: Siel Imaging
Equipment Ltd, Aldermosten, Berkshire, U.K.)^The ovary was scanned in both the
vertical and horizontal planes, and the diameter of the antral cavity and the position of
all follicles > 2mm measured in the medial/lateral, dorsal/ventral and cranial/caudal
planes.
130
9.2.3. Analysis of Data
Follicle numbers at scanning were analysed on data that had been transformed
(Vx+V2) due to the presence of no follicles of a particular class at certain time points in
some animals. Peripheral hormone concentrations and ovarian hormone secretion rates
were analysed by repeated sample analysis of variance on data that had been In
transformed due to the large variation in hormone concentrations between animals.
Parameters of pulsatile hormone secretion were analysed using the Munro pulse
analysis programme and specific parameters compared using student's unpaired t -
tests. Mean rates of ovarian hormone secretion were determined by calculating the
average secretion rate over the period of intensive blood sampling from 12 to 20h after
antibody administration, and analysis was then performed on In transformed data using
a student's unpaired t - test.
9.3. Results
9.3.1. Plasma Hormone Binding Capacity
Following immunisation there was an increase (p < 0.001) in the ability of
plasma to bind inhibin and oestradiol in all the immunised animals. In the animals
immunised against inhibin, by 4h following immunisation, plasma inhibin-binding
capacity, at a dilution of 1:15, was 71.4±2.3 % (± S.E.M.) compared to a pre-
immunisation non specific binding of 7.2±0.5%. The binding capacity then showed a
steady decline (p < 0.001) over the course of the experiment in both groups, falling to
63.4±2.7% by 48h. In the oestradiol-immunised animals, by 2h following antibody
injection, plasma oestradiol-binding capacity, at a dilution of 1:400, was 74.8±2.5%
compared to a pre - immunisation non specific binding of 2.0±0.2%. Like the inhibin-
binding capacity, the oestradiol-binding capacity then showed a steady decline (p <
0.001), falling to 59.3±2.8% by 48h.
9.3.2. Follicle Numbers
During the course of the experiment there was a small though significant (p <
0.05) increase in the total number of follicles detected per ovary (Fig. 9.1.). In contrast
there was a large highly significant (p < 0.001) rise in the total number of follicles per
ovary in both treatment groups following immunisation. In the animals treated with
inhibin antibodies the total number of follicles per ovary rose from a mean of 5.5±1.0
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before immunisation to a maximum of 13.6±1.4, while in the group immunised against
oestradiol this rise was from 4.6±0.5 to 11.5±1.0. While the response seen in the
group immunised against inhibin was larger than that in the oestradiol immunised group
this difference was not significantly different. Fig 9.2 shows the proportions of small
(< 3.5 mm) medium (3.5 - 4.5 mm) and large (> 4.5 mm) follicles per ovary at the
various time periods. In the control group there was a small but significant (p < 0.05)
rise in the number of small follicles while in the two immunised groups large highly
significant (p < 0.001) rises in the number of small follicles were observed. In the
group immunised against oestradiol the rise in the total number of follicles per ovary
was due entirely to this rise in the number of small follicles while in the group
immunised against inhibin there was also a rise in the number of medium sized follicles
from 1.3±0.5 before to 3.2±1.0 by 48h after immunisation which approached statistical
significance (p < 0.07). In the control and inhibin immunised groups there were some
large follicles present at all time periods, while in the group immunised against inhibin,
none of the four ewes possessed a large follicle at 24h following immunisation.
Time Relative to Antibody Administration (h)
Fig. 9.1.
Mean (± S.E.M.) number of follicles per ovary in ewes injected at time Oh with a single
i.v. bolus of either normal sheep plasma (□ ; n = 4), inhibin antibody (o; n = 5) or
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Fig. 9.2.
Mean number of follicles per ovary with a diameter of either < 3.5 mm (E2), 3.5 - 4.5 mm
(■) or > 4.5 mm (□) in ewes injected at time Oh with a single i.v. bolus of either (a)
normal sheep plasma (n = 4), (b) inhibin antibody (n = 5) or (c) oestradiol antibody (n = 4).
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9.3.3. Peripheral Hormone Concentrations
Mean peripheral progesterone concentrations were 2.50±0.85 ng/ml in the
control group, 2.79±0.25 ng/ml in the inhibin immunised group and 3.39±0.63 ng/ml
in the oestradiol immunised groups, these concentrations being unaffected by
treatments. In the control group the peripheral concentration of FSH remained
unchanged while in the groups immunised against inhibin and oestradiol the mean FSH
concentration rose significantly (p < 0.001) following treatment (Fig. 9.3.) The rise in
FSH concentration in the group immunised against inhibin was significantly (p < 0.05)
greater than that in the oestradiol immunised group, and resulted in a mean elevation in
FSH concentration over the 24h period following immunisation, as a percentage of the
pre-immunisation concentration, of 54.1+7.4% compared to 35.2±15.6% in the
oestradiol immunised group.
In the group immunised against oestradiol there was a significant (p < 0.01) rise
in the peripheral concentration of inhibin over the 12h period following immunisation,
this rise in inhibin correlating positively with the rise in FSH seen at this time (R =
0.94; p < 0.06). Following treatment control inhibin concentrations showed no
significant changes, though there was a significant (p < 0.05) decline prior to treatment.
The characteristics of pulsatile LH secretion during the period of intensive blood
sampling from 12 to 20h are shown in Table 9.1. Due to the occurrence of only 2 LH
pulse in the animals in the control group it was not possible to produce an estimate of
Table 9.1.
LH pulse characteristics in control ewes (n = 4) and ewes immunised against inhibin
(n = 5) or oestradiol (n = 4) on day 10 of the luteal phase of the oestrous cycle. In the






Pulse Frequency /8h 0.5 1.0 1.5
(pulses/ewes) (2/4) (5/5) (6/4)
Pulse Amplitude (ng/ml) - 2.65±0.36 4.57±0.51*
Nadir (ng/ml) - 0.81±0.20 0.78±0.23













Time Relative to Antibody Administration (h)
Fig. 9.3.
Mean (±S.E.M.) peripheral plasma concentrations of FSH in groups of ewes injected at
time Oh on day 10 of the luteal phase with either (a) 10ml normal sheep plasma
(NSP; n = 4), 10ml inhibin antibody (Inh AB; n = 5) or (c) 10ml oestradiol antibody
(E2 AB; n = 4).
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LH pulse amplitude or nadir in this group, however estimates were possible in the two
immunised groups. The mean pulse amplitude was significantly (p < 0.05) higher in
the oestradiol immunised than in the inhibin immunised group, while the nadir was
similar in the two groups. While pulse frequency was highest in the oestradiol
immunised group this difference was not significant.
Time Relative to Antibody Administration (h)
Fig. 9.4.
Mean (±S.E.M.) peripheral plasma concentrations of inhibin in groups of ewes
injected at time Oh on day 10 of the luteal phase with either (a) 10ml normal sheep
plasma (NSP; n = 4) or (b) 10ml oestradiol antibody (E2 AB; n = 4)
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9.3.4. Ovarian Hormone Secretion Rates
The mean secretion rates of oestradiol, inhibin and androstenedione over the
period of intensive blood sampling, from 12 to 20h following treatment are shown in
Table 9.2. Due to the presence of antibodies to the hormones, inhibin was not
measured in the inhibin immunised group and oestradiol was not measured in the
oestradiol immunised group. The rate of oestradiol secretion in the inhibin immunised
group was higher than in the control group, this difference approaching statistical
significance (p < 0.07). The secretion rate of oestradiol in relation to peripheral LH
concentration is shown in a representative animal from both the control group and the
inhibin immunised group in Fig 9.5. The animal immunised against inhibin showed a
much larger release of oestradiol in response to the pulse of LH than the control animal.
While the mean secretion rate of inhibin over this period was higher in the oestradiol
immunised group than in the control group this difference did not prove to be
significant. The ovarian secretion rate of inhibin in the group of ewes immunised
against oestradiol showed a somewhat variable but significant (p < 0.05) rise
following antibody injection (Fig. 9.6), while the control group showed no significant
change. This rise in inhibin secretion rate was significantly correlated (R = 0.69; p <
0.05) with the peripheral concentration of FSH during the first 16h period following
immunisation (Fig. 9.7.). The mean ovarian secretion rates of androstenedione in the
two immunised groups was considerably higher than in the control group, though these
differences were not statistically significant.
Table 9.2.
Mean (±S.E.M.) rate of ovarian secretion of oestradiol, inhibin and androstenedione
during the period of intensive blood sampling from 12 to 20h following injection of
control plasma (n = 3), inhibin antibody (n = 4) or oestradiol antibody (n = 4) on day














Androstenedione 3.03±1.11 5.98±1.21 7.76±2.91
(ng/min)
(* p < 0.07, student's unpaired t - test)
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Fig. 9.5
Graph showing peripheral concentration of LH ( o) and ovarian secretion rate of
oestradiol (•) during the period of intensive blood sampling from 12 to 20h
following treatment in a representative animal selected from (a) the control group
and (b) the inhibin - immunised group. The ewes selected showed mean secretion
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Time Relative to Antibody Administration (h)
Fig. 9.6.
Mean (±S.E.M.) ovarian secretion rate of inhibin in ewes injected on day 10 of the
luteal phase at time Oh with either (a) 10ml normal sheep plasma (NSP; n = 3) or
10ml oestradiol antibody (E2 AB; n = 4).
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Fig. 9.7.
Mean peripheral concentration of FSH (°) and ovarian secretion rate of inhibin (■) in
ewes passively immunised against oestradiol at time Oh on day 10 of the luteal phase of
the oestrous cycle (n = 4).
9.4. Discussion
The rise in FSH concentration following immunisation resulted in a marked
stimulation of follicle growth within 12h. The small rise in the number of follicles in the
control group was probably, at least in part, an experimental artifact resulting from an
increased familiarity with the ovaries as progressive scans were performed. Waves of
follicle growth and regression occur throughout the oestrous cycle (Smeaton &
Robinson, 1971; Mattner & Braden; 1972), and it is also possible that the rise in follicle
number in the control group could have resulted from some animals in this group being
in the rise phase of one of these waves. The rises in follicle number in the two
immunisation groups were, however, significantly (p < 0.001) greater than in the
control group demonstrating them to be a real effect of treatment. In the inhibin
immunised animals there was a rise in the number of both small and medium sized
follicles. This suggests that the rise in FSH had stimulated a new cohort of small
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follicle with diameters below the sensitivity of the scanning procedure (< 2mm) to
develop to sizes of up to 3.5 mm, as well as stimulating some of the follicles of up to
3.5 mm diameter present at the start of the experiment to develop to a diameter of 3.5 to
4.5 mm. In the oestradiol immunised group an increase in the number of small follicles
was seen, but there was no increase in the number of medium sized follicles, and at 24h
following treatment there were no large follicles present in this group. In this group the
mean LH pulse amplitude was significantly (p < 0.05) higher than in the inhibin
immunised group. This finding suggests that these high amplitude LH pulses had
inhibited follicle development above a diameter of 3.5mm, a finding in keeping with
Picton (1989), who also found that high amplitude LH pulses inhibited follicle
development in FSH - stimulated GnRH suppressed ewes.
In both immunised groups there was a significant, though transitory rise in the
concentration of FSH following treatment, this rise in FSH concentration lasting
approximately 24h in both groups. This increase in FSH concentration was
significantly (p < 0.05) larger in the inhibin immunised group than in the oestradiol
immunised group, this fact possibly reflecting the low concentrations of oestradiol
found during the luteal phase of the sheep oestrous cycle (Baird & McNeilly, 1981). In
both groups the compensatory fall in FSH concentration was occurring during the
period of rapid blood sampling from 12 to 20h following treatment, and so if changes
in ovarian hormone secretion were involved in this compensatory mechanism they
should be in evidence at this time. FSH has been shown to stimulate inhibin secretion
(McNeilly et al., 1989), and in the group immunised against oestradiol there was a
significant rise in the secretion rate of inhibin at this time of elevated FSH
concentration. In the sheep, small follicles have been shown to produce significant
amounts of inhibin (Chapter 4), and so this rise in inhibin secretion was probably partly
due to the large number of small follicles stimulated to develop in this group. Inhibin
secretion by granulosa cells has been shown to be responsive to stimulation by FSH
(Bicksak et al., 1986; Suzuki, et al., 1987), and so this rise in inhibin secretion may
also have resulted from an increase in inhibin secretion from those larger follicles
already present in the ovary, and an increase in secretion from these larger follicles
might have been responsible for the increase in peripheral inhibin concentration seen in
the oestradiol immunised group immediately after treatment. The elevated secretion rate
of inhibin, at the time when FSH levels were declining, provides evidence that an
increase in the secretion rate of inhibin is involved in the compensatory fall in FSH seen
following the post - oestradiol immunisation rise. It seems likely that the FSH -
stimulated increase in follicle development results in an increase in follicular inhibin
secretion which in turn exerts negative feedback on the pituitary resulting in the decline
141
seen in the secretion of FSH. Due to the acutely pulsatile nature of oestradiol release,
and the infrequency of LH pulses during the luteal phase it is hard to demonstrate a rise
in oestradiol secretion at this time. However, in the animal immunised against inhibin
the mean secretion rate of oestradiol over the period of intensive blood sampling from
12 to 20h was higher than in the control group, though this differences was only
marginally significant (p < 0.07). This finding does, however, suggest that there was
an increase in the secretion rate of oestradiol during the period of compensation in FSH
concentration following inhibin immunisation. As well as increases in inhibin secretion
in response to oestradiol immunisation and oestradiol secretion in response to inhibin
immunisation it is probable that immunisation against each hormone results in an
increase in its own secretion rate. This idea is supported by the fact that active
immunisation against androstenedione results in a large increase in the rate of secretion
of the hormone (Campbell et al., 1990c). The mean secretion rates of androstenedione
during the period of intensive blood sampling from 12 to 20h following treatment in the
two immunised groups were approximately double that seen in the control group.
While this difference was not significant, the mean androstenedione secretion rate in the
two immunised groups in this study were also double the luteal phase secretion rate
found in another study performed on these animals during the previous year (Campbell
et al., 1990a). This suggests that the increase in the number of follicles > 2mm
following passive immunisation against inhibin or oestradiol does result in an increase
in the ovarian secretion rate of androstenedione.
The results of this study demonstrate that the elevation in the concentration of
FSH resulting from passive immunisation against inhibin or oestradiol results in a large
increase in the number of follicles > 2mm per ovary. The results also show that inhibin
secretion rises in response to oestradiol immunisation, and that oestradiol secretion
tends to rise following inhibin immunisation in order to maintain normal plasma FSH
concentrations. This finding provides further evidence for the theory that inhibin and




10.1. The Source of Ovarian Inhibin Production
The aim of the experiments carried out in Chapters 3 was to determine the
ovarian source of inhibin in the ewe and in particular to try and clarify the ambiguity
that exists over the role of the corpus luteum in inhibin production in the sheep. The
ovarian follicles are now widely accepted as a major source of inhibin production in the
sheep, and in this study the secretion of inhibin was found to be significantly higher
from ovaries with large (> 3mm) antral follicle than from contralateral ovaries with only
small (< 3mm) follicles. In this study the secretion rate of inhibin into the ovarian vein
was found to be unaffected by the presence or absence of a corpus luteum in the ovary.
Following enucleation of the corpora lutea the expected marked fall in the secretion rate
of progesterone was seen, while inhibin secretion showed a much smaller fall, of
similar magnitude to that seen in the secretion rate of oestradiol which is only produced
by the follicles. This fall in the secretion rate of inhibin and oestradiol could be
accounted for by the trauma of enucleation and the effects of anaesthesia and so these
finding demonstrate that in the sheep, the corpus luteum does not secrete inhibin. In an
earlier study Tsonis et al. (1988a) demonstrated that inhibin secretion was higher from
ovaries containing luteal tissue and that this secretion declined following luteal
regression, suggesting that, as in the rat and human, the corpus luteum of the sheep
secretes inhibin. However, in this study samples were collected from both control ewes
and ewes which had been immunised against androstenedione. As such immunisation
increases both ovulation rate and the secretion rate of inhibin (Campbell et al., 1988),
an over - representation of immunised animals in the samples from ovaries with corpora
lutea presumably affected the results in this study. This lack of inhibin production by
luteal tissue is supported by two studies in which attempts to demonstrate mRNA for
inhibin in ovine and bovine luteal tissue were unsuccessful (Rodgers et al., 1989;
Torney et al., 1989), and by Henderson & Franchimont (1981) who failed to show
inhibin production from cultured bovine luteal cells.
While it now appears that the follicles are the only major source of ovarian
inhibin production, there is a lack of knowledge on inhibin production from follicles at
different stages of development. In Chapter 4 inhibin production was measured in
individual follicles collected at various stages of the oestrous cycle. In agreement with
other studies inhibin production was found to increase with increasing follicle diameter
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and to be higher in oestrogenic than in non oestrogenic follicles. However, compared to
oestradiol, which is produced almost exclusively by the largest one or two healthy
antral follicles, a larger proportion of inhibin was produced by smaller antral follicles
and by large non - oestrogenic atretic follicles, which together accounted for almost half
of the total inhibin production. When oestradiol production from follicles was examined
separately at different stages of the oestrous cycle more oestrogenic follicles were found
during the early and mid stages of the follicular phase than during the late follicular
phase or the luteal phase. In contrast, the number of follicles with high inhibin
production was similar at all stages of the cycle. It appears, therefore, that while the
level of oestradiol secretion by the ovary reflects the development of large oestrogenic
follicles, the amount of inhibin the ovary secretes is more closely related to the total
population of large antral follicles. This finding provides an explanation for the fact that
inhibin shows less marked fluctuations during the oestrous cycle than oestradiol.
10.2. The Physiological Role of Inhibin
Inhibin is defined as a selective suppressor of FSH secretion, though in a
number of studies high doses of inhibin have been shown to affect the secretion of LH
in the sheep. In Chapter 5 a dose of inhibin approximately equivalent to normal ovarian
output was shown to suppress FSH secretion in oestradiol benzoate - treated
ovariectomised ewes while having no effect on the degree of LH suppression or on the
characteristics of the LH surge which was induced by the oestradiol treatment. In the
experiments described in Chapters 6-9 passive immunisation against inhibin had no
effect on the peripheral concentration of LH during either the luteal or the follicular
phase of the oestrous cycle. Furthermore, in the experiment described in Chapter 8,
treatment with a dose of inhibin approximately equivalent to normal ovarian output had
no effect on the rise in the concentration of LH seen following acute ovariectomy.
These results support the idea that in studies where inhibin has been shown to have an
effect on LH secretion, this was a pharmacological effect resulting from the use of
amounts of inhibin far in excess of those seen in physiological situations. It would
seem from the results presented in this study, therefore, that inhibin plays little if any
role in the physiological control of LH secretion in the ewe.
The fact that passive immunisation against inhibin results in a marked rise in
FSH secretion during both the luteal and the follicular phases of the oestrous cycle
provides strong evidence that inhibin does play an important physiological role in the
control of FSH secretion in the ewe. In Chapter 8, it was shown that doses of inhibin
or oestradiol, estimated as approximately equivalent to normal ovarian output, were
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each able to partially prevent the post - castration rise in FSH concentration in the ewe,
while a combination of the two treatments was sufficient to completely prevent this rise.
This result confirms the similar findings of Martin et al. (1988), and suggests that
inhibin and oestradiol act together in the control of FSH secretion. This interaction of
inhibin and oestradiol is further supported by the observation that passive immunisation
against either hormone results in a moderate rise in the peripheral concentration of FSH,
while a combined immunisation against both hormones results in a significantly larger
increase in FSH concentration. In Chapter 8 immunisation against inhibin and
oestradiol in combination was shown to cause a rise in the peripheral concentration of
FSH similar to that seen following acute ovariectomy. This finding adds weight to the
idea that inhibin and oestradiol act together in the control of FSH secretion, and
suggests that inhibin and oestradiol are the only two hormones with an important role in
the control of FSH secretion in the ewe.
Following luteal regression, during the early to mid follicular phase of the sheep
oestrous cycle, there is an increase in the ovarian secretion rate of oestradiol, resulting
from an increase in the production of oestradiol by the preovulatory follicle(s). This rise
in oestradiol secretion is thought to be important in causing the decline seen in FSH
concentration at this time which is, in turn, thought to be responsible for regulating the
number of preovulatory follicles which develop to ovulation. In Chapter 3 the ovarian
secretion rate of inhibin showed little change during this period while the secretion rate
of oestradiol was significantly elevated. This finding, combined with the lack of
variation in the pattern of inhibin production by individual follicles at different stages of
the oestrous cycle and the relatively high level of inhibin production by large non -
oestrogenic follicles shown in Chapter 4, suggests that inhibin does not play a major
role in causing this decline in the secretion of FSH.
Active immunisation against oestradiol results in an increase in the peripheral
concentration of FSH, and an increase in follicular development, though ovulation does
not occur due to failure of oestradiol to induce a preovulatory LH surge (Martenz et al.,
1979). In a number of studies, active immunisation of ewes against inhibin has been
shown to cause an increase in ovulation rate. However, in these studies the expected
increase in FSH concentration has been small and variable, or not detected. The reason
for this lack of a detectable increase in the peripheral concentration in FSH is not
known, but could result from a compensatory increase in the secretion of inhibitory
substances by the ovary necessitating more acute monitoring of FSH concentrations.
The passive immunisation studies reported in this thesis show that immunisation against
inhibin does result in an increase in the peripheral concentration of FSH, but that this
rise is transitory. This suggests that some form of compensation does occur to maintain
145
normal concentrations of FSH. In Chapter 9 this compensatory mechanism was
investigated. Immunisation against inhibin or oestradiol resulted in a large increase in
the number of follicles per ovary. In the animals immunised against inhibin there was
an increase in the secretion rate of oestradiol, while in the animals immunised oestradiol
there was an increase in the secretion rate of inhibin. These finding suggest that inhibin
and oestradiol are, to some extent, interchangeable in the control of FSH secretion, and
suggest that the two hormones are acting together to regulate the peripheral
concentration of FSH.
10.3. Conclusions
From the data presented in this thesis it can be concluded that, in the sheep, the
main source of inhibin is the large antral follicles, and that the corpus luteum secretes
little, if any, immunoactive or bioactive inhibin. Furthermore, the results demonstrate
that compared to their small contribution to total oestradiol production, small antral and
large non - oestrogenic follicles produce large quantities of inhibin, this more even
distribution of follicle inhibin production being reflected in relatively small variations in
ovarian inhibin secretion during the oestrous cycle. The results of this study also
suggest that inhibin has no major role in the physiological control of LH secretion in the
ewe, supporting the definition of inhibin as a selective suppressor of FSH. The passive
immunisation studies show that inhibin has an important role in the control of FSH
secretion, and together, the results of these studies demonstrate that inhibin and
oestradiol act together in the control of FSH secretion in the ewe. It seems most
probable that the changes in FSH concentration occurring during the oestrous cycle,
which control follicle selection and ovulation rate, result mainly from changes in the
secretion of oestradiol, while inhibin, with its much longer half life, combines with












Phosphate Citrate Buffer (PCB)
17.85 g Na2HP04.2H20
7.75 g citric Acid
0.1 g thiomersalate
11 deionised water








Buffer - PCB + 0.1% gelatin (PCBG), pH 6.0.
Day 1 - 50 fil sample +-100 (0.1 buffer
or 100 |il standard + 50 p.1 ovx plasma
100 (il antibody (Anti Progesterone 361 at 1:10000)
100 p.1125I tracer (15000 cpm in PCB + lmg/ml ANS)
Incubate overnight at 4°C
Day 2 - 1ml 0.9% saline + 15% PEG then spin at 2000g for 30 min at 4°C
Aspirate supernatant and count precipitate.
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11.1.3. M91/1 FSH Assay
Buffer - PBS + 1.0% BSA, pH 7.4
Day 1 - 100 |il sample/standard
300 |il buffer
100 |il antibody (M91/1; 1:5000 in special buffer - PBS +o£?,NRS)
Incubate for 1 day at 4°C
Day 2 - 100 p.1125I tracer (15000 cpm)
Incubate for 1 day at 4°C
Day 3 - 100 *ilDARS (1:16 in PBS + 4% dextran)
Incubate overnight at 40C
Day 4 - 0.7 ml PBS + 5% PEG then spin at 2000g for 30 min at 4°C
Aspirate supernatant and count precipitate.
11.1.4. NIAMMD - I - 1 FSH Assay
Buffer - PBS + 1.0 % BSA, pH 7.4.
Day 1 - 150 |il sample/standard
150 [il buffer
50 nl antibody (NIAMMD - oFSH -1 - 1 at 1:12000)
Incubate for 1 day at 4°C
Day 2 - 50 pi 125I tracer (15000 cpm)
Incubate for 1 day at 4°C
Day 3 - 100 [L\ DARS (5257M 1:32)
100 Hi NRS (5106L 1:800)
Incubate overnight at 4°C
Day 4 - 1ml 0.9% saline then spin at 2000g for 30 min at 4"C
Aspirate supernatant and count precipitate.
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11.1.5. LH Assay
Buffer - PBS +0.1% BSA, pH 7.4.
Day 1 - 100 |il sample/standard
200 pi buffer
100 pi antibody (And oLH R29 at 1:120000)
Incubate for 1 day at 4°C
Day 2 - 100 pi125I tracer (15000 cpm)
Incubate for 1 day at 4°C
Day 3 - 100 pi DARS (5257M 1:16; 5104L 1:32)
100 nl NRS (5106L 1:800)
Incubate overnight at 4°C
Day 4 - 1ml 0.9% saline then spin at 2000g for 30 min at 4°C
Aspirate supernatant and count precipitate.
11.1.6. Inhibin Assay
Buffer - PBS + 1.0% BSA, pH 7.5.
Plasma Medium
Day 1 - 200 |il sample + 100 pi buffer 50 |il sample/standard
100 pi standard + 200 |il ovx plasma 250 pi buffer
100 pi antibody (Anti 1 - 26a R150 at 1:15000)
Incubate for 1 day at 4°C
Day 2 - 100 pi 125I tracer (15000 cpm)
Incubate for 1 day at 4°C
Day 3 - 100 pi DARS (5257M 1:40)
100 pi NRS (5162L 1:500)
Incubate overnight at 4°C
Day 4 - 1ml 0.9% saline then spin at 2000g for 30 min at 4°C
Aspirate supernatant and count precipitate.
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11.1.7. Oestradiol Assay
Buffer - PBS + 0.1% gelatin (PBSG), pH 7.2.
Extraction - 100 JJ.1 sample/standard + 1ml diethyl ether (AnalR) to 75 x 12 glass tubes
Vortex for 2 x 30 seconds. Freeze in dry ice/ethanol bath
Decant ether extract into 75 x 10 mm glass tubes
Dry down in heating block (40°C) under gas (N2)
Plasma Extraction Assay Medium Assay
Day 1 - 200 |il antibody (anti E2 BW at 1:2000000) 100 |il sample/standard
200 |ll i25! tracer (15000 cpm) 100 |ll buffer (PGBS)
100 ^il antibody (1:1000000)
100 |il 125I tracer (15000 cpm)
Incubate overnight at 4°C
Day 2 - Place tubes on ice and add 500 |il PGBS +0.125% dextran + 1.25% charcoal
Vortex and leave on ice for 10 min
Centrifuge at 2000g for 10 min at 4°C
Decant supernatant into LP3 plastic tubes and count
11.1.8. Androstenedione Assay
Buffer - PBS + 0.25% BSA, pH 7.4.
Extraction - 200 |il sample/standard + 2ml 4:1 hexane:diethyl ether to 75x12 glass tubes
Vortex for 2 x 60 seconds then freeze in dry ice/ethanol bath
Decant ether extract into 75 x 10 mm glass tubes
Dry down in heating block (40°C) under gas (N2)
Plasma Extraction Assay Medium Assay
Day 1 - 200 jil antibody (anti A4 at 1:56000) 100 |il sample + 100 |il buffer
200 |il 125I tracer (10000 cpm) (PBS + 0.25% BSA)
or 200 p.1 standard
100 jj.1 antibody (1:28000)
100 jj.1 125I tracer (10000 cpm)
Incubate overnight at 4"C
Day 2 - 200 jj.1 DARS (5257M 1:40) + 200 jj.1 NRS (5162L 1:500)
Incubate overnight at 4°C
Day 3 - Spin at 2000g for 45 min at 4°C and aspirate supernatant and count precipitate
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